data_2n4x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n4x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 156' ' ' MET . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.582 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.478 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.429 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.421 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.621 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.621 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.496 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.582 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.514 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 127' ' ' ILE . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 135' ' ' ASN . 0.3 OUTLIER -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.475 ' H ' HD21 ' A' ' 144' ' ' LEU . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.415 ' O ' ' CD1' ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.573 ' N ' ' CD1' ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.474 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.666 0.27 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.809 0.338 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CB ' ' O ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.572 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 85' ' ' SER . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.613 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.613 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.625 ' CD1' ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.625 ' H ' ' CD1' ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.595 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 119' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CZ ' ' CE2' ' A' ' 142' ' ' TYR . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 135' ' ' ASN . 16.4 p30 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.514 ' OG1' ' CE ' ' A' ' 170' ' ' LYS . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 150' ' ' ILE . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.402 ' CB ' ' O ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.497 HE22 ' NH1' ' A' ' 169' ' ' ARG . 8.8 mm100 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 168' ' ' ILE . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.497 ' NH1' HE22 ' A' ' 166' ' ' GLN . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 177' ' ' LEU . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.518 ' CB ' ' HH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' ALA . 7.5 t . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.418 ' H ' HD23 ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.6 ' CD1' HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 35.3 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.495 0.188 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.6 HH21 ' CD1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.659 ' HZ3' ' HG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NE ' ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 96' ' ' SER . 90.3 m95 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 116' ' ' LEU . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.424 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.535 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.561 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.561 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.454 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.648 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.648 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 165' ' ' PHE . 2.3 t-20 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.523 ' H ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 168' ' ' ILE . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.659 ' HG1' ' HZ3' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 122' ' ' PHE . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.623 0.249 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.405 ' HG ' ' CG2' ' A' ' 153' ' ' VAL . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' PHE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 91.0 m95 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.415 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.604 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 116' ' ' LEU . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 119' ' ' ILE . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.625 ' CZ ' ' CE1' ' A' ' 142' ' ' TYR . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 126' ' ' ALA . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.432 ' N ' HG23 ' A' ' 125' ' ' ILE . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 125' ' ' ILE . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.446 ' CD1' ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.446 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 138' ' ' VAL . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.405 ' CG2' ' HG ' ' A' ' 11' ' ' SER . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.441 ' CD1' ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.434 ' N ' HG23 ' A' ' 175' ' ' ILE . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 120.521 0.201 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.497 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 44' ' ' ILE . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.393 0.616 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.436 ' O ' ' OG ' ' A' ' 77' ' ' SER . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.556 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' LYS . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.447 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.459 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.429 ' O ' ' SD ' ' A' ' 65' ' ' MET . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.608 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' CE2' ' OH ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 126' ' ' ALA . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.404 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.497 ' HH ' ' CB ' ' A' ' 181' ' ' ALA . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.62 ' HG1' ' HZ2' ' A' ' 170' ' ' LYS . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' HZ2' ' CB ' ' A' ' 155' ' ' LYS . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 169' ' ' ARG . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.408 ' H ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.62 ' HZ2' ' HG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.497 ' CB ' ' HH ' ' A' ' 142' ' ' TYR . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 7.5 p . . . . . 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.501 0.667 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.413 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE2' ' OG ' ' A' ' 45' ' ' SER . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.431 ' O ' ' OG ' ' A' ' 77' ' ' SER . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 74' ' ' ILE . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 84' ' ' VAL . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.579 ' HZ2' ' CD1' ' A' ' 86' ' ' ILE . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.588 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CD1' ' HZ2' ' A' ' 83' ' ' LYS . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 92' ' ' THR . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 89' ' ' SER . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 94' ' ' GLY . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 93' ' ' SER . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 97' ' ' TRP . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.618 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.522 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.55 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.498 ' H ' ' HG ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.508 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.583 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.555 ' C ' HE21 ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.536 0.208 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.48 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.456 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.504 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 94' ' ' GLY . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.4 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.511 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 118' ' ' ALA . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.617 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.617 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' SER . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 141' ' ' SER . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 137' ' ' LEU . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.442 ' CB ' ' HZ3' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.459 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.413 ' OD1' ' CG1' ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HZ1' ' CB ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.437 ' CG2' ' CD1' ' A' ' 115' ' ' TRP . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.463 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.577 0.227 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.601 0.239 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.463 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.546 0.212 . . . . 0.0 111.491 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.65 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' A' ' 89' ' ' SER . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.633 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.633 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.958 0.408 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.439 ' O ' ' OG ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.423 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.45 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.502 ' OG1' ' CB ' ' A' ' 170' ' ' LYS . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.428 ' H ' ' CG1' ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' ALA . 3.8 m120 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 1.7 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 169' ' ' ARG . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.403 ' N ' HG23 ' A' ' 168' ' ' ILE . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.502 ' CB ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 175' ' ' ILE . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.4 ' H ' HD22 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.645 0.259 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 156' ' ' MET . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.463 HD11 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' HD11 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.579 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 39' ' ' VAL . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 48' ' ' ILE . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' N ' ' C ' ' A' ' 49' ' ' LEU . 73.3 t80 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 74' ' ' ILE . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.722 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.722 ' H ' ' HG ' ' A' ' 96' ' ' SER . 21.0 m-90 . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.59 ' CG ' ' SD ' ' A' ' 109' ' ' MET . 11.7 m-85 . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 109' ' ' MET . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD21 ' H ' ' A' ' 114' ' ' LEU . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.579 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.57 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.507 ' SD ' ' OE1' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.451 ' H ' ' CG1' ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.288 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 11' ' ' SER . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 8' ' ' GLY . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 11' ' ' SER . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 16' ' ' ALA . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HG1' ' N ' ' A' ' 44' ' ' ILE . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' N ' ' HG1' ' A' ' 43' ' ' THR . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.572 0.701 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.402 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 75' ' ' LEU . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HZ2' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 86' ' ' ILE . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.471 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 110' ' ' LEU . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.585 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' ILE . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 142' ' ' TYR . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 125' ' ' ILE . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 139' ' ' MET . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CE1' ' CE2' ' A' ' 122' ' ' PHE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.516 ' CD1' ' HZ2' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.508 ' HG1' ' N ' ' A' ' 173' ' ' GLY . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.508 ' N ' ' HG1' ' A' ' 172' ' ' THR . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.578 ' HG ' ' N ' ' A' ' 12' ' ' VAL . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 ' N ' ' HG ' ' A' ' 11' ' ' SER . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t . . . . . 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.517 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.478 ' C ' ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.694 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.765 0.793 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.694 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.464 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.44 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' SER . 5.7 m-90 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 CA--C 1.527 0.067 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 119' ' ' ILE . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.56 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.468 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.468 ' OH ' ' O ' ' A' ' 122' ' ' PHE . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 16.0 mm100 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 174' ' ' ALA 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.517 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.728 0.299 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 16' ' ' ALA . 3.9 p . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.52 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.417 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 92' ' ' THR . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 89' ' ' SER . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.152 0.501 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.575 ' CZ ' ' SD ' ' A' ' 109' ' ' MET . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.597 ' O ' ' O ' ' A' ' 118' ' ' ALA . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.429 ' H ' ' HG2' ' A' ' 121' ' ' PRO . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 166' ' ' GLN . 0.1 OUTLIER 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.497 ' N ' HD21 ' A' ' 164' ' ' ASN . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.692 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.1 OUTLIER -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' ALA . 1.3 t . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' GLY . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.361 0.124 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD1' ' CZ ' ' A' ' 113' ' ' PHE . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.659 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.659 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.529 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' ALA . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 131' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 150' ' ' ILE . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' MET . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.403 ' CG2' ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.524 0.202 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.429 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 HD11 ' HE ' ' A' ' 61' ' ' ARG . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.037 0.446 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.686 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.495 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.686 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.495 ' CD1' ' O ' ' A' ' 92' ' ' THR . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 118' ' ' ALA . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.431 ' O ' ' OG1' ' A' ' 130' ' ' THR . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.51 ' HG1' ' N ' ' A' ' 131' ' ' LEU . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.51 ' N ' ' HG1' ' A' ' 130' ' ' THR . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.579 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.556 ' HA ' ' HZ1' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.476 ' CD2' ' C ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.556 ' HZ1' ' HA ' ' A' ' 149' ' ' THR . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.441 ' CD1' ' C ' ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.534 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.521 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.642 0.258 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.804 0.335 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.601 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.601 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.454 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.406 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.5 ' H ' ' HG ' ' A' ' 96' ' ' SER . 31.1 m0 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 112' ' ' ALA 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' H ' ' HD2' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.433 ' O ' ' OG ' ' A' ' 128' ' ' SER . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 125' ' ' ILE . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.429 ' O ' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.415 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.533 ' HG1' ' N ' ' A' ' 173' ' ' GLY . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.533 ' N ' ' HG1' ' A' ' 172' ' ' THR . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 3' ' ' MET . 45.2 mt-30 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.08 24.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.467 ' H ' ' C ' ' A' ' 1' ' ' GLN . 19.1 ptt? -159.34 -8.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.589 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 156' ' ' MET . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.5 121.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -48.55 -45.99 69.88 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.857 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 16.5 Cg_exo -67.46 -18.63 49.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.238 1.959 . . . . 0.0 110.862 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 17' ' ' VAL . 13.5 p 40.57 26.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.623 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' LEU . 14.4 p -45.55 134.65 6.04 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' VAL . 42.5 Cg_exo -33.75 88.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.263 1.975 . . . . 0.0 112.015 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' VAL . 10.7 tp -138.21 -54.77 0.64 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.636 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -92.2 17.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 48.54 14.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -93.25 -135.58 0.17 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.075 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.14 170.43 38.13 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.3 t -167.18 58.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -163.85 174.94 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.582 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.478 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 -114.58 -81.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 53' ' ' ALA . 7.5 t -171.12 79.45 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.947 0.403 . . . . 0.0 111.116 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -42.07 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.521 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 53' ' ' ALA . 1.4 t 79.17 10.35 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.538 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.06 53.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -145.45 -99.47 0.1 Allowed 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.34 0.59 . . . . 0.0 109.472 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 -155.34 50.65 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.65 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.429 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.421 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.621 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.621 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.489 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -47.13 124.98 7.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -156.24 -70.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.48 18.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.911 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -173.11 63.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.958 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.3 m -95.81 155.96 16.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.965 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.401 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -100.62 104.07 28.39 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.349 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.27 113.73 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.932 1.755 . . . . 0.0 112.412 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -170.88 -128.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.42 44.32 1.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 43.14 60.53 2.5 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.496 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.582 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.569 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.514 ' CD1' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.514 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 127' ' ' ILE . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 135' ' ' ASN . 0.3 OUTLIER -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.475 ' H ' HD21 ' A' ' 144' ' ' LEU . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.421 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.421 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.415 ' O ' ' CD1' ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.573 ' CD1' ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.573 ' N ' ' CD1' ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.474 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 186' ' ' THR . . . -35.22 103.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.636 ' H ' ' CD2' ' A' ' 185' ' ' LEU . 1.9 pt? -68.05 38.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.509 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 184' ' ' ALA . 3.7 t -154.9 160.8 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.651 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 189' ' ' LEU . 48.7 mt-10 66.59 -144.17 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.016 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 49.5 5.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.229 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 187' ' ' GLU . 1.9 mm? -100.43 -77.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 190' ' ' LEU . 3.2 mm? 55.5 -79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LEU . 4.0 mm? -52.79 114.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.213 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.549 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 4' ' ' ALA . 13.7 mt 46.9 -149.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.642 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp 70.53 -45.35 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 2' ' ' LEU . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' H ' ' A' ' 18' ' ' LEU . 3.6 p -56.77 -166.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.492 ' H ' HG23 ' A' ' 17' ' ' VAL . 8.3 tp -86.21 -62.04 0.25 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 20' ' ' VAL . 15.4 Cg_endo -54.99 -47.0 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.978 1.785 . . . . 0.0 113.162 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 19' ' ' PRO . 25.9 m 45.04 121.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 94.6 t 118.16 -40.07 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.952 1.301 . . . . 0.0 111.492 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 60.2 Cg_endo -79.78 12.99 2.24 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.138 1.225 . . . . 0.0 113.253 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -164.43 -3.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 26' ' ' ALA . 2.8 mt -148.32 136.82 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.74 70.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -152.58 -160.22 1.11 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.63 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.55 156.32 32.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.111 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -137.13 47.78 2.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.85 177.07 8.48 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 -129.39 81.98 2.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p 44.86 -122.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -178.11 -48.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.5 t 49.57 -86.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.367 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -158.46 49.59 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.858 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.05 -92.29 0.13 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.416 0.627 . . . . 0.0 110.396 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -148.2 39.98 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.318 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CB ' ' O ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.496 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.572 ' HG ' ' N ' ' A' ' 86' ' ' ILE . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 85' ' ' SER . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.613 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.449 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.613 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.625 ' CD1' ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.625 ' H ' ' CD1' ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 39.68 93.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -96.48 -53.41 3.6 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.892 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 101' ' ' THR . 12.5 tt -77.72 171.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.482 ' N ' ' CG1' ' A' ' 99' ' ' ILE . 14.7 pt20 36.83 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -38.38 136.42 0.67 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.04 126.33 85.61 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.049 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.45 -98.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.837 1.691 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 105' ' ' PHE . 41.9 t 42.03 -128.2 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.551 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 5.3 m-30 -60.97 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.578 0.704 . . . . 0.0 109.336 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 81.3 m-85 -163.41 65.04 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.595 ' O ' ' CE1' ' A' ' 113' ' ' PHE . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 119' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CZ ' ' CE2' ' A' ' 142' ' ' TYR . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 135' ' ' ASN . 16.4 p30 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.514 ' OG1' ' CE ' ' A' ' 170' ' ' LYS . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 150' ' ' ILE . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.402 ' CB ' ' O ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.497 HE22 ' NH1' ' A' ' 169' ' ' ARG . 8.8 mm100 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.497 ' NH1' HE22 ' A' ' 166' ' ' GLN . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 177' ' ' LEU . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' H ' HD13 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.518 ' CB ' ' HH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 185' ' ' LEU . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 185' ' ' LEU . . . 43.0 -96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 187' ' ' GLU . 57.2 tp 134.29 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.731 1.269 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' A' ' 185' ' ' LEU . 14.8 t 50.94 -9.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.608 ' H ' ' C ' ' A' ' 185' ' ' LEU . 7.6 tp10 -174.41 149.93 1.39 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.128 0.422 . . . . 0.0 111.115 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.8 t -111.44 -86.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.42 -166.43 1.28 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.83 -86.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.243 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? 55.69 -109.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.492 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -84.71 -6.16 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 109.851 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt -88.18 -33.35 18.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 7.5 t -43.78 168.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 8.3 mp -74.72 -70.66 0.23 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.747 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.13 -40.38 77.23 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.238 1.959 . . . . 0.0 113.783 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 19' ' ' PRO . 27.8 m 35.01 28.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 117.724 0.238 . . . . 0.0 111.566 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 19' ' ' PRO . 4.4 m -47.5 140.29 7.71 Favored Pre-proline 0 C--O 1.218 -0.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' VAL . 45.6 Cg_exo -31.36 84.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.504 2.136 . . . . 0.0 113.841 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -148.54 1.63 0.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.268 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.68 21.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 43.94 50.17 7.13 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.58 -160.21 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.263 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.21 171.94 48.66 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -155.04 153.83 31.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.698 0.285 . . . . 0.0 110.306 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.75 -50.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.418 ' H ' HD23 ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.6 ' CD1' HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 100.4 62.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -37.09 136.65 0.4 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.294 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.62 0.38 57.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.032 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m 43.12 41.69 2.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.674 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.72 22.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.506 ' O ' ' CD1' ' A' ' 57' ' ' PHE . 21.7 m-85 -125.45 -101.01 0.38 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.241 0.543 . . . . 0.0 110.079 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 35.3 m-85 -154.32 47.31 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.798 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.6 HH21 ' CD1' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.659 ' HZ3' ' HG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NE ' ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.524 ' CE3' ' O ' ' A' ' 100' ' ' GLN . 90.3 m95 -41.82 -95.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 75.65 -40.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -89.99 -82.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.87 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CE3' ' A' ' 97' ' ' TRP . 23.0 tm0? -95.08 102.89 14.73 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 102' ' ' LEU . 12.6 t 179.93 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.96 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' N ' ' CG2' ' A' ' 101' ' ' THR . 23.2 mt 65.81 146.75 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.222 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 131.12 19.33 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.11 1.873 . . . . 0.0 112.053 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 106' ' ' PHE . 5.0 t -167.46 127.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.848 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER 41.1 17.58 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 104' ' ' SER . 63.1 m-85 66.77 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 116' ' ' LEU . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.557 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.424 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.535 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.561 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.561 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.454 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.648 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.648 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 165' ' ' PHE . 2.3 t-20 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.523 ' H ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.639 ' H ' ' CD2' ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 168' ' ' ILE . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.659 ' HG1' ' HZ3' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 122' ' ' PHE . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 118' ' ' ALA . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.88 -130.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.63 -63.38 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.0 p -93.52 -155.61 0.45 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -72.67 -170.51 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.31 -0.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.63 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.5 mt -112.95 -30.27 7.08 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' LEU . 13.1 mt 59.14 -152.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.268 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER 57.87 113.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 192' ' ' GLU . 1.3 pm0 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 3.2 pm0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -141.72 28.65 1.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.133 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt -103.9 -20.99 13.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' HG ' ' CG2' ' A' ' 153' ' ' VAL . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 13' ' ' PHE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t -117.62 155.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 7.9 mp -53.09 -72.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.244 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 10.9 Cg_endo -55.22 -56.0 2.69 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.233 1.289 . . . . 0.0 112.059 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 19' ' ' PRO . 14.7 p 46.22 27.67 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.612 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 1.5 m -114.49 -34.8 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 122.271 -0.268 . . . . 0.0 111.169 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 42.2 Cg_endo -91.99 25.77 0.45 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.304 2.003 . . . . 0.0 112.997 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 168' ' ' ILE . 79.5 mt -145.18 -88.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -86.19 145.4 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.331 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.1 37.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -101.88 -167.17 1.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.794 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.79 150.53 23.48 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.043 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.7 t -176.12 31.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.19 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -69.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.388 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -163.37 171.88 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 p -48.06 119.49 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.49 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.3 121.74 42.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 p -98.05 87.7 4.03 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp 68.25 69.41 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.515 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.95 15.62 4.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 65.74 63.97 0.58 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.556 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.413 ' HB3' ' H ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' LYS . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.463 ' C ' ' H ' ' A' ' 99' ' ' ILE . 91.0 m95 58.25 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' SER . 20.9 mtpp 68.67 -43.99 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.447 0.467 . . . . 0.0 110.562 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -76.98 -80.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 102' ' ' LEU . 38.0 mt-30 -81.22 -69.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.368 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' LEU . 4.2 m 64.0 -68.46 0.09 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.841 0.353 . . . . 0.0 110.686 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 100' ' ' GLN . 4.8 tp 90.39 80.58 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.774 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 102' ' ' LEU . 81.8 Cg_exo -48.59 -130.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 123.294 2.663 . . . . 0.0 113.702 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.0 t 67.96 136.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 105' ' ' PHE . 1.9 t80 53.77 1.7 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 68.88 95.29 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.604 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 116' ' ' LEU . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.453 HD11 HG21 ' A' ' 119' ' ' ILE . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.625 ' CZ ' ' CE1' ' A' ' 142' ' ' TYR . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 126' ' ' ALA . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.432 ' N ' HG23 ' A' ' 125' ' ' ILE . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 125' ' ' ILE . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.446 ' CD1' ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.446 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 138' ' ' VAL . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.405 ' CG2' ' HG ' ' A' ' 11' ' ' SER . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.439 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.441 ' CD1' ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.434 ' N ' HG23 ' A' ' 175' ' ' ILE . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -36.52 106.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 185' ' ' LEU . 2.1 mm? -60.2 176.68 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.994 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.661 ' CG2' ' H ' ' A' ' 187' ' ' GLU . 4.2 m 60.21 -155.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.068 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.661 ' H ' ' CG2' ' A' ' 186' ' ' THR . 1.5 pp20? 14.05 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 190' ' ' LEU . 9.8 p -170.35 145.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.157 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 24.1 mt -37.29 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.26 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 188' ' ' VAL . 0.3 OUTLIER -92.28 112.94 25.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.993 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 tt -162.09 91.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.368 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.423 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.484 ' NE2' ' C ' ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.47 33.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.631 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm -140.91 45.05 1.8 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.99 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 20' ' ' VAL . 1.8 p -76.86 175.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 3.0 mt -62.97 -69.21 0.63 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.063 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 9.4 Cg_endo -52.87 -44.82 45.31 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.938 1.759 . . . . 0.0 112.333 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.511 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 8.6 p 27.62 64.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.659 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 9.0 p -173.25 -30.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 45.0 Cg_endo -99.19 -13.87 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.22 1.946 . . . . 0.0 112.877 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' H ' ' HD2' ' A' ' 22' ' ' PRO . 6.5 mp -104.62 -44.91 4.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.033 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ALA . 3.3 pt -137.3 126.27 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.627 0.251 . . . . 0.0 110.661 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.91 88.27 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -156.87 173.64 16.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.644 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.66 163.73 32.28 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.254 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.404 ' H ' ' HB1' ' A' ' 32' ' ' ALA . 5.4 m -164.42 -151.6 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.18 -0.51 . . . . 0.0 109.873 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 40.36 -98.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.269 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 28' ' ' SER . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.497 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 44' ' ' ILE . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.437 ' C ' ' N ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 -165.73 66.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -46.32 144.11 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.185 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 55' ' ' LEU . . . -113.75 139.73 48.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.283 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -81.84 32.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.136 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 53' ' ' ALA . 6.5 tp -168.15 38.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.369 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 87.3 t80 -135.87 7.54 3.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.332 0.587 . . . . 0.0 109.711 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 67.08 74.4 0.33 Allowed 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.223 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 ' O ' ' OG ' ' A' ' 77' ' ' SER . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' LYS . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.447 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.459 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER 59.6 144.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -149.76 -37.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mt -57.99 -67.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -83.18 -155.55 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.9 p -148.13 112.68 5.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.462 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 2.9 mm? -63.34 151.8 86.45 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -36.03 154.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.389 2.059 . . . . 0.0 112.419 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 106' ' ' PHE . 13.2 t -58.16 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 41.0 18.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.599 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' SER . 3.8 m-85 47.71 73.81 0.19 Allowed 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.429 ' O ' ' SD ' ' A' ' 65' ' ' MET . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.608 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.452 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' CE2' ' OH ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' N ' ' A' ' 126' ' ' ALA . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.404 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.524 ' ND2' ' OE2' ' A' ' 187' ' ' GLU . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.497 ' HH ' ' CB ' ' A' ' 181' ' ' ALA . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.62 ' HG1' ' HZ2' ' A' ' 170' ' ' LYS . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' HZ2' ' CB ' ' A' ' 155' ' ' LYS . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.446 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 169' ' ' ARG . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.408 ' H ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.62 ' HZ2' ' HG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.497 ' CB ' ' HH ' ' A' ' 142' ' ' TYR . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 185' ' ' LEU . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -47.89 91.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -75.96 71.95 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.95 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -174.14 155.03 2.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 111.203 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.524 ' OE2' ' ND2' ' A' ' 135' ' ' ASN . 19.6 tt0 67.97 21.43 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.062 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.0 t -58.54 -50.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 41.2 tp -174.95 132.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 24.8 mt -67.68 -74.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 69.7 -69.68 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.083 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.573 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -22.55 48.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.699 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -98.83 -3.1 36.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.556 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 20' ' ' VAL . 7.5 p -56.17 99.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mm? -1.04 -69.03 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.272 0.629 . . . . 0.0 112.628 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' VAL . 30.9 Cg_endo -61.84 -45.54 16.49 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.881 1.721 . . . . 0.0 113.915 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER 39.96 -161.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.426 0.557 . . . . 0.0 110.043 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' H ' HG13 ' A' ' 20' ' ' VAL . 20.6 t 89.19 -69.66 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.571 1.548 . . . . 0.0 112.867 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 20' ' ' VAL . 89.9 Cg_endo -92.61 9.94 2.47 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 CA-C-N 123.145 2.159 . . . . 0.0 112.009 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' PHE . 3.8 mm? -118.39 166.16 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 ' C ' ' N ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER 31.7 27.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.641 179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 40.11 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -98.04 -168.68 1.7 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.375 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.0 -175.92 20.55 Favored Glycine 0 N--CA 1.466 0.68 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -174.78 157.71 2.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.105 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 59.38 151.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.686 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.413 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -101.31 77.28 1.78 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.1 p -58.84 94.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' SER . . . -88.51 170.29 11.01 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 56' ' ' PHE . 5.1 t -59.28 -141.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -54.98 84.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' SER . 6.3 t80 -113.81 -101.59 0.42 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -153.9 33.32 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CE2' ' OG ' ' A' ' 45' ' ' SER . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 45' ' ' SER . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.431 ' O ' ' OG ' ' A' ' 77' ' ' SER . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 74' ' ' ILE . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' A' ' 84' ' ' VAL . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.579 ' HZ2' ' CD1' ' A' ' 86' ' ' ILE . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.588 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' CD1' ' HZ2' ' A' ' 83' ' ' LYS . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 92' ' ' THR . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 89' ' ' SER . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 94' ' ' GLY . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.548 ' N ' ' HG ' ' A' ' 93' ' ' SER . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 97' ' ' TRP . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 54.47 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -140.84 -41.41 0.4 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.45 132.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.977 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 44.67 55.95 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.519 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -42.54 141.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.6 mt -116.65 83.56 14.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.274 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' O ' ' OG ' ' A' ' 104' ' ' SER . 86.5 Cg_exo -46.58 133.53 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 112.915 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 103' ' ' PRO . 45.6 m -168.74 -136.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.201 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 56.9 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 40.76 63.8 1.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.618 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.522 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.55 ' H ' ' CD1' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.498 ' H ' ' HG ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.508 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.583 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.555 ' C ' HE21 ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.45 ' HB2' ' HZ2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 185' ' ' LEU . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.8 -94.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 186' ' ' THR . 2.5 tp -154.66 175.29 13.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.43 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.426 ' H ' ' HG ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -69.59 63.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 110.181 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -173.11 106.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.362 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.34 -171.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.84 104.62 5.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.231 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.411 ' CD1' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -66.84 115.29 6.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.073 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 44.9 tp -130.94 123.14 28.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.501 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.426 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 1.9 tp-100 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 6.0 tp -173.91 47.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.404 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp -170.21 -33.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.553 ' CG1' ' H ' ' A' ' 20' ' ' VAL . 1.1 p -65.66 167.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 3.6 mm? -65.2 -66.82 1.23 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.167 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' VAL . 8.4 Cg_endo -52.89 -26.19 30.33 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.023 1.815 . . . . 0.0 113.194 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.693 ' CG1' ' H ' ' A' ' 21' ' ' VAL . 5.3 p 11.79 -83.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.693 ' H ' ' CG1' ' A' ' 20' ' ' VAL 0.292 2.1 p 39.54 -140.18 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 114.726 -2.559 . . . . 0.0 107.766 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.48 ' CD ' ' CG1' ' A' ' 21' ' ' VAL . 48.1 Cg_exo -60.81 -130.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 1 CA-C-N 128.676 4.134 . . . . 0.0 112.438 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.4 mt 68.89 -57.72 0.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -123.54 16.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ALA . 3.5 m-30 53.52 -90.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 39.45 -162.3 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.56 134.99 3.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 p -177.73 65.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.712 0.292 . . . . 0.0 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -175.11 -171.17 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.163 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.48 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' THR . 14.5 m-85 -87.71 -82.29 0.23 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m 83.35 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.07 -123.63 0.16 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.524 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -140.59 -30.16 0.66 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -132.27 50.23 2.25 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.059 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -112.75 7.81 18.67 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 58.63 59.88 2.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.271 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.456 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.504 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 94' ' ' GLY . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -65.93 121.73 15.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.9 -21.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.9 mt -55.59 -69.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -171.38 58.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.6 m -80.72 -100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.78 106.11 41.83 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.3 Cg_exo -45.45 -24.06 1.57 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.079 1.853 . . . . 0.0 112.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.2 p -55.71 -161.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.282 . . . . 0.0 110.514 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -51.97 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' SER . 79.1 m-85 -16.49 -48.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.208 0.942 . . . . 0.0 112.739 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.511 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 118' ' ' ALA . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.617 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.617 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' SER . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 141' ' ' SER . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 137' ' ' LEU . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.442 ' CB ' ' HZ3' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.459 ' H ' ' CG2' ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.413 ' OD1' ' CG1' ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HZ1' ' CB ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.437 ' CG2' ' CD1' ' A' ' 115' ' ' TRP . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.463 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . 35.42 -150.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 186' ' ' THR . 0.2 OUTLIER -139.31 91.92 2.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.575 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER 34.33 96.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.427 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 188' ' ' VAL . 59.6 mt-10 -144.64 -105.94 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.276 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 187' ' ' GLU . 43.2 t 54.19 106.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.445 ' H ' ' CD1' ' A' ' 189' ' ' LEU . 10.1 mp -44.57 114.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.433 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.01 17.61 7.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.21 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.487 ' CG ' ' H ' ' A' ' 192' ' ' GLU . 4.9 tp 63.49 -135.88 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.305 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 191' ' ' LEU . 11.5 pt-20 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 3.2 pm0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.7 OUTLIER -154.22 -161.88 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.438 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 2' ' ' LEU . 12.0 ttt 80.33 -28.43 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.65 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 2' ' ' LEU . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 3.9 t -50.92 174.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 9.3 mp -82.83 -71.08 0.12 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 21' ' ' VAL . 71.3 Cg_exo -38.21 -50.02 2.22 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 113.818 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 19' ' ' PRO . 20.3 m 45.76 9.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 9.9 p -110.37 -29.66 0.15 Allowed Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 72.6 Cg_endo -95.42 -15.12 0.54 Allowed 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 121.824 1.683 . . . . 0.0 111.744 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.77 -97.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.6 mt -86.74 160.85 2.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 25.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -69.02 -168.64 0.14 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.428 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.22 149.26 19.48 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.084 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.483 ' H ' ' CB ' ' A' ' 32' ' ' ALA . 37.7 t -157.21 -179.1 7.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.168 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' H ' ' HG ' ' A' ' 28' ' ' SER . 15.1 mmp_? 48.96 -152.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.379 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' CB ' ' H ' ' A' ' 28' ' ' SER . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.463 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' THR . 51.4 m-85 -118.69 179.7 4.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' TYR . 41.4 p -53.77 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -171.94 112.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.422 0.629 . . . . 0.0 111.859 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -130.07 -52.7 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 4.99 10.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.628 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 2.3 m-30 -82.44 20.28 1.12 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.3 38.21 23.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.491 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.65 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' A' ' 89' ' ' SER . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 86' ' ' ILE . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.633 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.633 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -63.18 81.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 24.5 ttpp -82.13 -55.36 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.329 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -52.07 -171.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.804 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -70.77 117.9 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.248 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.4 m -161.0 -75.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.453 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.69 79.31 48.22 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.135 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.74 118.42 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.685 2.257 . . . . 0.0 111.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.8 t -154.59 -129.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -79.1 55.6 1.85 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 42.69 56.43 3.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.516 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.554 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.429 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.439 ' O ' ' OG ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.423 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.45 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.502 ' OG1' ' CB ' ' A' ' 170' ' ' LYS . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.428 ' H ' ' CG1' ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' ALA . 3.8 m120 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 1.7 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 169' ' ' ARG . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.403 ' N ' HG23 ' A' ' 168' ' ' ILE . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' CB ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 175' ' ' ILE . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.4 ' H ' HD22 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 35.99 -144.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.71 -70.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 p -152.83 4.84 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -98.33 32.8 2.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.13 -39.41 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.275 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.48 143.65 13.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.864 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 tp -155.79 -46.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.496 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? -71.9 108.95 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.538 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -167.1 0.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 -28.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.382 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 156' ' ' MET . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG11 ' H ' ' A' ' 20' ' ' VAL . 4.9 p -70.39 158.49 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 8.9 mt -42.24 -68.71 0.25 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.729 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 38.3 Cg_endo -63.84 -28.97 67.74 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.347 2.031 . . . . 0.0 115.13 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' H ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER 36.7 73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.763 0.711 . . . . 0.0 111.238 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.763 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.2 p 175.2 -16.53 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.763 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 40.3 Cg_endo -91.0 -8.07 3.53 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 CA-C-N 121.398 1.535 . . . . 0.0 114.551 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mt -147.04 -36.49 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -97.96 -0.78 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.176 0.898 . . . . 0.0 111.333 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 42.69 42.82 3.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -132.99 -165.09 1.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.783 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' ALA . . . 45.06 -174.01 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 p -160.12 -159.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.334 0.587 . . . . 0.0 111.587 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.9 -147.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.463 HD11 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' HD11 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.579 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 39' ' ' VAL . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 48' ' ' ILE . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 52' ' ' THR . 73.3 t80 -127.03 -179.78 5.02 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 51' ' ' TYR . 5.8 m -59.23 -122.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.64 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -174.22 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.199 0.523 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m 58.73 -99.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.797 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 33.86 3.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.429 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.41 23.67 13.71 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 54.07 57.3 6.07 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.394 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 74' ' ' ILE . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.722 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.722 ' H ' ' HG ' ' A' ' 96' ' ' SER . 21.0 m-90 -63.83 135.98 57.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -145.79 47.23 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.766 0.317 . . . . 0.0 110.917 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mt -138.76 -48.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.757 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.34 43.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.41 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.666 ' HG1' ' H ' ' A' ' 102' ' ' LEU . 13.9 t -59.44 -160.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.125 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' H ' ' HG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -110.71 96.08 26.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.881 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.34 152.96 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.325 2.017 . . . . 0.0 113.449 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 106' ' ' PHE . 29.2 p -175.89 -162.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.888 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.604 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -59.54 -4.83 0.69 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.626 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 11.7 m-85 136.15 115.75 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 109' ' ' MET . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD21 ' H ' ' A' ' 114' ' ' LEU . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.579 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.57 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.507 ' SD ' ' OE1' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' CG1' ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.451 ' H ' ' CG1' ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.76 89.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.95 -24.74 62.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.935 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -80.6 -89.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -140.39 149.97 43.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.466 ' O ' ' CB ' ' A' ' 189' ' ' LEU . 7.8 p -105.79 34.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 188' ' ' VAL . 0.2 OUTLIER 84.0 -77.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.296 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 189' ' ' LEU . 11.9 mt 51.52 173.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 110.619 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 191' ' ' LEU . 2.3 tm? -77.79 -54.52 6.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.866 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.53 179.846 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 tp -71.31 -128.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.418 ' H ' ' CG ' ' A' ' 2' ' ' LEU . 25.2 mtt 63.56 -68.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.684 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 2' ' ' LEU . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 11' ' ' SER . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 8' ' ' GLY . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 11' ' ' SER . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 16' ' ' ALA . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t -34.08 -97.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -171.49 -48.88 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD2' ' H ' ' A' ' 20' ' ' VAL . 70.0 Cg_endo -93.09 -17.75 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.613 2.209 . . . . 0.0 109.82 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 31.63 47.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.978 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -96.72 -44.97 0.25 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -101.36 -157.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.151 2.567 . . . . 0.0 111.859 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 43.78 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -88.75 124.67 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.507 -178.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ALA . 3.1 m-85 -49.55 -13.75 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -37.66 162.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.34 152.84 24.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.877 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 28' ' ' SER . 20.2 p -173.59 62.95 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.761 0.315 . . . . 0.0 110.939 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -163.82 165.08 23.31 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.321 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HG1' ' N ' ' A' ' 44' ' ' ILE . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' N ' ' HG1' ' A' ' 43' ' ' THR . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 -173.63 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 p -41.62 152.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -169.65 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 55' ' ' LEU . 38.9 p 59.86 -71.2 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.545 ' N ' ' OG ' ' A' ' 54' ' ' SER . 2.2 tt -151.73 64.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.63 5.37 12.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.42 64.93 0.41 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.312 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.402 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 75' ' ' LEU . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' H ' ' CD1' ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HZ2' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 86' ' ' ILE . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.471 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -41.95 148.32 0.18 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -155.84 -71.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.27 139.77 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 45.52 50.34 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -78.08 161.68 27.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.66 148.58 45.8 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.117 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.59 110.32 3.04 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.207 1.938 . . . . 0.0 112.217 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.547 ' OG ' ' CD2' ' A' ' 107' ' ' PHE . 89.6 p -173.65 -171.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.411 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -50.33 -78.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 46.5 m-85 -166.28 69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.547 ' CD2' ' OG ' ' A' ' 104' ' ' SER . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 110' ' ' LEU . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.585 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.581 ' CE2' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' ILE . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 142' ' ' TYR . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 125' ' ' ILE . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 139' ' ' MET . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CE1' ' CE2' ' A' ' 122' ' ' PHE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.47 ' N ' ' CG2' ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.516 ' CD1' ' HZ2' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.508 ' HG1' ' N ' ' A' ' 173' ' ' GLY . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.508 ' N ' ' HG1' ' A' ' 172' ' ' THR . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.75 138.67 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 185' ' ' LEU . 7.3 mp -87.6 128.67 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.062 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.9 p -143.26 56.61 1.38 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 187' ' ' GLU . 28.5 mp0 45.36 94.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.681 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.91 -51.67 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER 179.73 22.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.864 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.15 -75.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' LEU . 6.8 tp 39.84 63.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.937 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 192' ' ' GLU . 4.2 pm0 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 3.9 mm? -48.3 118.68 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt 39.95 45.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.578 ' HG ' ' N ' ' A' ' 12' ' ' VAL . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 ' N ' ' HG ' ' A' ' 11' ' ' SER . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t 57.24 153.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' O ' ' N ' ' A' ' 20' ' ' VAL . 3.5 mm? -45.38 149.87 0.93 Allowed Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' C ' ' O ' ' A' ' 18' ' ' LEU . 20.5 Cg_exo -19.68 74.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.334 2.69 . . . . 0.0 113.131 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 18' ' ' LEU . 7.1 p -61.19 157.69 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.445 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 4.3 m -63.37 139.85 97.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.691 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -39.41 102.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.822 1.681 . . . . 0.0 111.613 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -150.43 -31.81 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.271 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -114.7 124.11 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ALA . 2.4 m-85 -46.04 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -48.6 -111.47 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.401 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 167.35 17.4 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -177.2 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.121 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -143.7 163.56 32.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.517 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.478 ' C ' ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.694 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 85.94 149.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.63 ' CG2' ' H ' ' A' ' 53' ' ' ALA . 24.5 m -96.96 -177.91 4.03 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.855 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.63 ' H ' ' CG2' ' A' ' 52' ' ' THR . . . -149.29 176.08 10.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.468 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -59.31 84.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 53' ' ' ALA . 10.9 mt 66.06 68.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.1 35.83 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' H ' ' C ' ' A' ' 55' ' ' LEU . 8.8 t80 40.74 48.29 2.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.694 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.464 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.485 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.44 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.699 ' H ' ' HG ' ' A' ' 96' ' ' SER . 5.7 m-90 -90.53 173.32 8.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.11 -54.31 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.732 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.76 -19.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -84.49 42.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.7 m -157.13 -101.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.576 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.09 77.2 2.76 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.833 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -50.73 167.08 0.29 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.894 2.396 . . . . 0.0 112.94 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 106' ' ' PHE . 7.6 t -173.77 -137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -66.83 67.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 104' ' ' SER . 37.2 m-85 53.85 62.69 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 119' ' ' ILE . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.56 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.468 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.468 ' OH ' ' O ' ' A' ' 122' ' ' PHE . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 16.0 mm100 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 174' ' ' ALA 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.517 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.26 91.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -16.12 63.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.1 m -92.33 46.07 1.24 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.796 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -177.19 31.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.906 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.24 -124.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -141.34 171.77 13.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.054 0.388 . . . . 0.0 110.706 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -171.0 174.78 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.35 159.68 42.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.315 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.541 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.28 82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.072 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp -174.06 -6.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.606 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 18' ' ' LEU . 3.9 p -54.54 -165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' H ' HG21 ' A' ' 17' ' ' VAL . 2.4 mt -87.23 -62.78 0.23 Allowed Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.52 -52.26 3.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.065 1.843 . . . . 0.0 113.016 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 22.0 m 46.78 42.54 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.682 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 10.0 p -164.39 -29.92 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 43.3 Cg_endo -101.27 16.79 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.167 1.911 . . . . 0.0 111.86 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 tp -143.84 -66.07 0.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.533 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' ALA . 1.6 mt -88.63 20.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.069 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' ILE . 14.3 t80 35.93 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.01 0.434 . . . . 0.0 110.745 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -110.65 -161.64 0.76 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.8 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' A' ' 28' ' ' SER . . . -162.14 139.66 6.1 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 27' ' ' GLY . 1.7 m -169.42 72.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -164.12 -106.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.286 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.52 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 41.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 71.9 m 51.97 -95.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . 160.71 25.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -56.15 78.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.1 tp 60.48 31.25 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.47 25.7 9.88 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 55.29 52.96 10.62 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.747 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.417 ' C ' ' CD2' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 92' ' ' THR . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 89' ' ' SER . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -87.5 110.51 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -132.61 -24.08 2.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.626 ' CD1' ' H ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -54.35 -91.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' THR . 88.8 mt-30 -86.74 -54.33 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 100' ' ' GLN . 9.8 t 44.7 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.182 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mp -112.99 106.13 55.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -42.96 128.4 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.816 1.678 . . . . 0.0 112.304 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m -163.74 -139.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.403 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 107' ' ' PHE . 3.0 t80 -80.07 52.99 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 68.85 -48.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.439 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 105' ' ' PHE . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.575 ' CZ ' ' SD ' ' A' ' 109' ' ' MET . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.597 ' O ' ' O ' ' A' ' 118' ' ' ALA . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' N ' ' CG2' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.429 ' H ' ' HG2' ' A' ' 121' ' ' PRO . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CZ ' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 166' ' ' GLN . 0.1 OUTLIER 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.497 ' N ' HD21 ' A' ' 164' ' ' ASN . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.692 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.1 OUTLIER -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.423 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -37.9 -45.55 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.462 ' O ' ' CG2' ' A' ' 188' ' ' VAL . 0.3 OUTLIER 71.84 -56.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 187' ' ' GLU . 0.1 OUTLIER -40.56 107.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.406 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 186' ' ' THR . 15.0 tt0 81.18 107.86 0.07 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.316 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 190' ' ' LEU . 1.8 t -146.4 58.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.637 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 190' ' ' LEU . 9.0 mp 57.07 6.31 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.789 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 188' ' ' VAL . 0.4 OUTLIER 25.01 -113.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.888 0.743 . . . . 0.0 112.351 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.483 ' H ' ' CG ' ' A' ' 190' ' ' LEU . 18.9 tp 52.01 54.04 11.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.479 ' N ' ' OE2' ' A' ' 192' ' ' GLU . 2.2 mp0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.02 -0.99 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tp -169.88 39.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.58 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 1.3 t -49.96 -177.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.537 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 1.7 mt -75.47 -69.49 0.25 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' C ' ' H ' ' A' ' 21' ' ' VAL . 11.1 Cg_endo -52.96 -65.2 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.04 1.827 . . . . 0.0 111.691 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 6.4 t 60.56 -22.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 19' ' ' PRO . 4.5 p -72.0 -34.46 2.95 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.383 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 71.7 Cg_endo -102.4 -1.3 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.821 2.347 . . . . 0.0 111.386 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.07 -88.64 0.46 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.321 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.626 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.1 mt -89.15 148.9 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.52 6.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -83.53 -154.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 146.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -155.44 -12.64 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.619 0.247 . . . . 0.0 110.988 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 39.39 -107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.126 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' GLY . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.412 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' GLY . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -143.07 130.69 21.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 m -54.16 139.06 36.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -129.02 2.99 5.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.027 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 89.03 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.94 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.22 77.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.49 0.662 . . . . 0.0 111.443 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' SER . 3.9 m-85 -116.49 -97.49 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -149.87 33.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.314 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.407 ' CD2' ' N ' ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD1' ' CZ ' ' A' ' 113' ' ' PHE . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.659 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.659 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 51.26 -101.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 53.7 50.75 16.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 0.0 110.99 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.12 -31.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' THR . 41.1 tt0 -174.69 30.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -57.59 -139.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.184 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' H ' HG23 ' A' ' 101' ' ' THR . 0.2 OUTLIER -157.08 73.57 4.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.601 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.89 174.28 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.911 2.407 . . . . 0.0 112.412 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.1 p -178.43 -102.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.806 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -91.06 50.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 27.0 16.56 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' ALA . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.529 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 131' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 150' ' ' ILE . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 156' ' ' MET . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.403 ' CG2' ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . 27.31 -132.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.18 -167.83 1.95 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.713 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 186' ' ' THR . 6.1 p -86.5 101.06 12.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' VAL . 8.6 pt-20 -169.72 -48.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.86 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 187' ' ' GLU . 45.1 t 56.91 155.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.337 . . . . 0.0 110.604 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 189' ' ' LEU . 3.5 mm? -64.2 91.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.026 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.44 163.89 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 191' ' ' LEU . 0.6 OUTLIER -159.66 19.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.613 179.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.58 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 16.1 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.58 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 0.2 OUTLIER 78.4 22.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm -173.41 -38.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.705 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 2.9 t -50.98 96.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' VAL . 3.4 mm? -30.13 -62.88 0.22 Allowed Pre-proline 0 N--CA 1.474 0.774 0 O-C-N 122.953 0.158 . . . . 0.0 111.089 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 21' ' ' VAL . 75.9 Cg_exo -37.13 -22.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.246 1.964 . . . . 0.0 113.326 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' LEU . 5.2 m -27.12 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.666 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.0 t -124.57 -40.22 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.328 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.666 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 26.0 Cg_endo -103.75 -2.1 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 110.833 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 mt -86.74 -93.36 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.096 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -131.66 131.82 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.309 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -46.39 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -160.92 178.8 9.04 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.764 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.49 53.29 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.118 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -153.83 151.19 29.25 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 -172.0 38.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.521 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 HD11 ' HE ' ' A' ' 61' ' ' ARG . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -101.77 -177.39 3.41 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -81.86 -20.31 39.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.387 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.01 87.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.826 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.6 m -101.47 -23.35 14.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.71 11.16 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.784 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -96.17 40.97 1.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.605 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 43.0 52.66 5.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.686 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.495 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.686 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.495 ' CD1' ' O ' ' A' ' 92' ' ' THR . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 -75.24 171.52 14.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.579 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -142.71 -178.0 5.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.161 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.579 ' H ' ' CG ' ' A' ' 98' ' ' LYS . 76.6 mt 58.28 -90.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 101' ' ' THR . 63.4 tt0 -71.34 -77.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 102' ' ' LEU . 50.7 m 51.92 169.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 103' ' ' PRO . 30.6 tp -105.03 106.92 57.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 102' ' ' LEU . 30.8 Cg_exo -38.12 -106.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.501 2.134 . . . . 0.0 113.48 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 106' ' ' PHE . 2.6 p 71.28 131.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.28 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 27.1 t80 -1.24 -65.31 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.223 0.952 . . . . 0.0 112.923 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 22.4 m-85 -174.7 87.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.479 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.525 ' O ' ' O ' ' A' ' 118' ' ' ALA . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.611 ' CD2' ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.431 ' O ' ' OG1' ' A' ' 130' ' ' THR . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.51 ' HG1' ' N ' ' A' ' 131' ' ' LEU . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.51 ' N ' ' HG1' ' A' ' 130' ' ' THR . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.579 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.556 ' HA ' ' HZ1' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.476 ' CD2' ' C ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.426 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.556 ' HZ1' ' HA ' ' A' ' 149' ' ' THR . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.441 ' CD1' ' C ' ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.534 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.521 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -27.25 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.447 ' CD1' ' H ' ' A' ' 185' ' ' LEU . 10.1 mp -45.11 -53.45 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.773 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.1 m -157.02 103.79 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.499 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.41 -44.04 2.68 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.696 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.5 t -50.97 110.62 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.538 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 47.2 mt -52.91 174.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.472 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -155.89 177.11 11.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 191' ' ' LEU . 0.5 OUTLIER -160.54 18.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.662 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.605 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.494 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER 44.07 63.89 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.507 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -144.0 -57.35 0.38 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 37.8 t -49.76 164.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 21' ' ' VAL . 8.9 mp -83.16 -69.86 0.15 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.002 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 68.9 Cg_exo -33.49 -30.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.429 2.086 . . . . 0.0 114.111 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' LEU . 10.1 m -86.85 9.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.382 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' LEU . 1.4 t -47.93 -49.36 59.19 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -92.88 59.99 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.659 2.239 . . . . 0.0 111.218 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tt -153.17 -57.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.374 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' C ' ' N ' ' A' ' 26' ' ' ALA . 4.0 mt -83.37 27.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 110.46 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 119' ' ' ILE . 0.1 OUTLIER 44.93 21.5 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 0.0 109.384 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -122.5 -149.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.402 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.88 -155.23 16.4 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -154.29 -101.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.379 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 50.95 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.601 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 64.47 -173.48 0.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER 34.31 79.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.609 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . . . -175.98 94.07 0.06 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 t -127.65 -23.58 3.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.991 0.424 . . . . 0.0 110.394 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.68 46.65 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.63 ' CD2' ' N ' ' A' ' 57' ' ' PHE . 17.0 p90 -97.08 -63.81 1.1 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.998 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.63 ' N ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 175.3 50.99 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.821 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.601 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 ' N ' ' CG1' ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.454 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.406 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 97' ' ' TRP . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.5 ' H ' ' HG ' ' A' ' 96' ' ' SER . 31.1 m0 -56.76 155.05 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 99' ' ' ILE . 65.1 tttp -157.08 -45.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.738 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.526 ' C ' ' H ' ' A' ' 101' ' ' THR . 28.8 mm -53.24 -105.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -75.17 30.11 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 0.0 110.492 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 99' ' ' ILE . 12.6 t -48.53 154.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 102' ' ' LEU . 3.3 mm? -85.28 126.88 65.98 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.59 61.45 7.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.923 1.749 . . . . 0.0 111.762 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.5 m -99.54 -130.04 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.793 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.1 24.63 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.484 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 104' ' ' SER . 89.4 m-85 59.6 83.11 0.14 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.127 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.551 ' CE2' ' O ' ' A' ' 112' ' ' ALA 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.457 ' HB ' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.433 ' O ' ' OG ' ' A' ' 128' ' ' SER . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 125' ' ' ILE . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.429 ' O ' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.415 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.533 ' HG1' ' N ' ' A' ' 173' ' ' GLY . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.533 ' N ' ' HG1' ' A' ' 172' ' ' THR . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.74 -149.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 19.1 tp -144.25 67.58 1.27 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 8.3 m 53.13 62.19 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 190' ' ' LEU . 3.7 tm-20 -166.18 75.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.423 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 t -85.07 63.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tp 65.24 21.57 12.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.445 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 187' ' ' GLU . 6.1 tp 46.5 44.19 12.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.445 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.35 -46.32 90.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.561 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' HD22 ' A' ' 37' ' ' LEU . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.836 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 36' ' ' PHE . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 45' ' ' SER . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 182' ' ' TYR . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 110' ' ' LEU . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD13 ' HG3' ' A' ' 117' ' ' PRO . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 74' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.631 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' LEU . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.971 ' N ' HD22 ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' VAL . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 179' ' ' TYR . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 112' ' ' ALA . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.781 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.634 HG22 ' H ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.634 ' H ' HG22 ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.995 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.995 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 150' ' ' ILE . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 162' ' ' LYS . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.8 m-20 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.843 ' O ' HD12 ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.999 ' N ' HD13 ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 168' ' ' ILE . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.485 HD13 HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 111' ' ' LEU . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.666 0.27 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 6' ' ' ALA . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.569 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.809 0.338 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.616 ' CG2' HD23 ' A' ' 110' ' ' LEU . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 113' ' ' PHE . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 73' ' ' LEU . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 87' ' ' PHE . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' SER . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.512 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.519 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.892 ' O ' HD12 ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.632 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.076 HD13 ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 1.076 ' H ' HD13 ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.616 HD23 ' CG2' ' A' ' 62' ' ' VAL . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.696 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.487 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 175' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.662 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.668 ' CZ ' HD13 ' A' ' 177' ' ' LEU . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HG3' HD22 ' A' ' 135' ' ' ASN . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.577 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.588 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 0.5 OUTLIER 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 149' ' ' THR . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 160' ' ' PHE . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 162' ' ' LYS . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 152' ' ' ALA . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 171' ' ' VAL . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 168' ' ' ILE . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 172' ' ' THR . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.78 HD13 HD11 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.431 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' ALA . 7.5 t . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 39' ' ' VAL . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 71' ' ' PHE . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.712 HD12 HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 35.3 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.495 0.188 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' A' ' 63' ' ' VAL . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.712 HH21 HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 59' ' ' PHE . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 38' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' NZ ' ' OG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.546 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' HH21 ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 96' ' ' SER . 90.3 m95 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 115' ' ' TRP . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.54 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 120' ' ' LEU . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 1.011 ' N ' HD13 ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 129' ' ' GLN . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 137' ' ' LEU . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 139' ' ' MET . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.602 ' N ' HG23 ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.571 ' CD1' HD13 ' A' ' 177' ' ' LEU . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 150' ' ' ILE . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' THR . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.549 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' HD11 ' A' ' 150' ' ' ILE . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.915 ' H ' HG22 ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.784 ' H ' HD23 ' A' ' 167' ' ' LEU . 55.5 t30 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.475 ' N ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.524 HG23 ' HZ3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.535 ' OG1' ' NZ ' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 142' ' ' TYR . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.623 0.249 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 120' ' ' LEU . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' ILE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ALA . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 70' ' ' ILE . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 67' ' ' PHE . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 71' ' ' PHE . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 91.0 m95 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 65' ' ' MET . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 111' ' ' LEU . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.785 ' O ' HD11 ' A' ' 175' ' ' ILE . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.856 ' O ' HG12 ' A' ' 39' ' ' VAL . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 125' ' ' ILE . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.736 ' H ' HD13 ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 150' ' ' ILE . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.492 ' N ' HG23 ' A' ' 149' ' ' THR . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.465 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB1' HD21 ' A' ' 167' ' ' LEU . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.463 ' H ' ' HA ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.547 ' O ' HG22 ' A' ' 168' ' ' ILE . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 152' ' ' ALA . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 165' ' ' PHE . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 175' ' ' ILE . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 178' ' ' LEU . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 120.521 0.201 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.742 HD13 ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' N ' HD13 ' A' ' 33' ' ' LEU . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 35' ' ' ALA . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 118' ' ' ALA . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.597 ' N ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.393 0.616 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 110' ' ' LEU . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 117' ' ' PRO . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' ILE . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 84' ' ' VAL . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' OG1' ' A' ' 172' ' ' THR . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.934 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.863 ' O ' HD13 ' A' ' 110' ' ' LEU . 3.8 m-85 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 106' ' ' PHE . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.643 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' HD13 ' A' ' 68' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 120' ' ' LEU . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.487 HD12 ' NE2' ' A' ' 129' ' ' GLN . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 131' ' ' LEU . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 150' ' ' ILE . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 149' ' ' THR . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' GLY . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 149' ' ' THR . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.411 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.527 ' CB ' HD22 ' A' ' 167' ' ' LEU . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 152' ' ' ALA . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 172' ' ' THR . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.452 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 169' ' ' ARG . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 7' ' ' LEU . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 17' ' ' VAL . 7.5 p . . . . . 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.501 0.667 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 37' ' ' LEU . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.445 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 HH22 ' HA ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 71' ' ' PHE . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 81' ' ' ASP . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.585 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.402 ' HG2' ' N ' ' A' ' 92' ' ' THR . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.451 ' CA ' ' NH2' ' A' ' 90' ' ' ARG . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 95' ' ' LEU . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD13 ' CZ ' ' A' ' 179' ' ' TYR . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.673 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.678 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 1.01 ' N ' HD13 ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.717 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.512 ' N ' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 170' ' ' LYS . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.501 ' CD1' ' HZ1' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.739 ' HB3' HD21 ' A' ' 167' ' ' LEU . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.716 ' H ' HG22 ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.608 ' OD1' HG11 ' A' ' 161' ' ' VAL . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 152' ' ' ALA . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.501 ' HZ1' ' CD1' ' A' ' 150' ' ' ILE . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.536 0.208 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 33' ' ' LEU . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' NH1' ' A' ' 61' ' ' ARG . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.653 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 63' ' ' VAL . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 110' ' ' LEU . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 70' ' ' ILE . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.893 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' HD13 ' A' ' 116' ' ' LEU . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 95' ' ' LEU . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.401 ' HE1' ' HB2' ' A' ' 107' ' ' PHE . 1.4 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HB2' ' HE1' ' A' ' 97' ' ' TRP . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.555 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.647 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.805 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.923 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 130' ' ' THR . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.42 ' OE1' HG11 ' A' ' 138' ' ' VAL . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.42 HG11 ' OE1' ' A' ' 129' ' ' GLN . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 150' ' ' ILE . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 148' ' ' VAL . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 151' ' ' ALA . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.69 ' HB3' ' NZ ' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.626 ' N ' HG22 ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.653 ' O ' HG22 ' A' ' 168' ' ' ILE . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 165' ' ' PHE . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.69 ' NZ ' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 168' ' ' ILE . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.467 HG22 ' CD ' ' A' ' 90' ' ' ARG . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 177' ' ' LEU . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 176' ' ' VAL . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.577 0.227 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 6' ' ' ALA . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 11' ' ' SER . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.485 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.601 0.239 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 5' ' ' PHE . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.514 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.416 HD12 ' NH1' ' A' ' 61' ' ' ARG . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.546 0.212 . . . . 0.0 111.491 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 113' ' ' PHE . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 73' ' ' LEU . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.994 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.653 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.919 ' O ' HD22 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.653 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 110' ' ' LEU . 4.4 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.958 0.408 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 106' ' ' PHE . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.625 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.758 ' O ' HG12 ' A' ' 39' ' ' VAL . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 119' ' ' ILE . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 177' ' ' LEU . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.72 ' N ' HD13 ' A' ' 127' ' ' ILE . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.426 HE22 HG12 ' A' ' 138' ' ' VAL . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 131' ' ' LEU . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.592 ' N ' HD13 ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HD11 ' A' ' 150' ' ' ILE . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 167' ' ' LEU . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 147' ' ' ALA . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.622 ' H ' HG13 ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.495 ' ND2' HG11 ' A' ' 161' ' ' VAL . 51.9 m-20 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.707 ' O ' HG22 ' A' ' 168' ' ' ILE . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 14.4 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 149' ' ' THR . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 165' ' ' PHE . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.632 ' HE3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.48 ' H ' HD23 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.645 0.259 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' N ' ' A' ' 29' ' ' ARG . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.694 ' H ' HD12 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' ALA . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.457 HG23 HD23 ' A' ' 42' ' ' LEU . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.594 HD12 ' CZ ' ' A' ' 61' ' ' ARG . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' N ' ' C ' ' A' ' 49' ' ' LEU . 73.3 t80 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 63' ' ' VAL . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' HG23 ' A' ' 62' ' ' VAL . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.643 ' CE ' HD21 ' A' ' 114' ' ' LEU . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 113' ' ' PHE . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.415 HG23 ' H ' ' A' ' 70' ' ' ILE . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 81' ' ' ASP . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 84' ' ' VAL . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 172' ' ' THR . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.498 ' N ' HH21 ' A' ' 90' ' ' ARG . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' N ' ' OG ' ' A' ' 96' ' ' SER . 21.0 m-90 . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.59 ' CG ' ' SD ' ' A' ' 109' ' ' MET . 11.7 m-85 . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 95' ' ' LEU . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 69' ' ' LEU . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.643 HD21 ' CE ' ' A' ' 65' ' ' MET . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.835 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 122' ' ' PHE . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 137' ' ' LEU . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.595 ' N ' HG13 ' A' ' 138' ' ' VAL . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.689 ' OG ' HD21 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 149' ' ' THR . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.64 ' H ' HG13 ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.46 ' OG1' HD12 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.689 HD21 ' OG ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 111' ' ' LEU . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.288 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.735 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 42' ' ' LEU . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.572 0.701 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 74' ' ' ILE . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.645 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.618 ' O ' HG13 ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.61 ' NZ ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.919 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.918 ' N ' HD22 ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 62' ' ' VAL . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.767 ' O ' HG12 ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.584 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.778 ' O ' HG22 ' A' ' 125' ' ' ILE . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.627 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.611 ' N ' HG23 ' A' ' 138' ' ' VAL . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 177' ' ' LEU . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.642 ' OH ' HG21 ' A' ' 125' ' ' ILE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 170' ' ' LYS . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 167' ' ' LEU . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 168' ' ' ILE . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 164' ' ' ASN . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.61 HD12 ' NZ ' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.419 HG13 ' H ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t . . . . . 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 68' ' ' LEU . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.509 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.713 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.765 0.793 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 63' ' ' VAL . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.713 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' ILE . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' CE2' ' A' ' 113' ' ' PHE . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.522 ' N ' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.85 ' N ' HD22 ' A' ' 95' ' ' LEU . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 CA--C 1.527 0.067 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.748 ' O ' HD23 ' A' ' 110' ' ' LEU . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 107' ' ' PHE 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 112' ' ' ALA . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.416 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.414 ' HE2' HD21 ' A' ' 177' ' ' LEU . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 131' ' ' LEU . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 126' ' ' ALA . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 164' ' ' ASN . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 48.4 mm-40 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.583 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.757 ' C ' HD22 ' A' ' 177' ' ' LEU 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.575 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.427 ' N ' HD23 ' A' ' 178' ' ' LEU . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.728 0.299 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 16' ' ' ALA . 3.9 p . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 5.9 tpm_? . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.547 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 62' ' ' VAL . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.574 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 70' ' ' ILE . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.596 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 86' ' ' ILE . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.152 0.501 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 111' ' ' LEU . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 69' ' ' LEU . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 39' ' ' VAL . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.749 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.619 ' CD1' HD12 ' A' ' 178' ' ' LEU . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.547 HD13 ' O ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.449 ' O ' HG22 ' A' ' 150' ' ' ILE . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.488 HG23 ' HD3' ' A' ' 170' ' ' LYS . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.559 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 167' ' ' LEU . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.548 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 163' ' ' ALA . 33.1 t-20 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.427 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.619 HD12 ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.46 HD23 ' NH2' ' A' ' 90' ' ' ARG . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' ALA . 1.3 t . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 35' ' ' ALA . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 49' ' ' LEU . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.361 0.124 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 63' ' ' VAL . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 63' ' ' VAL . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.567 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.669 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 95' ' ' LEU . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.708 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' HD12 ' A' ' 95' ' ' LEU . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 110' ' ' LEU . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' CD2' HD21 ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 119' ' ' ILE . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.501 ' O ' HD13 ' A' ' 140' ' ' LEU . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 136' ' ' PRO . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 149' ' ' THR . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 170' ' ' LYS . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 153' ' ' VAL . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 150' ' ' ILE . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 4.4 m-20 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.531 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.5 HG23 ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HB3' HH21 ' A' ' 90' ' ' ARG . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.524 0.202 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' VAL . 2.9 t . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 33' ' ' LEU . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' VAL . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 37' ' ' LEU . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.44 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 47' ' ' LEU . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 ' CE1' ' A' ' 182' ' ' TYR . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.037 0.446 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 73' ' ' LEU . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.708 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.61 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.708 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' O ' HD13 ' A' ' 110' ' ' LEU . 22.4 m-85 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 106' ' ' PHE . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 69' ' ' LEU . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 87' ' ' PHE . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.744 ' O ' HG12 ' A' ' 39' ' ' VAL . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 174' ' ' ALA 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.857 HD22 ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.576 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' A' ' 177' ' ' LEU . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 170' ' ' LYS . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.908 HD22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.829 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.628 ' HD2' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 178' ' ' LEU . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.545 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.454 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.642 0.258 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 7' ' ' LEU . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.804 0.335 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 38' ' ' ILE . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.487 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.618 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 45' ' ' SER . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.618 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.576 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.491 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 110' ' ' LEU . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.683 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.579 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 81' ' ' ASP . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 84' ' ' VAL . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.899 ' O ' HD22 ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 92' ' ' THR . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.1 m0 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 62' ' ' VAL . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.58 ' CE3' HD11 ' A' ' 175' ' ' ILE 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 116' ' ' LEU . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 122' ' ' PHE . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 137' ' ' LEU . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.416 ' O ' HD21 ' A' ' 177' ' ' LEU . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 144' ' ' LEU . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 149' ' ' THR . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 170' ' ' LYS . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 150' ' ' ILE . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.622 HD11 ' HB1' ' A' ' 152' ' ' ALA . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 149' ' ' THR . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 168' ' ' ILE . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 175' ' ' ILE . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.58 HD11 ' CE3' ' A' ' 115' ' ' TRP . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 176' ' ' VAL . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 3' ' ' MET . 24.5 mt-30 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.08 24.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 1' ' ' GLN . 19.1 ptt? -159.34 -8.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.589 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.43 ' H ' ' H ' ' A' ' 3' ' ' MET . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' HD22 ' A' ' 37' ' ' LEU . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.5 121.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -48.55 -45.99 69.88 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.857 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 16.5 Cg_exo -67.46 -18.63 49.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.238 1.959 . . . . 0.0 110.862 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.5 p 40.57 26.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.623 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' LEU . 14.4 p -45.55 134.65 6.04 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' VAL . 42.5 Cg_exo -33.75 88.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.263 1.975 . . . . 0.0 112.015 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' VAL . 10.7 tp -138.21 -54.77 0.64 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.636 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -92.2 17.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 48.54 14.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -93.25 -135.58 0.17 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.075 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.14 170.43 38.13 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.3 t -167.18 58.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -163.85 174.94 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.836 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 36' ' ' PHE . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 45' ' ' SER . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 182' ' ' TYR . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 -114.58 -81.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 52' ' ' THR . 7.5 t -171.12 79.45 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.947 0.403 . . . . 0.0 111.116 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -42.07 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.521 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 53' ' ' ALA . 1.4 t 79.17 10.35 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.538 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.06 53.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -145.45 -99.47 0.1 Allowed 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.34 0.59 . . . . 0.0 109.472 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 -155.34 50.65 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.65 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 110' ' ' LEU . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.573 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD13 ' HG3' ' A' ' 117' ' ' PRO . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.541 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 74' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.519 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.631 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' LEU . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.971 ' N ' HD22 ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -47.13 124.98 7.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -156.24 -70.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -82.48 18.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.911 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -173.11 63.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.958 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 102' ' ' LEU . 89.3 m -95.81 155.96 16.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.965 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 ' C ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -100.62 104.07 28.39 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.349 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.27 113.73 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.932 1.755 . . . . 0.0 112.412 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -170.88 -128.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.42 44.32 1.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 43.14 60.53 2.5 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' VAL . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 179' ' ' TYR . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 112' ' ' ALA . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.781 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.634 HG22 ' H ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.634 ' H ' HG22 ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.995 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.995 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 150' ' ' ILE . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.522 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 162' ' ' LYS . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.8 m-20 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.843 ' O ' HD12 ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.999 ' N ' HD13 ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 168' ' ' ILE . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.485 HD13 HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 111' ' ' LEU . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 186' ' ' THR . . . -35.22 103.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.923 HD23 ' H ' ' A' ' 185' ' ' LEU . 1.9 pt? -68.05 38.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.509 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 184' ' ' ALA . 3.7 t -154.9 160.8 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.651 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 189' ' ' LEU . 48.7 mt-10 66.59 -144.17 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.016 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 188' ' ' VAL . 0.9 OUTLIER 49.5 5.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.229 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.543 ' H ' ' C ' ' A' ' 187' ' ' GLU . 1.9 mm? -100.43 -77.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 190' ' ' LEU . 3.2 mm? 55.5 -79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LEU . 4.0 mm? -52.79 114.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.213 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.549 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 4' ' ' ALA . 13.7 mt 46.9 -149.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.642 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp 70.53 -45.35 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 2' ' ' LEU . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 6' ' ' ALA . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 18' ' ' LEU . 3.6 p -56.77 -166.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.727 ' H ' HG22 ' A' ' 17' ' ' VAL . 8.3 tp -86.21 -62.04 0.25 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 20' ' ' VAL . 15.4 Cg_endo -54.99 -47.0 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.978 1.785 . . . . 0.0 113.162 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.9 m 45.04 121.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 20' ' ' VAL . 94.6 t 118.16 -40.07 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.952 1.301 . . . . 0.0 111.492 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 60.2 Cg_endo -79.78 12.99 2.24 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.138 1.225 . . . . 0.0 113.253 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -164.43 -3.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.617 HG13 HD22 ' A' ' 23' ' ' LEU . 2.8 mt -148.32 136.82 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.74 70.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -152.58 -160.22 1.11 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.63 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.55 156.32 32.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.111 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -137.13 47.78 2.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.85 177.07 8.48 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.569 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 -129.39 81.98 2.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p 44.86 -122.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -178.11 -48.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.461 ' OG ' HD23 ' A' ' 55' ' ' LEU . 38.5 t 49.57 -86.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.367 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -158.46 49.59 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.858 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.05 -92.29 0.13 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.416 0.627 . . . . 0.0 110.396 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -148.2 39.98 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.318 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.616 ' CG2' HD23 ' A' ' 110' ' ' LEU . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 113' ' ' PHE . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 73' ' ' LEU . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 87' ' ' PHE . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' SER . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.512 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.519 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.892 ' O ' HD12 ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.632 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.076 HD13 ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 1.076 ' H ' HD13 ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 39.68 93.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -96.48 -53.41 3.6 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.892 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 101' ' ' THR . 12.5 tt -77.72 171.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.482 ' N ' ' CG1' ' A' ' 99' ' ' ILE . 14.7 pt20 36.83 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -38.38 136.42 0.67 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.04 126.33 85.61 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.049 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.45 -98.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.837 1.691 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 105' ' ' PHE . 41.9 t 42.03 -128.2 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.551 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 5.3 m-30 -60.97 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.578 0.704 . . . . 0.0 109.336 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 81.3 m-85 -163.41 65.04 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.616 HD23 ' CG2' ' A' ' 62' ' ' VAL . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.696 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.487 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 175' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.662 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.668 ' CZ ' HD13 ' A' ' 177' ' ' LEU . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.411 ' HG3' HD22 ' A' ' 135' ' ' ASN . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.577 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.588 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 0.5 OUTLIER 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 149' ' ' THR . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 160' ' ' PHE . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 162' ' ' LYS . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 152' ' ' ALA . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 171' ' ' VAL . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 168' ' ' ILE . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 172' ' ' THR . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.78 HD13 HD11 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.431 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 185' ' ' LEU . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 185' ' ' LEU . . . 43.0 -96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 186' ' ' THR . 57.2 tp 134.29 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.731 1.269 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 185' ' ' LEU . 14.8 t 50.94 -9.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 185' ' ' LEU . 7.6 tp10 -174.41 149.93 1.39 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.128 0.422 . . . . 0.0 111.115 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.695 HG12 HD22 ' A' ' 189' ' ' LEU . 13.8 t -111.44 -86.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.695 HD22 HG12 ' A' ' 188' ' ' VAL . 1.3 mm? -102.42 -166.43 1.28 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 190' ' ' LEU . 9.9 mp -77.83 -86.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.243 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? 55.69 -109.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.492 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 1' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.4 OUTLIER -84.71 -6.16 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 109.851 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt -88.18 -33.35 18.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 10' ' ' LEU . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 7.5 t -43.78 168.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 8.3 mp -74.72 -70.66 0.23 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.747 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.13 -40.38 77.23 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.238 1.959 . . . . 0.0 113.783 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 17' ' ' VAL . 27.8 m 35.01 28.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 117.724 0.238 . . . . 0.0 111.566 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 19' ' ' PRO . 4.4 m -47.5 140.29 7.71 Favored Pre-proline 0 C--O 1.218 -0.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' VAL . 45.6 Cg_exo -31.36 84.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.504 2.136 . . . . 0.0 113.841 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -148.54 1.63 0.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.268 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.68 21.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 119' ' ' ILE . 0.3 OUTLIER 43.94 50.17 7.13 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.58 -160.21 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.263 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.21 171.94 48.66 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -155.04 153.83 31.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.698 0.285 . . . . 0.0 110.306 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.75 -50.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 39' ' ' VAL . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 71' ' ' PHE . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.712 HD12 HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 100.4 62.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 52' ' ' THR . 2.8 p -37.09 136.65 0.4 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.294 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -90.62 0.38 57.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.032 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.413 ' O ' HD22 ' A' ' 55' ' ' LEU . 54.7 m 43.12 41.69 2.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.674 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -174.72 22.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 21.7 m-85 -125.45 -101.01 0.38 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.241 0.543 . . . . 0.0 110.079 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 35.3 m-85 -154.32 47.31 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.798 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' A' ' 63' ' ' VAL . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.712 HH21 HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 59' ' ' PHE . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 38' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' NZ ' ' OG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.546 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' HH21 ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.524 ' CE3' ' O ' ' A' ' 100' ' ' GLN . 90.3 m95 -41.82 -95.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 75.65 -40.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -89.99 -82.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.87 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CE3' ' A' ' 97' ' ' TRP . 23.0 tm0? -95.08 102.89 14.73 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.49 HG23 ' N ' ' A' ' 102' ' ' LEU . 12.6 t 179.93 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.96 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 101' ' ' THR . 23.2 mt 65.81 146.75 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.222 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 131.12 19.33 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.11 1.873 . . . . 0.0 112.053 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 106' ' ' PHE . 5.0 t -167.46 127.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.848 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER 41.1 17.58 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 104' ' ' SER . 63.1 m-85 66.77 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 115' ' ' TRP . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.54 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CD2' ' A' ' 25' ' ' PHE . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 1.011 ' N ' HD13 ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 129' ' ' GLN . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 137' ' ' LEU . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 139' ' ' MET . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.602 ' N ' HG23 ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.571 ' CD1' HD13 ' A' ' 177' ' ' LEU . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 150' ' ' ILE . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' THR . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.549 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' HD11 ' A' ' 150' ' ' ILE . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.915 ' H ' HG22 ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.784 ' H ' HD23 ' A' ' 167' ' ' LEU . 55.5 t30 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' N ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.524 HG23 ' HZ3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.535 ' OG1' ' NZ ' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 142' ' ' TYR . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.88 -130.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.63 -63.38 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.0 p -93.52 -155.61 0.45 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -72.67 -170.51 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.31 -0.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.63 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.5 mt -112.95 -30.27 7.08 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' LEU . 13.1 mt 59.14 -152.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.268 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER 57.87 113.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.521 ' N ' HD13 ' A' ' 191' ' ' LEU . 1.3 pm0 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.84 HE22 HD23 ' A' ' 47' ' ' LEU . 3.2 pm0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -141.72 28.65 1.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.133 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt -103.9 -20.99 13.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 120' ' ' LEU . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' ILE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t -117.62 155.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 7.9 mp -53.09 -72.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.244 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' O ' HG12 ' A' ' 21' ' ' VAL . 10.9 Cg_endo -55.22 -56.0 2.69 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.233 1.289 . . . . 0.0 112.059 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 20' ' ' VAL . 14.7 p 46.22 27.67 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 1.5 m -114.49 -34.8 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 122.271 -0.268 . . . . 0.0 111.169 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 42.2 Cg_endo -91.99 25.77 0.45 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.304 2.003 . . . . 0.0 112.997 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 168' ' ' ILE . 79.5 mt -145.18 -88.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -86.19 145.4 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.331 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.1 37.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -101.88 -167.17 1.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.794 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.79 150.53 23.48 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.043 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.7 t -176.12 31.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.19 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -69.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.388 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ALA . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.84 HD23 HE22 ' A' ' 1' ' ' GLN . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.565 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -163.37 171.88 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 52' ' ' THR . 4.7 p -48.06 119.49 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.49 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 56' ' ' PHE . . . -101.3 121.74 42.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.732 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 p -98.05 87.7 4.03 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp 68.25 69.41 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.515 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 49.0 m-85 -131.95 15.62 4.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 65.74 63.97 0.58 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.556 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' CZ ' ' A' ' 105' ' ' PHE . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 70' ' ' ILE . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 67' ' ' PHE . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 71' ' ' PHE . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' LYS . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.418 ' C ' ' H ' ' A' ' 99' ' ' ILE . 91.0 m95 58.25 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' SER . 20.9 mtpp 68.67 -43.99 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.447 0.467 . . . . 0.0 110.562 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -76.98 -80.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 102' ' ' LEU . 38.0 mt-30 -81.22 -69.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.368 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' LEU . 4.2 m 64.0 -68.46 0.09 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.841 0.353 . . . . 0.0 110.686 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 100' ' ' GLN . 4.8 tp 90.39 80.58 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.774 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 102' ' ' LEU . 81.8 Cg_exo -48.59 -130.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 123.294 2.663 . . . . 0.0 113.702 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.0 t 67.96 136.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 105' ' ' PHE . 1.9 t80 53.77 1.7 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 68.88 95.29 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 105' ' ' PHE . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 111' ' ' LEU . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.785 ' O ' HD11 ' A' ' 175' ' ' ILE . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.856 ' O ' HG12 ' A' ' 39' ' ' VAL . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 125' ' ' ILE . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.736 ' H ' HD13 ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 150' ' ' ILE . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.492 ' N ' HG23 ' A' ' 149' ' ' THR . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.465 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB1' HD21 ' A' ' 167' ' ' LEU . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.463 ' H ' ' HA ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.547 ' O ' HG22 ' A' ' 168' ' ' ILE . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 152' ' ' ALA . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 165' ' ' PHE . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 175' ' ' ILE . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 178' ' ' LEU . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -36.52 106.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.865 HD22 ' H ' ' A' ' 185' ' ' LEU . 2.1 mm? -60.2 176.68 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.994 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 187' ' ' GLU . 4.2 m 60.21 -155.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.068 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.971 ' H ' HG22 ' A' ' 186' ' ' THR . 1.5 pp20? 14.05 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 190' ' ' LEU . 9.8 p -170.35 145.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.157 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 24.1 mt -37.29 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.26 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 188' ' ' VAL . 0.3 OUTLIER -92.28 112.94 25.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.993 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 190' ' ' LEU . 1.8 tt -162.09 91.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.423 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -164.47 33.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.631 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm -140.91 45.05 1.8 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.99 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 20' ' ' VAL . 1.8 p -76.86 175.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 3.0 mt -62.97 -69.21 0.63 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.063 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 9.4 Cg_endo -52.87 -44.82 45.31 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.938 1.759 . . . . 0.0 112.333 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 20' ' ' VAL . 8.6 p 27.62 64.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.76 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 9.0 p -173.25 -30.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.76 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 45.0 Cg_endo -99.19 -13.87 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.22 1.946 . . . . 0.0 112.877 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mp -104.62 -44.91 4.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.033 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ALA . 3.3 pt -137.3 126.27 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.627 0.251 . . . . 0.0 110.661 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.91 88.27 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -156.87 173.64 16.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.644 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.66 163.73 32.28 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.254 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' ' 32' ' ' ALA . 5.4 m -164.42 -151.6 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.18 -0.51 . . . . 0.0 109.873 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 40.36 -98.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.269 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' H ' ' A' ' 28' ' ' SER . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.742 HD13 ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' N ' HD13 ' A' ' 33' ' ' LEU . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 35' ' ' ALA . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 118' ' ' ALA . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.597 ' N ' ' SD ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' CA ' HG11 ' A' ' 188' ' ' VAL . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 -165.73 66.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -46.32 144.11 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.185 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.75 139.73 48.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -81.84 32.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.136 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -168.15 38.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 87.3 t80 -135.87 7.54 3.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.332 0.587 . . . . 0.0 109.711 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 67.08 74.4 0.33 Allowed 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.223 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 110' ' ' LEU . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 117' ' ' PRO . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' ILE . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 84' ' ' VAL . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' OG1' ' A' ' 172' ' ' THR . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.934 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER 59.6 144.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -149.76 -37.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mt -57.99 -67.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -83.18 -155.55 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.9 p -148.13 112.68 5.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.462 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 102' ' ' LEU . 2.9 mm? -63.34 151.8 86.45 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -36.03 154.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.389 2.059 . . . . 0.0 112.419 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 106' ' ' PHE . 13.2 t -58.16 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 41.0 18.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.599 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.863 ' O ' HD13 ' A' ' 110' ' ' LEU . 3.8 m-85 47.71 73.81 0.19 Allowed 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 106' ' ' PHE . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.643 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' HD13 ' A' ' 68' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 120' ' ' LEU . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.487 HD12 ' NE2' ' A' ' 129' ' ' GLN . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 131' ' ' LEU . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.524 ' ND2' ' OE2' ' A' ' 187' ' ' GLU . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 150' ' ' ILE . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 149' ' ' THR . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' GLY . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 149' ' ' THR . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.411 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.527 ' CB ' HD22 ' A' ' 167' ' ' LEU . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 152' ' ' ALA . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 172' ' ' THR . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 169' ' ' ARG . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 185' ' ' LEU . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -47.89 91.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 185' ' ' LEU . 0.4 OUTLIER -75.96 71.95 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.95 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -174.14 155.03 2.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 111.203 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.524 ' OE2' ' ND2' ' A' ' 135' ' ' ASN . 19.6 tt0 67.97 21.43 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.062 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.416 HG11 ' CA ' ' A' ' 50' ' ' GLY . 45.0 t -58.54 -50.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 41.2 tp -174.95 132.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 24.8 mt -67.68 -74.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.402 ' C ' HD13 ' A' ' 191' ' ' LEU . 0.3 OUTLIER 69.7 -69.68 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.083 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.573 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.496 ' H3 ' ' HB2' ' A' ' 4' ' ' ALA . 5.9 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -78.11 -22.55 48.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.699 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -98.83 -3.1 36.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.556 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.496 ' HB2' ' H3 ' ' A' ' 1' ' ' GLN . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 7' ' ' LEU . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 20' ' ' VAL . 7.5 p -56.17 99.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mm? -1.04 -69.03 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.272 0.629 . . . . 0.0 112.628 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' VAL . 30.9 Cg_endo -61.84 -45.54 16.49 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.881 1.721 . . . . 0.0 113.915 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.762 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER 39.96 -161.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.426 0.557 . . . . 0.0 110.043 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' H ' HG12 ' A' ' 20' ' ' VAL . 20.6 t 89.19 -69.66 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.571 1.548 . . . . 0.0 112.867 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 20' ' ' VAL . 89.9 Cg_endo -92.61 9.94 2.47 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 CA-C-N 123.145 2.159 . . . . 0.0 112.009 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' PHE . 3.8 mm? -118.39 166.16 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.521 ' C ' ' N ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER 31.7 27.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.641 179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 40.11 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -98.04 -168.68 1.7 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.375 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.0 -175.92 20.55 Favored Glycine 0 N--CA 1.466 0.68 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -174.78 157.71 2.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.105 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 59.38 151.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.686 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 37' ' ' LEU . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.445 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 52' ' ' THR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -101.31 77.28 1.78 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 49' ' ' LEU . 67.1 p -58.84 94.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' SER . . . -88.51 170.29 11.01 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 56' ' ' PHE . 5.1 t -59.28 -141.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -54.98 84.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' SER . 6.3 t80 -113.81 -101.59 0.42 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -153.9 33.32 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 HH22 ' HA ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 71' ' ' PHE . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 81' ' ' ASP . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.585 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ3' ' HG3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.402 ' HG2' ' N ' ' A' ' 92' ' ' THR . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.451 ' CA ' ' NH2' ' A' ' 90' ' ' ARG . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 95' ' ' LEU . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 54.47 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -140.84 -41.41 0.4 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.45 132.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.977 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 44.67 55.95 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.519 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -42.54 141.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.6 mt -116.65 83.56 14.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.274 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -46.58 133.53 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 112.915 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.6 m -168.74 -136.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.201 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 56.9 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 40.76 63.8 1.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD13 ' CZ ' ' A' ' 179' ' ' TYR . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.673 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.678 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 1.01 ' N ' HD13 ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.717 ' C ' HD22 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.512 ' N ' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 170' ' ' LYS . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.501 ' CD1' ' HZ1' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.739 ' HB3' HD21 ' A' ' 167' ' ' LEU . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.716 ' H ' HG22 ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.608 ' OD1' HG11 ' A' ' 161' ' ' VAL . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 152' ' ' ALA . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.501 ' HZ1' ' CD1' ' A' ' 150' ' ' ILE . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 185' ' ' LEU . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.8 -94.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 183' ' ' PHE . 2.5 tp -154.66 175.29 13.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.43 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 186' ' ' THR . 0.0 OUTLIER -69.59 63.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 110.181 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 185' ' ' LEU . 6.5 tp10 -173.11 106.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.362 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 188' ' ' VAL . 4.0 m -64.34 -171.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -74.84 104.62 5.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.231 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.581 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.9 OUTLIER -66.84 115.29 6.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.073 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.581 ' N ' HD13 ' A' ' 190' ' ' LEU . 44.9 tp -130.94 123.14 28.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.501 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.405 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 1.9 tp-100 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.405 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 6.0 tp -173.91 47.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.404 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp -170.21 -33.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 20' ' ' VAL . 1.1 p -65.66 167.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 mm? -65.2 -66.82 1.23 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.167 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' VAL . 8.4 Cg_endo -52.89 -26.19 30.33 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.023 1.815 . . . . 0.0 113.194 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' H ' ' A' ' 21' ' ' VAL . 5.3 p 11.79 -83.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.064 ' H ' HG13 ' A' ' 20' ' ' VAL 0.292 2.1 p 39.54 -140.18 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 114.726 -2.559 . . . . 0.0 107.766 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.911 ' CD ' HG13 ' A' ' 21' ' ' VAL . 48.1 Cg_exo -60.81 -130.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 1 CA-C-N 128.676 4.134 . . . . 0.0 112.438 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.4 mt 68.89 -57.72 0.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.603 ' CG2' HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -123.54 16.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 171' ' ' VAL . 3.5 m-30 53.52 -90.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 39.45 -162.3 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.56 134.99 3.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 p -177.73 65.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.712 0.292 . . . . 0.0 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -175.11 -171.17 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.163 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 33' ' ' LEU . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' NH1' ' A' ' 61' ' ' ARG . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.653 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' THR . 14.5 m-85 -87.71 -82.29 0.23 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m 83.35 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.07 -123.63 0.16 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.524 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -140.59 -30.16 0.66 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -132.27 50.23 2.25 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.059 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -112.75 7.81 18.67 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 58.63 59.88 2.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.271 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 63' ' ' VAL . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 110' ' ' LEU . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 70' ' ' ILE . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.893 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.647 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' HD13 ' A' ' 116' ' ' LEU . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 95' ' ' LEU . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.401 ' HE1' ' HB2' ' A' ' 107' ' ' PHE . 1.4 p90 -65.93 121.73 15.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.9 -21.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.9 mt -55.59 -69.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -171.38 58.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.576 HG22 HD23 ' A' ' 102' ' ' LEU . 47.6 m -80.72 -100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 101' ' ' THR . 3.8 mm? -100.78 106.11 41.83 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.3 Cg_exo -45.45 -24.06 1.57 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.079 1.853 . . . . 0.0 112.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.2 p -55.71 -161.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.282 . . . . 0.0 110.514 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -51.97 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' SER . 79.1 m-85 -16.49 -48.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.208 0.942 . . . . 0.0 112.739 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.555 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.647 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.805 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.923 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 130' ' ' THR . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.42 ' OE1' HG11 ' A' ' 138' ' ' VAL . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.42 HG11 ' OE1' ' A' ' 129' ' ' GLN . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 150' ' ' ILE . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 148' ' ' VAL . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 151' ' ' ALA . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.69 ' HB3' ' NZ ' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.626 ' N ' HG22 ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.653 ' O ' HG22 ' A' ' 168' ' ' ILE . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.603 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 165' ' ' PHE . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.69 ' NZ ' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 168' ' ' ILE . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.467 HG22 ' CD ' ' A' ' 90' ' ' ARG . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 177' ' ' LEU . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 176' ' ' VAL . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . 35.42 -150.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 186' ' ' THR . 0.2 OUTLIER -139.31 91.92 2.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.575 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER 34.33 96.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.427 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 188' ' ' VAL . 59.6 mt-10 -144.64 -105.94 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.276 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 187' ' ' GLU . 43.2 t 54.19 106.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 189' ' ' LEU . 10.1 mp -44.57 114.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.433 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 190' ' ' LEU . 0.2 OUTLIER -91.01 17.61 7.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.21 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.45 ' CG ' ' H ' ' A' ' 192' ' ' GLU . 4.9 tp 63.49 -135.88 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.305 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 191' ' ' LEU . 11.5 pt-20 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.478 ' N ' ' CD ' ' A' ' 1' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.7 OUTLIER -154.22 -161.88 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.438 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 2' ' ' LEU . 12.0 ttt 80.33 -28.43 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.65 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 6' ' ' ALA . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 11' ' ' SER . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 3.9 t -50.92 174.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 9.3 mp -82.83 -71.08 0.12 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' VAL . 71.3 Cg_exo -38.21 -50.02 2.22 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 113.818 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 19' ' ' PRO . 20.3 m 45.76 9.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.634 ' H ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 p -110.37 -29.66 0.15 Allowed Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' HD3' ' H ' ' A' ' 21' ' ' VAL . 72.6 Cg_endo -95.42 -15.12 0.54 Allowed 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 121.824 1.683 . . . . 0.0 111.744 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 23' ' ' LEU . 4.2 mm? -99.77 -97.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.6 mt -86.74 160.85 2.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 25.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -69.02 -168.64 0.14 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.428 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.22 149.26 19.48 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.084 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.7 t -157.21 -179.1 7.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.168 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 48.96 -152.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 5' ' ' PHE . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.514 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.416 HD12 ' NH1' ' A' ' 61' ' ' ARG . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' THR . 51.4 m-85 -118.69 179.7 4.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' TYR . 41.4 p -53.77 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -171.94 112.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.422 0.629 . . . . 0.0 111.859 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.63 ' C ' HD22 ' A' ' 55' ' ' LEU . 58.0 m -130.07 -52.7 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 54' ' ' SER . 4.4 mm? -121.1 4.99 10.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.628 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 2.3 m-30 -82.44 20.28 1.12 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.3 38.21 23.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.491 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 113' ' ' PHE . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 73' ' ' LEU . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 76' ' ' LEU . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.994 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.653 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.919 ' O ' HD22 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.653 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -63.18 81.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 24.5 ttpp -82.13 -55.36 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.329 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -52.07 -171.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.804 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -70.77 117.9 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.248 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.4 m -161.0 -75.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.453 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.69 79.31 48.22 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.135 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.74 118.42 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.685 2.257 . . . . 0.0 111.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.8 t -154.59 -129.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -79.1 55.6 1.85 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 110' ' ' LEU . 4.4 m-85 42.69 56.43 3.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.516 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 106' ' ' PHE . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.625 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.758 ' O ' HG12 ' A' ' 39' ' ' VAL . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 119' ' ' ILE . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 177' ' ' LEU . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.72 ' N ' HD13 ' A' ' 127' ' ' ILE . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.426 HE22 HG12 ' A' ' 138' ' ' VAL . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 131' ' ' LEU . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.592 ' N ' HD13 ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HD11 ' A' ' 150' ' ' ILE . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 167' ' ' LEU . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 147' ' ' ALA . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.622 ' H ' HG13 ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.495 ' ND2' HG11 ' A' ' 161' ' ' VAL . 51.9 m-20 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.707 ' O ' HG22 ' A' ' 168' ' ' ILE . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 14.4 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 149' ' ' THR . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 165' ' ' PHE . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.632 ' HE3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.48 ' H ' HD23 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 35.99 -144.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.71 -70.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 p -152.83 4.84 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -98.33 32.8 2.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.13 -39.41 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.275 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.5 OUTLIER -160.48 143.65 13.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.864 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 189' ' ' LEU . 42.5 tp -155.79 -46.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.496 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? -71.9 108.95 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.538 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -167.1 0.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 -28.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.382 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 20' ' ' VAL . 4.9 p -70.39 158.49 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 8.9 mt -42.24 -68.71 0.25 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.729 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 38.3 Cg_endo -63.84 -28.97 67.74 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.347 2.031 . . . . 0.0 115.13 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER 36.7 73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.763 0.711 . . . . 0.0 111.238 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.859 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.2 p 175.2 -16.53 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.859 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 40.3 Cg_endo -91.0 -8.07 3.53 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 CA-C-N 121.398 1.535 . . . . 0.0 114.551 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mt -147.04 -36.49 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 162' ' ' LYS . 0.7 OUTLIER -97.96 -0.78 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.176 0.898 . . . . 0.0 111.333 -178.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 42.69 42.82 3.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -132.99 -165.09 1.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.783 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' ALA . . . 45.06 -174.01 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 p -160.12 -159.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.334 0.587 . . . . 0.0 111.587 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -177.9 -147.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' N ' ' A' ' 29' ' ' ARG . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.694 ' H ' HD12 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' ALA . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.457 HG23 HD23 ' A' ' 42' ' ' LEU . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.594 HD12 ' CZ ' ' A' ' 61' ' ' ARG . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 52' ' ' THR . 73.3 t80 -127.03 -179.78 5.02 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 51' ' ' TYR . 5.8 m -59.23 -122.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.64 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -174.22 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.199 0.523 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m 58.73 -99.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.797 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 33.86 3.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.429 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 48' ' ' ILE . 9.7 m-85 -111.41 23.67 13.71 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 54.07 57.3 6.07 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.394 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 63' ' ' VAL . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' HG23 ' A' ' 62' ' ' VAL . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.643 ' CE ' HD21 ' A' ' 114' ' ' LEU . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 113' ' ' PHE . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.415 HG23 ' H ' ' A' ' 70' ' ' ILE . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 81' ' ' ASP . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 84' ' ' VAL . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 172' ' ' THR . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' O ' ' NE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.498 ' N ' HH21 ' A' ' 90' ' ' ARG . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' N ' ' OG ' ' A' ' 96' ' ' SER . 21.0 m-90 -63.83 135.98 57.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -145.79 47.23 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.766 0.317 . . . . 0.0 110.917 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mt -138.76 -48.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.757 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.34 43.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.41 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.9 t -59.44 -160.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.125 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.71 96.08 26.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.881 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.34 152.96 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.325 2.017 . . . . 0.0 113.449 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 106' ' ' PHE . 29.2 p -175.89 -162.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.888 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.604 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -59.54 -4.83 0.69 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.626 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 11.7 m-85 136.15 115.75 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 95' ' ' LEU . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 69' ' ' LEU . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.643 HD21 ' CE ' ' A' ' 65' ' ' MET . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.835 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 122' ' ' PHE . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 137' ' ' LEU . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.595 ' N ' HG13 ' A' ' 138' ' ' VAL . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.689 ' OG ' HD21 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 149' ' ' THR . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.64 ' H ' HG13 ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.46 ' OG1' HD12 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.689 HD21 ' OG ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 111' ' ' LEU . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.76 89.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.95 -24.74 62.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.935 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -80.6 -89.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -140.39 149.97 43.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 188' ' ' VAL . 7.8 p -105.79 34.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 188' ' ' VAL . 0.2 OUTLIER 84.0 -77.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.296 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 189' ' ' LEU . 11.9 mt 51.52 173.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 110.619 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 191' ' ' LEU . 2.3 tm? -77.79 -54.52 6.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.866 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.443 ' N ' HD13 ' A' ' 191' ' ' LEU . 16.5 pt-20 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.53 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 tp -71.31 -128.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 mtt 63.56 -68.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.684 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 2' ' ' LEU . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t -34.08 -97.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -171.49 -48.88 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD2' ' H ' ' A' ' 18' ' ' LEU . 70.0 Cg_endo -93.09 -17.75 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.613 2.209 . . . . 0.0 109.82 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 31.63 47.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.978 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -96.72 -44.97 0.25 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -101.36 -157.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.151 2.567 . . . . 0.0 111.859 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 43.78 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -88.75 124.67 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.507 -178.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ALA . 3.1 m-85 -49.55 -13.75 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -37.66 162.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.34 152.84 24.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.877 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 p -173.59 62.95 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.761 0.315 . . . . 0.0 110.939 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -163.82 165.08 23.31 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.321 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.735 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 42' ' ' LEU . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 -173.63 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 p -41.62 152.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -169.65 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 55' ' ' LEU . 38.9 p 59.86 -71.2 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 ' N ' ' OG ' ' A' ' 54' ' ' SER . 2.2 tt -151.73 64.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.63 5.37 12.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.42 64.93 0.41 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.312 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 74' ' ' ILE . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.618 ' O ' HG13 ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.61 ' NZ ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.919 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.918 ' N ' HD22 ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -41.95 148.32 0.18 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -155.84 -71.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.27 139.77 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 45.52 50.34 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -78.08 161.68 27.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.66 148.58 45.8 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.117 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.59 110.32 3.04 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.207 1.938 . . . . 0.0 112.217 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.534 ' OG ' ' CD2' ' A' ' 107' ' ' PHE . 89.6 p -173.65 -171.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.411 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -50.33 -78.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 46.5 m-85 -166.28 69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CD2' ' OG ' ' A' ' 104' ' ' SER . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 62' ' ' VAL . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.767 ' O ' HG12 ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.584 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.778 ' O ' HG22 ' A' ' 125' ' ' ILE . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.627 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.611 ' N ' HG23 ' A' ' 138' ' ' VAL . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 177' ' ' LEU . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.642 ' OH ' HG21 ' A' ' 125' ' ' ILE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 170' ' ' LYS . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 167' ' ' LEU . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 168' ' ' ILE . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 164' ' ' ASN . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.61 HD12 ' NZ ' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.419 HG13 ' H ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.75 138.67 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 185' ' ' LEU . 7.3 mp -87.6 128.67 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.062 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.9 p -143.26 56.61 1.38 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 187' ' ' GLU . 28.5 mp0 45.36 94.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.681 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.91 -51.67 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER 179.73 22.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.864 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER 62.15 -75.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.064 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' LEU . 6.8 tp 39.84 63.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.937 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 192' ' ' GLU . 4.2 pm0 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -48.3 118.68 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt 39.95 45.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t 57.24 153.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' O ' ' N ' ' A' ' 20' ' ' VAL . 3.5 mm? -45.38 149.87 0.93 Allowed Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' C ' ' O ' ' A' ' 18' ' ' LEU . 20.5 Cg_exo -19.68 74.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.334 2.69 . . . . 0.0 113.131 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 18' ' ' LEU . 7.1 p -61.19 157.69 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.445 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' N ' HG22 ' A' ' 20' ' ' VAL . 4.3 m -63.37 139.85 97.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.691 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -39.41 102.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.822 1.681 . . . . 0.0 111.613 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -150.43 -31.81 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.271 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -114.7 124.11 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ALA . 2.4 m-85 -46.04 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -48.6 -111.47 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.401 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 167.35 17.4 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -177.2 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.121 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -143.7 163.56 32.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 68' ' ' LEU . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.509 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.713 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 85.94 149.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.874 HG22 ' H ' ' A' ' 53' ' ' ALA . 24.5 m -96.96 -177.91 4.03 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.855 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 52' ' ' THR . . . -149.29 176.08 10.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.468 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -59.31 84.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 53' ' ' ALA . 10.9 mt 66.06 68.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.1 35.83 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 55' ' ' LEU . 8.8 t80 40.74 48.29 2.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 63' ' ' VAL . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.713 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' ILE . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' CE2' ' A' ' 113' ' ' PHE . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.522 ' N ' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.937 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.85 ' N ' HD22 ' A' ' 95' ' ' LEU . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -90.53 173.32 8.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.11 -54.31 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.732 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.76 -19.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -84.49 42.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.7 m -157.13 -101.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.576 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.09 77.2 2.76 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.833 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -50.73 167.08 0.29 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.894 2.396 . . . . 0.0 112.94 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 106' ' ' PHE . 7.6 t -173.77 -137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -66.83 67.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 104' ' ' SER . 37.2 m-85 53.85 62.69 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.748 ' O ' HD23 ' A' ' 110' ' ' LEU . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 107' ' ' PHE 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 112' ' ' ALA . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.416 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.414 ' HE2' HD21 ' A' ' 177' ' ' LEU . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 131' ' ' LEU . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 126' ' ' ALA . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 164' ' ' ASN . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 48.4 mm-40 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 24' ' ' ILE . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.583 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.757 ' C ' HD22 ' A' ' 177' ' ' LEU 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.575 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.427 ' N ' HD23 ' A' ' 178' ' ' LEU . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.26 91.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.485 ' O ' HD13 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -69.07 -16.12 63.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 186' ' ' THR . 17.1 m -92.33 46.07 1.24 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.796 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -177.19 31.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.906 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 189' ' ' LEU . 2.3 t -77.24 -124.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.762 HD13 HG12 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -141.34 171.77 13.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.054 0.388 . . . . 0.0 110.706 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.678 ' C ' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -171.0 174.78 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -144.35 159.68 42.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.541 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.28 82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.072 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp -174.06 -6.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.606 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 18' ' ' LEU . 3.9 p -54.54 -165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' H ' HG22 ' A' ' 17' ' ' VAL . 2.4 mt -87.23 -62.78 0.23 Allowed Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 20' ' ' VAL . 77.2 Cg_exo -41.52 -52.26 3.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.065 1.843 . . . . 0.0 113.016 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 22.0 m 46.78 42.54 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.777 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 10.0 p -164.39 -29.92 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.777 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 43.3 Cg_endo -101.27 16.79 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.167 1.911 . . . . 0.0 111.86 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 163' ' ' ALA . 3.8 tp -143.84 -66.07 0.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.533 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG23 ' CD2' ' A' ' 167' ' ' LEU . 1.6 mt -88.63 20.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.069 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' ILE . 14.3 t80 35.93 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.01 0.434 . . . . 0.0 110.745 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -110.65 -161.64 0.76 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.8 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 28' ' ' SER . . . -162.14 139.66 6.1 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 27' ' ' GLY . 1.7 m -169.42 72.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 5.9 tpm_? -164.12 -106.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.286 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.547 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 56' ' ' PHE . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.527 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 41.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 71.9 m 51.97 -95.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' THR . . . 160.71 25.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -56.15 78.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.1 tp 60.48 31.25 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.2 m-85 -104.47 25.7 9.88 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 55.29 52.96 10.62 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.747 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 62' ' ' VAL . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.574 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 70' ' ' ILE . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.596 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 86' ' ' ILE . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 98' ' ' LYS . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -87.5 110.51 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.685 ' HG3' HD13 ' A' ' 95' ' ' LEU . 19.7 mmmt -132.61 -24.08 2.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.825 ' H ' HD13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -54.35 -91.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' THR . 88.8 mt-30 -86.74 -54.33 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 100' ' ' GLN . 9.8 t 44.7 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.182 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mp -112.99 106.13 55.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -42.96 128.4 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.816 1.678 . . . . 0.0 112.304 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m -163.74 -139.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.403 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -80.07 52.99 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 68.85 -48.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.439 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 111' ' ' LEU . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 69' ' ' LEU . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 39' ' ' VAL . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.749 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.619 ' CD1' HD12 ' A' ' 178' ' ' LEU . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.547 HD13 ' O ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 144' ' ' LEU . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.449 ' O ' HG22 ' A' ' 150' ' ' ILE . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.488 HG23 ' HD3' ' A' ' 170' ' ' LYS . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.559 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 167' ' ' LEU . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.548 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.479 ' O ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' HD23 ' A' ' 23' ' ' LEU . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' O ' ' O ' ' A' ' 163' ' ' ALA . 33.1 t-20 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.509 ' CD2' HG23 ' A' ' 24' ' ' ILE . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.619 HD12 ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.46 HD23 ' NH2' ' A' ' 90' ' ' ARG . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -37.9 -45.55 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 185' ' ' LEU . 0.3 OUTLIER 71.84 -56.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 187' ' ' GLU . 0.1 OUTLIER -40.56 107.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.406 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 186' ' ' THR . 15.0 tt0 81.18 107.86 0.07 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.316 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 190' ' ' LEU . 1.8 t -146.4 58.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.637 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 190' ' ' LEU . 9.0 mp 57.07 6.31 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.789 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 188' ' ' VAL . 0.4 OUTLIER 25.01 -113.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.888 0.743 . . . . 0.0 112.351 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.456 ' H ' ' CG ' ' A' ' 190' ' ' LEU . 18.9 tp 52.01 54.04 11.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 192' ' ' GLU . 2.2 mp0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.02 -0.99 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tp -169.88 39.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.58 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 1.3 t -49.96 -177.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.537 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 1.7 mt -75.47 -69.49 0.25 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 21' ' ' VAL . 11.1 Cg_endo -52.96 -65.2 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.04 1.827 . . . . 0.0 111.691 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 6.4 t 60.56 -22.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 19' ' ' PRO . 4.5 p -72.0 -34.46 2.95 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.383 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 71.7 Cg_endo -102.4 -1.3 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.821 2.347 . . . . 0.0 111.386 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.07 -88.64 0.46 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.321 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.1 mt -89.15 148.9 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -62.52 6.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -83.53 -154.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 146.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -155.44 -12.64 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.619 0.247 . . . . 0.0 110.988 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 39.39 -107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.126 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 35' ' ' ALA . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 49' ' ' LEU . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -143.07 130.69 21.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 m -54.16 139.06 36.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -129.02 2.99 5.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.027 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 89.03 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.94 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.22 77.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.49 0.662 . . . . 0.0 111.443 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' SER . 3.9 m-85 -116.49 -97.49 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -149.87 33.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.314 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 63' ' ' VAL . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 63' ' ' VAL . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.567 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 76' ' ' LEU . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.669 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 95' ' ' LEU . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.708 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' HD12 ' A' ' 95' ' ' LEU . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 51.26 -101.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 53.7 50.75 16.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 0.0 110.99 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.12 -31.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' THR . 41.1 tt0 -174.69 30.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -57.59 -139.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.184 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.08 73.57 4.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.601 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.89 174.28 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.911 2.407 . . . . 0.0 112.412 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.1 p -178.43 -102.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.806 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -91.06 50.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 27.0 16.56 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 110' ' ' LEU . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' CD2' HD21 ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 119' ' ' ILE . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.501 ' O ' HD13 ' A' ' 140' ' ' LEU . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 136' ' ' PRO . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 149' ' ' THR . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 170' ' ' LYS . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 153' ' ' VAL . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 150' ' ' ILE . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 4.4 m-20 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.531 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.5 HG23 ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HB3' HH21 ' A' ' 90' ' ' ARG . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . 27.31 -132.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.18 -167.83 1.95 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.713 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 186' ' ' THR . 6.1 p -86.5 101.06 12.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' VAL . 8.6 pt-20 -169.72 -48.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.86 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 187' ' ' GLU . 45.1 t 56.91 155.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.337 . . . . 0.0 110.604 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.5 mm? -64.2 91.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.026 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.44 163.89 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.6 OUTLIER -159.66 19.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.613 179.978 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.552 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 25.9 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.552 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 0.2 OUTLIER 78.4 22.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm -173.41 -38.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.705 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.9 t -50.98 96.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.4 mm? -30.13 -62.88 0.22 Allowed Pre-proline 0 N--CA 1.474 0.774 0 O-C-N 122.953 0.158 . . . . 0.0 111.089 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 21' ' ' VAL . 75.9 Cg_exo -37.13 -22.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.246 1.964 . . . . 0.0 113.326 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 17' ' ' VAL . 5.2 m -27.12 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.741 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.0 t -124.57 -40.22 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.328 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.741 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 26.0 Cg_endo -103.75 -2.1 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 110.833 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 mt -86.74 -93.36 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.096 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.646 HG13 HD11 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -131.66 131.82 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.309 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -46.39 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -160.92 178.8 9.04 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.764 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.49 53.29 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.118 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -153.83 151.19 29.25 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 -172.0 38.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 33' ' ' LEU . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' VAL . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 37' ' ' LEU . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.44 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 47' ' ' LEU . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 ' CE1' ' A' ' 182' ' ' TYR . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -101.77 -177.39 3.41 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -81.86 -20.31 39.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.387 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.01 87.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.826 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.6 m -101.47 -23.35 14.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.71 11.16 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.784 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -96.17 40.97 1.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.605 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 43.0 52.66 5.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 73' ' ' LEU . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.708 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.61 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.708 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 -75.24 171.52 14.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -142.71 -178.0 5.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.161 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' ' CG ' ' A' ' 98' ' ' LYS . 76.6 mt 58.28 -90.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 101' ' ' THR . 63.4 tt0 -71.34 -77.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 102' ' ' LEU . 50.7 m 51.92 169.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.642 ' N ' HG22 ' A' ' 101' ' ' THR . 30.6 tp -105.03 106.92 57.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 102' ' ' LEU . 30.8 Cg_exo -38.12 -106.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.501 2.134 . . . . 0.0 113.48 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 106' ' ' PHE . 2.6 p 71.28 131.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.28 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 27.1 t80 -1.24 -65.31 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.223 0.952 . . . . 0.0 112.923 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 22.4 m-85 -174.7 87.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 106' ' ' PHE . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 69' ' ' LEU . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 87' ' ' PHE . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.744 ' O ' HG12 ' A' ' 39' ' ' VAL . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 174' ' ' ALA 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.857 HD22 ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.576 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' A' ' 177' ' ' LEU . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 170' ' ' LYS . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.908 HD22 ' O ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.829 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.628 ' HD2' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 178' ' ' LEU . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.545 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -27.25 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 185' ' ' LEU . 10.1 mp -45.11 -53.45 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.773 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.1 m -157.02 103.79 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.499 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.41 -44.04 2.68 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.696 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.5 t -50.97 110.62 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.538 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 47.2 mt -52.91 174.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.472 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -155.89 177.11 11.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.5 OUTLIER -160.54 18.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.662 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.605 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.484 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.741 ' N ' HD22 ' A' ' 2' ' ' LEU . 0.9 OUTLIER 44.07 63.89 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.507 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -144.0 -57.35 0.38 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 7' ' ' LEU . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 18' ' ' LEU . 37.8 t -49.76 164.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 21' ' ' VAL . 8.9 mp -83.16 -69.86 0.15 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.002 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 68.9 Cg_exo -33.49 -30.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.429 2.086 . . . . 0.0 114.111 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' LEU . 10.1 m -86.85 9.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.382 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' LEU . 1.4 t -47.93 -49.36 59.19 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -92.88 59.99 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.659 2.239 . . . . 0.0 111.218 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 23' ' ' LEU . 4.4 tt -153.17 -57.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.374 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' C ' ' N ' ' A' ' 26' ' ' ALA . 4.0 mt -83.37 27.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 110.46 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 119' ' ' ILE . 0.1 OUTLIER 44.93 21.5 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 0.0 109.384 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -122.5 -149.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.402 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.88 -155.23 16.4 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -154.29 -101.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.379 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 50.95 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 38' ' ' ILE . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.618 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 45' ' ' SER . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 64.47 -173.48 0.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER 34.31 79.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.609 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.964 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -175.98 94.07 0.06 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 t -127.65 -23.58 3.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.991 0.424 . . . . 0.0 110.394 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.68 46.65 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 17.0 p90 -97.08 -63.81 1.1 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.998 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.63 ' N ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 175.3 50.99 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.821 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.618 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.576 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.491 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 110' ' ' LEU . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.683 ' O ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.579 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 81' ' ' ASP . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 84' ' ' VAL . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.899 ' O ' HD22 ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 92' ' ' THR . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -56.76 155.05 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 99' ' ' ILE . 65.1 tttp -157.08 -45.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.738 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 101' ' ' THR . 28.8 mm -53.24 -105.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -75.17 30.11 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 0.0 110.492 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 99' ' ' ILE . 12.6 t -48.53 154.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.3 mm? -85.28 126.88 65.98 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.59 61.45 7.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.923 1.749 . . . . 0.0 111.762 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.5 m -99.54 -130.04 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.793 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.1 24.63 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.484 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' SER . 89.4 m-85 59.6 83.11 0.14 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.127 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 62' ' ' VAL . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.58 ' CE3' HD11 ' A' ' 175' ' ' ILE 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 116' ' ' LEU . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 122' ' ' PHE . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 137' ' ' LEU . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.416 ' O ' HD21 ' A' ' 177' ' ' LEU . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 144' ' ' LEU . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 149' ' ' THR . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 170' ' ' LYS . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 150' ' ' ILE . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.622 HD11 ' HB1' ' A' ' 152' ' ' ALA . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 149' ' ' THR . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 168' ' ' ILE . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 175' ' ' ILE . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.58 HD11 ' CE3' ' A' ' 115' ' ' TRP . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 176' ' ' VAL . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.74 -149.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 19.1 tp -144.25 67.58 1.27 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 8.3 m 53.13 62.19 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 190' ' ' LEU . 3.7 tm-20 -166.18 75.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.423 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 t -85.07 63.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tp 65.24 21.57 12.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.445 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 187' ' ' GLU . 6.1 tp 46.5 44.19 12.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.445 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.35 -46.32 90.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.561 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 ptt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.668 0.271 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' HD22 ' A' ' 37' ' ' LEU . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.836 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 36' ' ' PHE . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 45' ' ' SER . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 182' ' ' TYR . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 110' ' ' LEU . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD13 ' HG3' ' A' ' 117' ' ' PRO . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 74' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.631 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' LEU . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.971 ' N ' HD22 ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' VAL . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 179' ' ' TYR . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 112' ' ' ALA . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.781 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.634 HG22 ' H ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.634 ' H ' HG22 ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.995 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.995 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 135' ' ' ASN . 0.3 OUTLIER -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 150' ' ' ILE . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.591 HG21 ' ND2' ' A' ' 164' ' ' ASN . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.591 ' ND2' HG21 ' A' ' 161' ' ' VAL . 1.9 m120 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.843 ' O ' HD12 ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.999 ' N ' HD13 ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 168' ' ' ILE . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.485 HD13 HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 111' ' ' LEU . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.666 0.27 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 6' ' ' ALA . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.809 0.338 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.616 ' CG2' HD23 ' A' ' 110' ' ' LEU . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 113' ' ' PHE . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 73' ' ' LEU . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 87' ' ' PHE . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' SER . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.512 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.519 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.892 ' O ' HD12 ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.632 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.076 HD13 ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 1.076 ' H ' HD13 ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.616 HD23 ' CG2' ' A' ' 62' ' ' VAL . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 114' ' ' LEU . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.696 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.487 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 175' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.662 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.668 ' CZ ' HD13 ' A' ' 177' ' ' LEU . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 135' ' ' ASN . 16.4 p30 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 149' ' ' THR . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 160' ' ' PHE . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 162' ' ' LYS . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.525 HE22 ' NH1' ' A' ' 169' ' ' ARG . 8.8 mm100 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 152' ' ' ALA . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 171' ' ' VAL . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' HE22 ' A' ' 166' ' ' GLN . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 168' ' ' ILE . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 172' ' ' THR . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.78 HD13 HD11 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.431 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' ALA . 7.5 t . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 39' ' ' VAL . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 71' ' ' PHE . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.712 HD12 HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 . . . . . 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 35.3 m-85 . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.495 0.188 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' A' ' 63' ' ' VAL . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.712 HH21 HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 59' ' ' PHE . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 38' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' NZ ' ' OG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' HH21 ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 96' ' ' SER . 90.3 m95 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 115' ' ' TRP . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.54 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 120' ' ' LEU . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 1.011 ' N ' HD13 ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 129' ' ' GLN . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 137' ' ' LEU . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 139' ' ' MET . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.602 ' N ' HG23 ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.571 ' CD1' HD13 ' A' ' 177' ' ' LEU . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 150' ' ' ILE . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' THR . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.549 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' HD11 ' A' ' 150' ' ' ILE . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.915 ' H ' HG22 ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.784 ' H ' HD23 ' A' ' 167' ' ' LEU . 2.3 t-20 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.475 ' N ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.524 HG23 ' HZ3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HB2' ' HZ3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.535 ' OG1' ' NZ ' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 142' ' ' TYR . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.623 0.249 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 120' ' ' LEU . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' ILE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ALA . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 70' ' ' ILE . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 67' ' ' PHE . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 71' ' ' PHE . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 91.0 m95 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 65' ' ' MET . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 111' ' ' LEU . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.554 ' O ' HD23 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.785 ' O ' HD11 ' A' ' 175' ' ' ILE . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.856 ' O ' HG12 ' A' ' 39' ' ' VAL . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 125' ' ' ILE . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.736 ' H ' HD13 ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 150' ' ' ILE . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.492 ' N ' HG23 ' A' ' 149' ' ' THR . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.465 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB1' HD21 ' A' ' 167' ' ' LEU . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.463 ' H ' ' HA ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.547 ' O ' HG22 ' A' ' 168' ' ' ILE . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 152' ' ' ALA . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 165' ' ' PHE . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 175' ' ' ILE . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 120.521 0.201 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.742 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' N ' HD13 ' A' ' 33' ' ' LEU . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 35' ' ' ALA . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 118' ' ' ALA . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.393 0.616 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 110' ' ' LEU . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 117' ' ' PRO . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' ILE . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' N ' HD22 ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 84' ' ' VAL . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' OG1' ' A' ' 172' ' ' THR . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.934 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.863 ' O ' HD13 ' A' ' 110' ' ' LEU . 3.8 m-85 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 106' ' ' PHE . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.643 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.61 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' HD13 ' A' ' 68' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 120' ' ' LEU . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.487 HD12 ' NE2' ' A' ' 129' ' ' GLN . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 131' ' ' LEU . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.637 ' H ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 150' ' ' ILE . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 149' ' ' THR . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' GLY . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 149' ' ' THR . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.411 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.527 ' CB ' HD22 ' A' ' 167' ' ' LEU . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 152' ' ' ALA . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 172' ' ' THR . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.452 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 169' ' ' ARG . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.758 0.313 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 7' ' ' LEU . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.712 ' O ' HG13 ' A' ' 17' ' ' VAL . 7.5 p . . . . . 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.501 0.667 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.494 HD12 ' H ' ' A' ' 37' ' ' LEU . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.445 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 HH22 ' HA ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 71' ' ' PHE . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 81' ' ' ASP . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.585 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.402 ' HG2' ' N ' ' A' ' 92' ' ' THR . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.451 ' CA ' ' NH2' ' A' ' 90' ' ' ARG . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 95' ' ' LEU . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.522 HD13 ' CZ ' ' A' ' 179' ' ' TYR . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.673 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.678 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 1.01 ' N ' HD13 ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.512 ' N ' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 170' ' ' LYS . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.501 ' CD1' ' HZ1' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.739 ' HB3' HD21 ' A' ' 167' ' ' LEU . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.716 ' H ' HG22 ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.608 ' OD1' HG11 ' A' ' 161' ' ' VAL . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.578 ' C ' HE21 ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 152' ' ' ALA . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.501 ' HZ1' ' CD1' ' A' ' 150' ' ' ILE . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.536 0.208 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 33' ' ' LEU . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' NH1' ' A' ' 61' ' ' ARG . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 63' ' ' VAL . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 110' ' ' LEU . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 70' ' ' ILE . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.893 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' HD13 ' A' ' 116' ' ' LEU . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 95' ' ' LEU . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.401 ' HE1' ' HB2' ' A' ' 107' ' ' PHE . 1.4 p90 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HB2' ' HE1' ' A' ' 97' ' ' TRP . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.555 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.647 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.805 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.923 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 130' ' ' THR . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.42 ' OE1' HG11 ' A' ' 138' ' ' VAL . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.42 HG11 ' OE1' ' A' ' 129' ' ' GLN . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 150' ' ' ILE . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 148' ' ' VAL . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 151' ' ' ALA . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.69 ' HB3' ' NZ ' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.626 ' N ' HG22 ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.653 ' O ' HG22 ' A' ' 168' ' ' ILE . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 165' ' ' PHE . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.69 ' NZ ' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 168' ' ' ILE . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.467 HG22 ' CD ' ' A' ' 90' ' ' ARG . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 177' ' ' LEU . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 176' ' ' VAL . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 ttt . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.577 0.227 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 6' ' ' ALA . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 11' ' ' SER . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.485 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.601 0.239 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 5' ' ' PHE . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.514 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.416 HD12 ' NH1' ' A' ' 61' ' ' ARG . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.546 0.212 . . . . 0.0 111.491 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 113' ' ' PHE . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.994 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.653 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.919 ' O ' HD22 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.653 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 110' ' ' LEU . 4.4 m-85 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.958 0.408 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 106' ' ' PHE . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.625 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.758 ' O ' HG12 ' A' ' 39' ' ' VAL . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 119' ' ' ILE . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 177' ' ' LEU . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.72 ' N ' HD13 ' A' ' 127' ' ' ILE . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.426 HE22 HG12 ' A' ' 138' ' ' VAL . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 131' ' ' LEU . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.592 ' N ' HD13 ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HD11 ' A' ' 150' ' ' ILE . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 167' ' ' LEU . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 147' ' ' ALA . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.622 ' H ' HG13 ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' ALA . 3.8 m120 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.707 ' O ' HG22 ' A' ' 168' ' ' ILE . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 1.7 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 149' ' ' THR . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 165' ' ' PHE . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.632 ' HE3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.48 ' H ' HD23 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.645 0.259 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' N ' ' A' ' 29' ' ' ARG . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.694 ' H ' HD12 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' ALA . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.457 HG23 HD23 ' A' ' 42' ' ' LEU . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.594 HD12 ' CZ ' ' A' ' 61' ' ' ARG . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' N ' ' C ' ' A' ' 49' ' ' LEU . 73.3 t80 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 63' ' ' VAL . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' HG23 ' A' ' 62' ' ' VAL . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.643 ' CE ' HD21 ' A' ' 114' ' ' LEU . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 113' ' ' PHE . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.415 ' H ' HG23 ' A' ' 70' ' ' ILE . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 81' ' ' ASP . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 84' ' ' VAL . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 172' ' ' THR . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.498 ' N ' HH21 ' A' ' 90' ' ' ARG . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.517 ' N ' ' OG ' ' A' ' 96' ' ' SER . 21.0 m-90 . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.59 ' CG ' ' SD ' ' A' ' 109' ' ' MET . 11.7 m-85 . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 95' ' ' LEU . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 69' ' ' LEU . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.643 HD21 ' CE ' ' A' ' 65' ' ' MET . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.835 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 122' ' ' PHE . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 137' ' ' LEU . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.595 ' N ' HG13 ' A' ' 138' ' ' VAL . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.689 ' OG ' HD21 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 149' ' ' THR . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.64 ' H ' HG13 ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.46 ' OG1' HD12 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.689 HD21 ' OG ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 111' ' ' LEU . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.704 0.288 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.644 ' C ' HD13 ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.735 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 42' ' ' LEU . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.572 0.701 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 74' ' ' ILE . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.645 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.618 ' O ' HG13 ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.61 ' NZ ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.918 ' N ' HD22 ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 62' ' ' VAL . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.767 ' O ' HG12 ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.584 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.778 ' O ' HG22 ' A' ' 125' ' ' ILE . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.627 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.611 ' N ' HG23 ' A' ' 138' ' ' VAL . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 177' ' ' LEU . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.642 ' OH ' HG21 ' A' ' 125' ' ' ILE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 170' ' ' LYS . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 167' ' ' LEU . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 168' ' ' ILE . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 164' ' ' ASN . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.61 HD12 ' NZ ' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.419 HG13 ' H ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t . . . . . 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 68' ' ' LEU . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.509 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.713 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.8 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.765 0.793 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 63' ' ' VAL . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.713 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' ILE . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' CE2' ' A' ' 113' ' ' PHE . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.522 ' N ' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.85 ' N ' HD22 ' A' ' 95' ' ' LEU . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 CA--C 1.527 0.067 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.748 ' O ' HD23 ' A' ' 110' ' ' LEU . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 107' ' ' PHE 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 112' ' ' ALA . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.416 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.414 ' HE2' HD21 ' A' ' 177' ' ' LEU . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.481 ' H ' ' HG ' ' A' ' 131' ' ' LEU . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 126' ' ' ALA . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 164' ' ' ASN . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 16.0 mm100 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.583 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.757 ' C ' HD22 ' A' ' 177' ' ' LEU 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.575 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.427 ' N ' HD23 ' A' ' 178' ' ' LEU . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.728 0.299 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 16' ' ' ALA . 3.9 p . . . . . 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 5.9 tpm_? . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.547 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 62' ' ' VAL . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.574 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.865 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 70' ' ' ILE . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.596 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 86' ' ' ILE . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.152 0.501 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 111' ' ' LEU . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 69' ' ' LEU . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 39' ' ' VAL . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.749 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.619 ' CD1' HD12 ' A' ' 178' ' ' LEU . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.547 ' O ' HD13 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.449 ' O ' HG22 ' A' ' 150' ' ' ILE . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.488 HG23 ' HD3' ' A' ' 170' ' ' LYS . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.559 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 167' ' ' LEU . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.548 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 166' ' ' GLN . 0.1 OUTLIER 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.532 ' N ' HD22 ' A' ' 164' ' ' ASN . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.427 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.619 HD12 ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.46 HD23 ' NH2' ' A' ' 90' ' ' ARG . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 16' ' ' ALA . 1.3 t . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 35' ' ' ALA . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.704 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.361 0.124 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 63' ' ' VAL . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 63' ' ' VAL . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.567 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.669 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 95' ' ' LEU . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.669 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.708 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' HD12 ' A' ' 95' ' ' LEU . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 110' ' ' LEU . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' CD2' HD21 ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 119' ' ' ILE . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.501 ' O ' HD13 ' A' ' 140' ' ' LEU . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 136' ' ' PRO . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 149' ' ' THR . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 170' ' ' LYS . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 153' ' ' VAL . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 150' ' ' ILE . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.531 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.43 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.5 HG23 ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HB3' HH21 ' A' ' 90' ' ' ARG . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.524 0.202 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 17' ' ' VAL . 2.9 t . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 33' ' ' LEU . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' VAL . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 37' ' ' LEU . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.44 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 ' CE1' ' A' ' 182' ' ' TYR . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.037 0.446 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 73' ' ' LEU . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.708 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.61 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.708 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' O ' HD13 ' A' ' 110' ' ' LEU . 22.4 m-85 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 106' ' ' PHE . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 69' ' ' LEU . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 87' ' ' PHE . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.744 ' O ' HG12 ' A' ' 39' ' ' VAL . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 174' ' ' ALA 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.857 HD22 ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.576 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' A' ' 177' ' ' LEU . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 170' ' ' LYS . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.908 ' O ' HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.829 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.628 ' HD2' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.545 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.454 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.642 0.258 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 7' ' ' LEU . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.804 0.335 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 38' ' ' ILE . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.487 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.618 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 45' ' ' SER . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.618 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.576 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.491 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 110' ' ' LEU . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.579 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 81' ' ' ASP . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 84' ' ' VAL . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.899 ' O ' HD22 ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 92' ' ' THR . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.1 m0 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 62' ' ' VAL . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.58 ' CE3' HD11 ' A' ' 175' ' ' ILE 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 116' ' ' LEU . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 122' ' ' PHE . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 137' ' ' LEU . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.416 ' O ' HD21 ' A' ' 177' ' ' LEU . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 144' ' ' LEU . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 149' ' ' THR . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 170' ' ' LYS . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 150' ' ' ILE . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.429 ' O ' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.622 HD11 ' HB1' ' A' ' 152' ' ' ALA . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 149' ' ' THR . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 168' ' ' ILE . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 175' ' ' ILE . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.58 HD11 ' CE3' ' A' ' 115' ' ' TRP . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 176' ' ' VAL . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 3' ' ' MET . 45.2 mt-30 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.08 24.74 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.437 ' H ' ' C ' ' A' ' 1' ' ' GLN . 19.1 ptt? -159.34 -8.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.589 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.43 ' H ' ' H ' ' A' ' 3' ' ' MET . . . -57.99 -37.99 75.27 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.227 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' HD22 ' A' ' 37' ' ' LEU . 27.5 t80 -57.98 -41.92 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.76 84.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.937 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -42.25 84.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.545 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.06 97.18 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.958 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -57.82 -37.91 62.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.898 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.17 -38.81 90.5 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 m -62.13 -39.06 91.29 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.424 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.92 -37.74 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.772 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -44.96 -70.39 0.1 Allowed 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 m -38.31 100.43 0.21 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.82 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 50.3 Cg_exo -51.45 -77.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.165 1.91 . . . . 0.0 113.77 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 83.41 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 110.189 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -48.5 121.88 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -48.55 -45.99 69.88 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.857 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 16.5 Cg_exo -67.46 -18.63 49.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.238 1.959 . . . . 0.0 110.862 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 20' ' ' VAL . 13.5 p 40.57 26.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.065 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.623 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 23' ' ' LEU . 14.4 p -45.55 134.65 6.04 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 21' ' ' VAL . 42.5 Cg_exo -33.75 88.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.263 1.975 . . . . 0.0 112.015 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 21' ' ' VAL . 10.7 tp -138.21 -54.77 0.64 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.636 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -92.2 17.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 48.54 14.0 0.06 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -93.25 -135.58 0.17 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.075 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.14 170.43 38.13 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.3 t -167.18 58.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -163.85 174.94 10.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.51 -44.99 14.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -58.0 -37.79 74.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.104 0.478 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -37.85 74.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.893 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.84 -40.64 80.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.131 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -61.97 -41.75 98.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 109.907 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.9 86.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.865 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.836 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.6 m-85 -57.94 -37.77 74.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.77 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.83 -37.93 74.7 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.73 -42.07 84.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.791 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 36' ' ' PHE . 29.1 m -57.98 -42.15 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.516 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.67 86.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.472 0.653 . . . . 0.0 111.137 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.82 -37.86 86.07 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.645 -1.162 . . . . 0.0 114.837 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -57.78 -42.27 83.73 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 14.0 p -62.44 -42.61 99.59 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 45' ' ' SER . 10.4 tp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 4.1 m -62.84 -42.68 99.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.733 1.254 . . . . 0.0 111.985 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 182' ' ' TYR . 57.4 mtt -62.17 -37.25 84.51 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 112.472 -2.149 . . . . 0.0 114.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.06 -37.37 71.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 tp -57.36 -37.79 59.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.956 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 51' ' ' TYR . 28.6 mt -57.95 -37.85 74.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.975 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -14.27 -50.15 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.107 0.879 . . . . 0.0 113.752 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.1 t80 -114.58 -81.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.003 0.401 . . . . 0.0 111.015 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 52' ' ' THR . 7.5 t -171.12 79.45 0.07 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.947 0.403 . . . . 0.0 111.116 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' THR . . . -42.07 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.521 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 53' ' ' ALA . 1.4 t 79.17 10.35 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.538 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -173.06 53.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -145.45 -99.47 0.1 Allowed 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 121.34 0.59 . . . . 0.0 109.472 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 16.8 m-85 -155.34 50.65 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.65 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.19 -37.19 63.56 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -64.94 -34.83 79.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.395 0.141 . . . . 0.0 111.251 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' HB3' HH11 ' A' ' 61' ' ' ARG . 86.1 t80 -54.81 -34.84 63.26 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.431 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 45' ' ' SER . 10.5 mpt_? -61.91 -45.58 93.08 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.546 -0.862 . . . . 0.0 112.133 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' O ' HD12 ' A' ' 110' ' ' LEU . 4.5 m -65.77 -45.49 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -65.38 -42.68 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.394 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.76 -44.54 73.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.683 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -65.11 -34.8 79.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.69 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.78 -45.09 82.37 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.29 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.69 -34.9 76.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.291 0.567 . . . . 0.0 110.413 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD13 ' HG3' ' A' ' 117' ' ' PRO . 3.1 mt -63.64 -34.82 78.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.71 -34.64 62.66 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.363 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.541 HD13 ' O ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.87 -45.06 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.976 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 74' ' ' ILE . 40.6 m-85 -65.04 -35.19 80.37 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.494 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.8 79.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.93 -35.01 63.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.825 -178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.9 tp -61.94 -36.2 72.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.516 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.08 -45.03 94.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.9 0.381 . . . . 0.0 110.514 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.1 mp -65.09 -34.96 79.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.313 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ASP . 18.4 p -54.89 -34.87 63.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.352 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . 35.4 p30 -30.56 150.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.02 0.438 . . . . 0.0 111.986 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.5 pm0 -74.49 56.39 0.67 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.178 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 79' ' ' GLU . 41.6 tp 57.93 147.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.041 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -176.36 -172.52 0.48 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.914 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -78.9 -97.44 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.842 0.353 . . . . 0.0 111.851 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' PHE . 8.1 mptt -33.37 -33.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.087 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 85' ' ' SER . 1.7 m -60.73 -44.36 97.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.802 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 82' ' ' GLU . 78.6 p -65.21 -45.26 85.47 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.189 -0.605 . . . . 0.0 109.612 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.3 mt -65.21 -35.25 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.521 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.4 t80 -55.0 -43.07 73.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.339 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.67 -34.74 71.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 t -54.77 -34.58 62.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.146 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.631 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.69 -34.59 62.54 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -54.83 -42.93 72.51 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.938 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' LEU . 16.9 m -65.23 -45.48 84.5 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' NH1' ' A' ' 90' ' ' ARG . 36.9 p -65.88 -45.41 82.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.75 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.631 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -65.53 -45.23 90.88 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 -177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.971 HD22 ' N ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -67.56 159.58 29.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.815 0.807 . . . . 0.0 110.076 -177.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.971 ' N ' HD22 ' A' ' 95' ' ' LEU . 30.0 t -145.38 -67.87 0.3 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.794 0.331 . . . . 0.0 110.914 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -47.13 124.98 7.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.817 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -156.24 -70.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.492 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -82.48 18.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.911 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -173.11 63.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.958 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 102' ' ' LEU . 89.3 m -95.81 155.96 16.53 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.965 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 ' C ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -100.62 104.07 28.39 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.349 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -40.27 113.73 0.22 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.932 1.755 . . . . 0.0 112.412 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 t -170.88 -128.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.258 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.42 44.32 1.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 43.14 60.53 2.5 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.223 0.535 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -36.35 -50.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.42 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.47 97.39 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.019 -177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 51.4 mtt -60.47 -40.34 90.89 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.757 0.778 . . . . 0.0 110.813 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 62' ' ' VAL . 1.9 mm? -60.3 -39.87 88.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.775 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 179' ' ' TYR . 14.5 tp -59.92 -39.85 86.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.592 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.96 -39.82 86.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.321 0.581 . . . . 0.0 110.845 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.9 m-30 -59.96 -38.83 83.6 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 111.49 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.4 tt -59.08 -39.73 83.04 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -173.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 112' ' ' ALA . 1.1 p90 -60.16 -39.23 85.66 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.3 mp -59.35 -40.18 78.39 Favored Pre-proline 0 N--CA 1.485 1.32 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.781 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.5 Cg_endo -59.64 -39.83 70.69 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 CA-C-N 121.792 1.676 . . . . 0.0 114.521 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.09 -142.93 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.634 HG22 ' H ' ' A' ' 120' ' ' LEU . 0.1 OUTLIER 89.57 -81.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 110.868 -2.878 . . . . 0.0 112.398 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.634 ' H ' HG22 ' A' ' 119' ' ' ILE . 21.2 tp -60.27 -40.53 77.7 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 121.092 1.769 . . . . 0.0 110.702 -177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.3 Cg_exo -59.92 -39.82 67.99 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.929 1.753 . . . . 0.0 109.086 172.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -59.7 -40.11 86.83 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.39 -39.99 89.28 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.622 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.41 97.07 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 120.124 -1.036 . . . . 0.0 114.297 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.995 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.26 -39.69 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.599 1.2 . . . . 0.0 110.661 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.995 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.86 -39.82 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.397 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.03 -40.18 82.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.717 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.402 ' HB3' HE21 ' A' ' 1' ' ' GLN . 4.3 p -60.28 -39.89 88.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.194 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -59.85 -39.67 85.97 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.1 t -59.75 -39.96 86.51 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.948 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.94 52.59 0.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 133' ' ' SER . 31.9 tp -173.16 120.41 0.35 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.994 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 132' ' ' LEU . 5.9 m 37.73 -159.5 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' OE2' ' O ' ' A' ' 133' ' ' SER . 67.7 mm-40 -142.31 144.78 33.4 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.763 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 135' ' ' ASN . 0.3 OUTLIER -177.32 71.17 0.23 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.898 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -60.54 -16.94 45.59 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.059 2.506 . . . . 0.0 113.686 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.8 mp -61.74 -45.25 94.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.965 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.516 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.0 m -65.2 -45.17 94.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.516 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 32.6 ttp -60.88 -45.14 95.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.011 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.19 -45.35 85.17 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.943 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.512 ' O ' ' CD2' ' A' ' 144' ' ' LEU . 39.8 p -65.61 -45.43 83.16 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.963 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.407 ' CB ' ' O ' ' A' ' 138' ' ' VAL . 20.9 t80 -65.67 -34.53 78.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.898 -1.501 . . . . 0.0 113.941 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 139' ' ' MET . . . -54.76 -45.02 80.56 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 141' ' ' SER . 2.3 pt? -65.04 -45.32 85.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.691 1.745 . . . . 0.0 111.253 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.41 -41.14 96.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.455 ' SD ' ' C ' ' A' ' 146' ' ' MET . 6.6 tmm? -65.05 -45.07 86.89 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.43 94.66 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 118.818 -1.153 . . . . 0.0 113.063 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.77 -45.73 90.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.966 -1.094 . . . . 0.0 113.142 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.0 t -65.65 -45.27 83.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 150' ' ' ILE . 0.2 OUTLIER -63.17 -41.17 91.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.673 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 150' ' ' ILE . . . -65.06 -44.62 88.41 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.972 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.1 -45.17 86.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.333 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.26 -34.92 73.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.898 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -54.89 -34.82 63.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.603 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -54.94 -34.67 63.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.46 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 6.0 ptt? -54.57 -43.74 72.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -39.2 -43.18 1.88 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -88.66 -41.41 12.63 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 160' ' ' PHE . 17.7 mttt 170.18 123.77 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.6 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.522 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -54.35 -167.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.591 HG21 ' ND2' ' A' ' 164' ' ' ASN . 5.2 p -116.23 162.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 10.0 mtmp? -38.15 -59.0 0.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.946 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 168.53 44.59 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.973 0.892 . . . . 0.0 108.972 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.591 ' ND2' HG21 ' A' ' 161' ' ' VAL . 1.9 m120 -35.55 112.05 0.15 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 122.963 1.363 . . . . 0.0 111.865 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.843 ' O ' HD12 ' A' ' 168' ' ' ILE . 5.0 t80 -57.92 -37.65 74.46 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.613 -2.085 . . . . 0.0 109.734 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -60.71 -37.46 81.75 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.178 0.513 . . . . 0.0 111.507 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -57.46 -37.61 73.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.004 0.921 . . . . 0.0 113.429 -176.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.999 HD13 ' N ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.51 -37.03 55.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.333 -179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.999 ' N ' HD13 ' A' ' 168' ' ' ILE . 26.7 ttp180 -57.54 -37.56 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.6 OUTLIER -57.64 -37.33 73.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.144 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 168' ' ' ILE . 0.5 OUTLIER -57.98 -41.17 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.2 t -61.96 -42.29 98.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.21 -42.3 99.72 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.995 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.17 -42.17 99.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.485 HD13 HD12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -62.47 -42.59 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.828 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.69 -42.58 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 119.116 -1.034 . . . . 0.0 112.133 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 mt -62.59 -40.26 96.33 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.713 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -57.95 -42.39 84.83 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD1' HD11 ' A' ' 111' ' ' LEU . 45.6 t80 -62.41 -42.17 99.24 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.28 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 7.6 mt -62.47 -42.31 99.39 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.84 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.52 99.4 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.109 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.19 -37.91 87.1 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.503 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -57.85 -37.91 74.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.036 -179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 186' ' ' THR . . . -35.22 103.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.923 ' H ' HD23 ' A' ' 185' ' ' LEU . 1.9 pt? -68.05 38.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.509 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 184' ' ' ALA . 3.7 t -154.9 160.8 41.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.651 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 189' ' ' LEU . 48.7 mt-10 66.59 -144.17 0.16 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.016 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 188' ' ' VAL . 0.9 OUTLIER 49.5 5.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.229 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.543 ' H ' ' C ' ' A' ' 187' ' ' GLU . 1.9 mm? -100.43 -77.43 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 190' ' ' LEU . 3.2 mm? 55.5 -79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LEU . 4.0 mm? -52.79 114.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.213 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.549 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 4' ' ' ALA . 13.7 mt 46.9 -149.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.642 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.7 tpp 70.53 -45.35 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.777 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 2' ' ' LEU . . . -60.85 -41.32 95.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.489 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -57.93 -41.85 83.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.961 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.1 -38.4 88.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.19 -42.14 99.0 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.465 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.05 -42.23 99.72 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.54 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 6' ' ' ALA . 4.9 tp -61.88 -37.68 78.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.006 0.903 . . . . 0.0 110.124 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.28 -40.04 89.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -61.88 -42.16 98.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.61 0.719 . . . . 0.0 110.006 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.98 -37.76 62.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.276 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -46.46 -55.65 7.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.855 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 156' ' ' MET . 8.7 t -74.92 115.9 48.9 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.4 173.36 5.54 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.289 1.992 . . . . 0.0 111.534 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.47 -117.38 0.13 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 18' ' ' LEU . 3.6 p -56.77 -166.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.727 ' H ' HG22 ' A' ' 17' ' ' VAL . 8.3 tp -86.21 -62.04 0.25 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 20' ' ' VAL . 15.4 Cg_endo -54.99 -47.0 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.978 1.785 . . . . 0.0 113.162 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.9 m 45.04 121.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 20' ' ' VAL . 94.6 t 118.16 -40.07 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.952 1.301 . . . . 0.0 111.492 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 60.2 Cg_endo -79.78 12.99 2.24 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.138 1.225 . . . . 0.0 113.253 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HG13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -164.43 -3.99 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.617 HG13 HD22 ' A' ' 23' ' ' LEU . 2.8 mt -148.32 136.82 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -66.74 70.95 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -152.58 -160.22 1.11 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.63 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.55 156.32 32.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.111 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 p -137.13 47.78 2.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.774 0.321 . . . . 0.0 110.722 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.85 177.07 8.48 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.58 1.91 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -58.76 -37.97 77.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.02 87.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.146 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.1 tp -58.14 -42.09 85.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.921 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.9 p30 -62.06 -40.61 96.37 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.242 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.13 -37.94 87.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.495 . . . . 0.0 109.915 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CZ ' HD13 ' A' ' 120' ' ' LEU . 0.7 OUTLIER -62.03 -41.88 98.58 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.152 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 tt -62.09 -37.42 84.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.294 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.64 -37.82 61.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.294 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.6 m -57.72 -41.04 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 118.424 -1.311 . . . . 0.0 109.744 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -57.97 -37.48 74.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.421 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.91 86.59 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.752 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.86 -42.17 98.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.764 -178.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 27.7 p -62.46 -42.59 99.58 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.72 -43.02 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 p -62.79 -42.52 99.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 123.087 1.422 . . . . 0.0 110.507 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.437 ' O ' ' OH ' ' A' ' 182' ' ' TYR . 7.0 mmt -62.15 -37.72 86.28 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 111.564 -2.562 . . . . 0.0 114.473 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.5 tp -57.35 -37.89 73.28 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.319 -175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.569 HD13 ' O ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -57.92 -37.89 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.867 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 51' ' ' TYR . 50.7 tp -58.05 -37.87 75.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.773 0.321 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -41.59 -17.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' LEU . 66.6 t80 -129.39 81.98 2.05 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.495 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 p 44.86 -122.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -178.11 -48.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.461 ' OG ' HD23 ' A' ' 55' ' ' LEU . 38.5 t 49.57 -86.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.367 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -158.46 49.59 0.38 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.858 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -90.05 -92.29 0.13 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.416 0.627 . . . . 0.0 110.396 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -148.2 39.98 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.318 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.94 -39.65 96.64 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -65.07 -34.89 79.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.677 0.275 . . . . 0.0 111.309 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -54.78 -43.46 72.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 1.5 mtm-85 -65.04 -45.7 84.33 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.539 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.616 ' CG2' HD23 ' A' ' 110' ' ' LEU . 2.6 p -65.91 -46.3 88.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.38 -45.26 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 119.096 -1.041 . . . . 0.0 113.584 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.4 77.4 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.925 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 113' ' ' PHE . 35.5 mtt -63.35 -34.32 77.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.788 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.41 -34.93 62.29 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.136 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.84 72.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -60.05 -34.7 73.77 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -54.64 -34.89 62.84 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 pt -54.89 -34.98 32.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.211 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -37.13 79.62 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.099 0.476 . . . . 0.0 110.091 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.3 83.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 73' ' ' LEU . 4.4 mm? -55.02 -45.08 75.12 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.976 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -65.11 -34.92 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.196 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD23 ' CE2' ' A' ' 87' ' ' PHE . 36.7 tp -62.46 -34.97 77.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.77 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.18 -44.65 75.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.461 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 78' ' ' ASP . 5.7 t -65.02 -45.06 87.08 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 10.8 t70 32.83 -145.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 111.617 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 5.1 tp10 -154.3 68.26 0.74 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt 60.25 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.556 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 82' ' ' GLU . 3.1 t70 -172.43 166.23 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.413 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.552 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 3.1 tm-20 -88.73 -60.74 1.88 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -48.81 -38.64 22.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.403 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG23 ' N ' ' A' ' 85' ' ' SER . 17.2 m -55.0 -44.03 72.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.895 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.512 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.2 p -65.07 -45.04 86.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 0.0 110.044 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.02 -34.73 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.352 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -36.48 64.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.11 -34.96 79.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.7 p -61.05 -34.99 75.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.144 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -60.34 -41.92 94.6 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.645 -178.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.519 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 37.3 mtp -65.04 -41.03 95.6 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.09 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.892 ' O ' HD12 ' A' ' 95' ' ' LEU . 23.9 m -65.09 -45.25 85.99 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.599 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.1 m -65.35 -45.36 84.52 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.539 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.632 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.43 -35.1 90.94 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.05 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.076 HD13 ' H ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -18.54 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 1.076 ' H ' HD13 ' A' ' 95' ' ' LEU . 27.6 t 47.56 165.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.583 0.706 . . . . 0.0 112.72 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 89.3 m95 39.68 93.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.617 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -96.48 -53.41 3.6 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.892 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 101' ' ' THR . 12.5 tt -77.72 171.55 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.482 ' N ' ' CG1' ' A' ' 99' ' ' ILE . 14.7 pt20 36.83 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.373 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -38.38 136.42 0.67 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.6 tp -77.04 126.33 85.61 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.049 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.45 -98.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.837 1.691 . . . . 0.0 112.034 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 105' ' ' PHE . 41.9 t 42.03 -128.2 0.61 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.551 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 5.3 m-30 -60.97 -99.46 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.578 0.704 . . . . 0.0 109.336 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 81.3 m-85 -163.41 65.04 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -38.57 -60.09 0.85 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.502 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.71 97.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.928 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.56 -40.17 90.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.686 0.755 . . . . 0.0 110.287 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.616 HD23 ' CG2' ' A' ' 62' ' ' VAL . 1.9 mp -60.09 -39.86 87.59 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.194 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.76 -39.36 84.56 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.131 0.491 . . . . 0.0 111.427 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -59.47 -39.69 84.49 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.595 ' CE1' ' O ' ' A' ' 110' ' ' LEU . 0.1 OUTLIER -60.13 -38.97 84.63 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -178.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.807 ' O ' HD23 ' A' ' 114' ' ' LEU . 3.4 tt -59.37 -39.92 84.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -171.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 19.0 p-90 -60.47 -39.72 88.67 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -59.9 -40.42 78.13 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 116.812 2.152 . . . . 0.0 116.812 -173.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.696 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.8 Cg_exo -60.1 -39.89 65.59 Favored 'Trans proline' 0 N--CA 1.505 2.186 0 C-N-CA 122.896 2.397 . . . . 0.0 115.642 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.487 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -52.28 -157.19 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.78 HD11 HD13 ' A' ' 175' ' ' ILE . 11.7 mt 94.29 -74.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 110.339 -3.119 . . . . 0.0 114.107 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.662 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 9.6 mt -59.79 -40.83 81.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 117.736 -1.586 . . . . 0.0 111.042 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 50.4 Cg_endo -60.42 -39.75 63.67 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.867 2.378 . . . . 0.0 109.373 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.668 ' CZ ' HD13 ' A' ' 177' ' ' LEU . 53.0 t80 -59.51 -39.72 84.8 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.53 84.8 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.96 -39.83 96.12 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.724 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.7 OUTLIER -59.73 -39.34 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 122.522 0.329 . . . . 0.0 111.703 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.89 85.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.312 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 127' ' ' ILE . 4.0 mp -60.09 -40.4 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.676 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 131' ' ' LEU . 13.5 m -60.23 -39.8 87.96 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.951 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -59.65 -39.79 85.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.564 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -59.84 -39.86 86.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.639 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.2 pp -107.98 170.91 7.7 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.15 0.5 . . . . 0.0 111.442 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.4 tp 74.94 -77.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.863 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.0 p -113.79 -163.52 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.595 0.236 . . . . 0.0 111.035 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 40.2 mm-40 -137.6 -53.34 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.703 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 135' ' ' ASN . 16.4 p30 36.64 74.39 0.6 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 121.077 0.465 . . . . 0.0 111.263 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.18 -39.43 51.85 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.427 2.751 . . . . 0.0 114.864 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.5 -45.21 91.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.246 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -65.17 -45.05 95.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 20.7 ttt -61.9 -45.01 95.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.169 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.5 tm? -64.57 -45.07 88.63 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.2 m -65.21 -45.14 85.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.214 0.53 . . . . 0.0 110.786 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 3.6 m-30 -65.09 -45.08 86.68 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.201 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.04 88.08 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.633 -0.712 . . . . 0.0 114.255 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.1 tt -65.14 -45.72 83.87 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 118.604 -1.238 . . . . 0.0 113.705 -176.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.71 -45.75 87.3 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 118.543 -1.789 . . . . 0.0 110.74 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 146' ' ' MET . 18.3 tmm? -65.89 -45.31 82.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.14 -45.54 84.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 149' ' ' THR . 17.7 m -65.95 -45.99 89.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 117.076 -1.85 . . . . 0.0 112.003 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.583 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.6 t -66.06 -45.22 82.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 149' ' ' THR . 16.3 tt -54.78 -34.77 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.839 -175.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.83 -39.05 68.15 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 117.563 -1.655 . . . . 0.0 108.002 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.29 -45.19 85.39 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.666 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.11 -34.86 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -34.71 62.89 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.559 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 160' ' ' PHE . 20.3 mmtp -54.72 -34.68 62.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 158' ' ' GLU . 11.2 ptt? -54.6 -43.27 72.04 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.637 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -47.0 -8.34 0.02 OUTLIER Glycine 0 CA--C 1.535 1.29 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.682 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 156' ' ' MET . 28.7 tt0 -144.15 -45.52 0.26 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.577 0.688 . . . . 0.0 112.474 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 160' ' ' PHE . 23.0 mtpp -141.12 -30.78 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 155' ' ' LYS . 0.1 OUTLIER 80.88 -162.52 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.848 0.356 . . . . 0.0 110.076 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 162' ' ' LYS . 85.5 t -95.59 -87.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 1.0 OUTLIER 171.16 -67.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 174.13 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -79.38 137.66 37.37 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 123.384 1.564 . . . . 0.0 110.171 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -37.67 74.4 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 111.236 -2.711 . . . . 0.0 110.933 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.525 HE22 ' NH1' ' A' ' 169' ' ' ARG . 8.8 mm100 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.443 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 152' ' ' ALA . 3.2 mm? -57.98 -37.82 74.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.489 ' O ' HG12 ' A' ' 171' ' ' VAL . 13.3 mm -57.81 -37.59 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.09 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.525 ' NH1' HE22 ' A' ' 166' ' ' GLN . 99.5 mtt180 -57.88 -37.49 74.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.514 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.8 OUTLIER -57.55 -37.56 73.3 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.676 -177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 168' ' ' ILE . 2.0 p -57.89 -42.54 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.878 -175.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 172' ' ' THR . 2.9 p -62.84 -42.98 99.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.523 -1.271 . . . . 0.0 113.047 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.78 99.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 119.734 -1.222 . . . . 0.0 113.97 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.81 99.81 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.371 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.78 HD13 HD11 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -63.14 -43.2 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.3 m -62.78 -42.9 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 178' ' ' LEU . 1.1 pp -62.69 -37.83 88.01 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 177' ' ' LEU . 6.3 tt -57.92 -42.67 85.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -173.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -62.65 -42.73 99.77 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 117.265 -1.774 . . . . 0.0 110.379 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.9 mm? -62.93 -42.53 99.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.296 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.431 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.48 -42.22 99.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.493 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.3 -37.92 87.38 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.18 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 185' ' ' LEU . 52.4 t80 -58.27 -38.04 76.18 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 185' ' ' LEU . . . 43.0 -96.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 186' ' ' THR . 57.2 tp 134.29 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.731 1.269 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 185' ' ' LEU . 14.8 t 50.94 -9.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 185' ' ' LEU . 7.6 tp10 -174.41 149.93 1.39 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.128 0.422 . . . . 0.0 111.115 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.695 HG12 HD22 ' A' ' 189' ' ' LEU . 13.8 t -111.44 -86.4 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.695 HD22 HG12 ' A' ' 188' ' ' VAL . 1.3 mm? -102.42 -166.43 1.28 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 190' ' ' LEU . 9.9 mp -77.83 -86.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.243 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? 55.69 -109.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.492 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.4 OUTLIER -84.71 -6.16 59.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 109.851 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mmt -88.18 -33.35 18.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.434 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.27 -42.03 85.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 5' ' ' PHE . 7.5 t80 -59.69 -42.16 92.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.09 -40.99 97.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.289 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.18 -42.34 99.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.776 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -42.45 99.71 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.859 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.28 -38.02 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 117.305 0.552 . . . . 0.0 111.02 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -60.12 -38.48 83.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.146 -178.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' CE ' ' A' ' 156' ' ' MET . 4.0 t -62.13 -42.15 98.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.722 0.772 . . . . 0.0 109.55 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.21 -37.76 79.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.189 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -40.69 -73.16 0.05 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.991 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -48.3 108.18 0.88 Allowed Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 14' ' ' SER . 51.2 Cg_exo -51.95 -170.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.502 1.468 . . . . 0.0 111.531 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -166.66 -156.35 0.23 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.368 0.604 . . . . 0.0 110.977 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 7.5 t -43.78 168.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.498 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 8.3 mp -74.72 -70.66 0.23 Allowed Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.747 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' VAL . 19.3 Cg_endo -58.13 -40.38 77.23 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.238 1.959 . . . . 0.0 113.783 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 17' ' ' VAL . 27.8 m 35.01 28.08 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 117.724 0.238 . . . . 0.0 111.566 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 19' ' ' PRO . 4.4 m -47.5 140.29 7.71 Favored Pre-proline 0 C--O 1.218 -0.574 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' VAL . 45.6 Cg_exo -31.36 84.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.504 2.136 . . . . 0.0 113.841 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -148.54 1.63 0.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.268 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.68 21.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 119' ' ' ILE . 0.3 OUTLIER 43.94 50.17 7.13 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -178.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.58 -160.21 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.263 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.21 171.94 48.66 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -155.04 153.83 31.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.698 0.285 . . . . 0.0 110.306 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.75 -50.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.115 0.483 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.57 -66.04 0.14 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -61.93 -37.95 86.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.012 0.434 . . . . 0.0 109.87 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.99 -37.84 74.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.71 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tt -58.01 -42.06 84.42 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.105 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 29.4 t70 -62.05 -40.8 96.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.292 0.567 . . . . 0.0 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.88 86.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.132 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 39' ' ' VAL . 83.3 t80 -57.97 -42.39 84.95 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -62.17 -37.58 85.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.754 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 71' ' ' PHE . 4.9 mt -57.52 -37.65 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.695 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.45 -42.14 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.842 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.18 -37.56 85.74 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.298 0.571 . . . . 0.0 110.33 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -58.0 -41.52 94.45 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 116.635 1.414 . . . . 0.0 116.635 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.83 -42.23 98.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.749 1.775 . . . . 0.0 112.386 -176.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 42' ' ' LEU . 72.2 p -62.38 -42.72 99.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 45' ' ' SER . 4.2 tp -62.81 -43.33 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 117.928 -1.509 . . . . 0.0 113.922 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -63.14 -42.82 99.54 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 123.088 1.423 . . . . 0.0 110.878 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.443 ' CG ' ' O ' ' A' ' 42' ' ' LEU . 13.3 mmt -62.15 -37.63 85.94 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 111.488 -2.596 . . . . 0.0 115.532 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.52 -37.89 73.75 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.712 HD12 HH21 ' A' ' 61' ' ' ARG . 0.8 OUTLIER -59.24 -37.72 70.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.069 178.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.1 tt -57.87 -38.01 74.96 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.014 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 51' ' ' TYR . . . -64.56 69.71 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' LEU . 20.2 t80 100.4 62.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.8 0.941 . . . . 0.0 109.557 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 52' ' ' THR . 2.8 p -37.09 136.65 0.4 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.294 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . . . -90.62 0.38 57.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.032 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.413 ' O ' HD22 ' A' ' 55' ' ' LEU . 54.7 m 43.12 41.69 2.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.674 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -174.72 22.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 21.7 m-85 -125.45 -101.01 0.38 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.241 0.543 . . . . 0.0 110.079 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 35.3 m-85 -154.32 47.31 0.59 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.798 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.35 -40.47 76.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' A' ' 63' ' ' VAL . 86.1 t80 -64.94 -34.9 79.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 7.3 t80 -54.89 -34.86 63.47 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.898 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.712 HH21 HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -59.92 -45.54 92.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.263 -0.975 . . . . 0.0 113.118 -176.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 63' ' ' VAL . 1.9 m -65.79 -45.7 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.681 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 59' ' ' PHE . 3.2 t -65.47 -34.96 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.17 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.85 -34.86 63.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.303 0.573 . . . . 0.0 109.524 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.6 mmt -59.74 -34.97 73.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -57.26 -45.23 84.21 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 2.0 p90 -65.15 -34.96 79.64 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -34.88 73.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.036 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -54.92 -34.58 63.3 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.333 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -54.69 -44.33 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.294 -177.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.5 ' CE2' HD11 ' A' ' 38' ' ' ILE . 50.8 m-85 -65.02 -34.89 79.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.352 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.07 92.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -56.54 -39.55 73.59 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 pt -65.1 -34.93 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.082 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 32.8 tp -54.88 -40.84 70.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.135 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.7 mp -65.06 -36.61 84.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.291 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 79' ' ' GLU . 39.7 t -63.85 -45.04 91.28 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.6 p-10 -35.44 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 77' ' ' SER . 55.8 mt-10 32.25 -151.49 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.325 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.44 150.12 21.97 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.04 166.65 32.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.156 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.1 pm0 -101.95 -18.51 15.64 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' NZ ' ' OG1' ' A' ' 172' ' ' THR . 29.8 tptt -97.42 -31.67 12.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.267 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 m -55.18 -34.84 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -58.64 -42.94 89.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.854 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 mm -65.12 -35.08 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.858 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -54.9 -44.93 74.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.512 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.24 -34.9 79.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.046 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -60.3 -35.0 74.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -59.29 -34.94 72.9 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 59.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.237 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.5 p -65.21 -45.21 85.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.505 ' CB ' HH21 ' A' ' 90' ' ' ARG . 79.2 p -65.29 -45.14 85.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.293 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.05 -40.53 97.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -37.71 158.5 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.572 0.225 . . . . 0.0 110.709 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 97' ' ' TRP . 11.2 p -144.62 -82.54 0.16 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.049 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.524 ' CE3' ' O ' ' A' ' 100' ' ' GLN . 90.3 m95 -41.82 -95.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.452 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER 75.65 -40.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 97' ' ' TRP . 1.0 OUTLIER -89.99 -82.39 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.87 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' O ' ' CE3' ' A' ' 97' ' ' TRP . 23.0 tm0? -95.08 102.89 14.73 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.49 HG23 ' N ' ' A' ' 102' ' ' LEU . 12.6 t 179.93 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.96 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.49 ' N ' HG23 ' A' ' 101' ' ' THR . 23.2 mt 65.81 146.75 0.1 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.222 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 131.12 19.33 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.11 1.873 . . . . 0.0 112.053 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 106' ' ' PHE . 5.0 t -167.46 127.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.848 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER 41.1 17.58 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.039 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 104' ' ' SER . 63.1 m-85 66.77 101.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 109.854 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 -73.92 0.64 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.866 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.93 96.16 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 tpp -59.88 -39.61 85.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.553 0.692 . . . . 0.0 109.882 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 tp -59.73 -39.98 86.53 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.163 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.826 ' O ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -60.0 -40.04 87.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.11 -39.52 86.51 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.618 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -59.63 -39.33 83.95 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 115' ' ' TRP . 0.4 OUTLIER -59.58 -39.57 84.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -174.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.569 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 22.4 p-90 -60.33 -39.74 88.16 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.54 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 5.2 tt -59.72 -40.27 77.64 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 -175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.682 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.1 Cg_endo -59.89 -39.77 68.76 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.82 1.68 . . . . 0.0 114.604 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . . . -63.88 -134.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.542 HD12 ' CD2' ' A' ' 25' ' ' PHE . 42.6 mt 88.21 -85.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 111.779 -2.464 . . . . 0.0 112.617 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 20.4 mt -59.99 -40.91 81.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.726 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.4 Cg_endo -60.68 -40.3 56.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.529 1.486 . . . . 0.0 109.905 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 14.4 t80 -60.07 -39.92 87.7 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.91 -39.64 86.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.23 96.86 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.63 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.604 ' CD1' ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -60.21 -39.65 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 117.714 0.757 . . . . 0.0 112.397 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.71 -40.36 87.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.011 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.4 -40.44 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 117.855 -1.538 . . . . 0.0 109.784 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 1.011 ' N ' HD13 ' A' ' 127' ' ' ILE . 29.9 m -60.44 -40.21 90.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.728 0.775 . . . . 0.0 111.198 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.604 ' NE2' ' CD1' ' A' ' 125' ' ' ILE . 0.7 OUTLIER -60.08 -39.6 86.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.427 -178.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 67.3 p -59.68 -39.98 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.298 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -99.41 44.06 1.04 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.953 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.0 tp -172.21 138.99 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.2 m 56.37 -173.92 0.06 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.68 62.04 1.49 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.043 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.422 HD21 ' HG2' ' A' ' 129' ' ' GLN . 3.4 p30 -103.29 104.94 43.9 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.15 -34.67 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.175 1.917 . . . . 0.0 113.467 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 137' ' ' LEU . 2.0 tt -55.78 -45.09 78.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 111.011 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 139' ' ' MET . 16.0 m -65.09 -45.12 95.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.198 0.523 . . . . 0.0 109.984 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.602 ' N ' HG23 ' A' ' 138' ' ' VAL . 36.1 ttp -64.47 -43.28 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.09 -43.64 97.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.517 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.7 t -65.06 -45.24 86.15 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.534 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.571 ' CD1' HD13 ' A' ' 177' ' ' LEU . 7.3 m-30 -65.14 -35.02 79.78 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.262 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.01 -45.24 82.29 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.3 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 tp -65.25 -45.64 83.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.33 1.065 . . . . 0.0 111.242 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.56 -45.2 90.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.433 ' O ' HG22 ' A' ' 150' ' ' ILE . 11.2 mmt -65.1 -45.19 86.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.52 93.53 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.771 -0.771 . . . . 0.0 112.274 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 149' ' ' THR . 20.7 m -65.66 -45.53 91.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.865 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.45 ' N ' HG23 ' A' ' 148' ' ' VAL . 27.9 m -65.56 -45.39 83.53 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.8 tp -65.04 -42.12 93.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.477 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.549 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -55.76 -44.98 78.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.282 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.19 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.03 -34.92 73.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.411 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HE1' HD11 ' A' ' 150' ' ' ILE . 2.1 m-85 -54.9 -34.87 63.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 159' ' ' LYS . 2.1 tppt? -54.92 -34.84 63.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.566 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.604 ' SD ' ' CE2' ' A' ' 160' ' ' PHE . 1.7 mtm -54.71 -45.0 73.95 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -31.48 -31.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 156' ' ' MET . 20.7 mp0 -121.89 -42.52 2.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 34.9 ttmt -175.91 133.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.91 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.604 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -56.54 -159.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.2 -178.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.915 HG22 ' H ' ' A' ' 162' ' ' LYS . 11.5 p -107.15 -171.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.915 ' H ' HG22 ' A' ' 161' ' ' VAL . 44.0 mmtt -42.33 -67.43 0.27 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.154 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 162' ' ' LYS . . . 116.56 58.0 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.674 1.234 . . . . 0.0 109.402 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.784 ' H ' HD23 ' A' ' 167' ' ' LEU . 2.3 t-20 -142.34 -118.93 0.1 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.475 ' N ' ' CG ' ' A' ' 164' ' ' ASN . 2.1 t80 -62.58 -42.52 99.61 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -62.07 -38.77 90.07 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.904 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 167' ' ' LEU . 2.0 mm? -62.02 -37.92 86.72 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.279 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.524 HG23 ' HZ3' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -61.23 -42.23 92.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.764 -178.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 17.7 ttt-85 -62.45 -42.62 99.59 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.34 -1.344 . . . . 0.0 112.723 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HB2' ' HZ3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -62.52 -37.93 87.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.16 -42.13 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 118.348 -1.341 . . . . 0.0 112.547 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.535 ' OG1' ' NZ ' ' A' ' 83' ' ' LYS . 3.2 m -62.4 -42.5 99.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.928 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.61 -42.48 99.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.51 -1.329 . . . . 0.0 113.712 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.51 -42.52 99.56 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 118.439 -1.305 . . . . 0.0 110.051 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.97 -43.33 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.6 t -62.96 -43.05 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.571 HD13 ' CD1' ' A' ' 142' ' ' TYR . 2.2 pp -62.7 -41.93 99.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.3 tt -58.02 -42.63 85.69 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -62.64 -42.62 99.7 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.275 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 1.0 OUTLIER -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.406 -0.517 . . . . 0.0 112.207 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.25 99.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.36 -38.02 87.92 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.412 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.75 -42.1 88.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.398 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.88 -130.44 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.427 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.63 -63.38 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.854 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 64.0 p -93.52 -155.61 0.45 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.276 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 187' ' ' GLU . 0.0 OUTLIER -72.67 -170.51 0.69 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.31 -0.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.63 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.5 mt -112.95 -30.27 7.08 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.701 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 191' ' ' LEU . 13.1 mt 59.14 -152.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.268 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 192' ' ' GLU . 0.3 OUTLIER 57.87 113.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.176 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.521 ' N ' HD13 ' A' ' 191' ' ' LEU . 1.3 pm0 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.84 HE22 HD23 ' A' ' 47' ' ' LEU . 3.2 pm0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.839 ' N ' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -141.72 28.65 1.77 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.133 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.6 mtt -103.9 -20.99 13.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.679 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.18 95.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -61.49 -42.07 98.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.12 -37.91 86.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.799 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.31 -42.08 90.55 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.616 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.521 ' CA ' HD23 ' A' ' 120' ' ' LEU . . . -61.81 -42.03 99.7 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 12' ' ' VAL . 4.3 tp -62.1 -37.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 117.434 0.617 . . . . 0.0 111.275 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.11 -42.11 98.9 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.343 -0.543 . . . . 0.0 112.248 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 t -62.43 -42.64 99.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.396 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 9' ' ' ILE . 3.6 m -62.6 -37.64 79.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.58 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' VAL . 43.6 t80 -24.93 -45.14 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.24 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 156' ' ' MET . 35.9 t -98.37 107.47 42.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.165 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' SER . 55.0 Cg_exo -51.02 -162.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.288 1.992 . . . . 0.0 112.98 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -165.91 -77.37 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.925 0.869 . . . . 0.0 109.876 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 162' ' ' LYS . 4.0 t -117.62 155.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.639 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 7.9 mp -53.09 -72.69 0.18 Allowed Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 119.181 -1.007 . . . . 0.0 109.244 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' O ' HG12 ' A' ' 21' ' ' VAL . 10.9 Cg_endo -55.22 -56.0 2.69 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.233 1.289 . . . . 0.0 112.059 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 20' ' ' VAL . 14.7 p 46.22 27.67 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.667 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 1.5 m -114.49 -34.8 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 122.271 -0.268 . . . . 0.0 111.169 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 42.2 Cg_endo -91.99 25.77 0.45 Allowed 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.304 2.003 . . . . 0.0 112.997 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 168' ' ' ILE . 79.5 mt -145.18 -88.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 111.279 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -86.19 145.4 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.331 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.1 37.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -101.88 -167.17 1.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.794 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.79 150.53 23.48 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.043 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.7 t -176.12 31.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.19 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -69.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.388 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.6 -75.87 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -61.59 -37.96 85.8 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.92 75.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.102 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.97 -38.08 75.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.95 -38.08 84.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.08 -37.98 87.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.725 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -57.89 -37.91 74.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.547 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -57.85 -37.53 74.05 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ALA . 5.3 tp -57.67 -37.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.9 m -57.75 -41.24 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.3 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.09 -37.72 86.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.801 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.86 -38.05 87.04 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.803 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.7 OUTLIER -61.95 -37.92 86.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.994 0.897 . . . . 0.0 111.887 -178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 p -62.09 -42.4 99.17 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 45' ' ' SER . 10.2 tp -62.37 -42.66 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.779 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.545 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -62.48 -42.19 99.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.712 1.244 . . . . 0.0 109.733 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.2 -37.41 82.86 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 112.449 -2.159 . . . . 0.0 112.173 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.84 HD23 HE22 ' A' ' 1' ' ' GLN . 0.2 OUTLIER -57.36 -37.23 72.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 mm -57.54 -37.87 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.138 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -61.47 -38.45 87.29 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -24.59 -47.83 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.869 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -163.37 171.88 15.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 52' ' ' THR . 4.7 p -48.06 119.49 2.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.49 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 56' ' ' PHE . . . -101.3 121.74 42.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.732 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 p -98.05 87.7 4.03 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tp 68.25 69.41 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.515 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 49.0 m-85 -131.95 15.62 4.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 65.74 63.97 0.58 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.556 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.99 -34.83 58.29 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -54.83 -34.35 62.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.772 -0.714 . . . . 0.0 112.012 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.26 -42.64 70.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 45' ' ' SER . 2.7 ptp85 -65.05 -45.52 85.04 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 117.765 -1.574 . . . . 0.0 112.344 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG12 ' CZ ' ' A' ' 105' ' ' PHE . 51.3 t -65.87 -46.19 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 118.162 -1.415 . . . . 0.0 113.342 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.98 -45.05 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.09 -34.77 63.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.687 0.756 . . . . 0.0 109.657 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.458 ' HB3' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.86 -35.32 63.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.854 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 20.3 mt -65.05 -43.56 91.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.75 0.31 . . . . 0.0 111.51 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 70' ' ' ILE . 51.6 t80 -54.85 -34.95 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.502 0.668 . . . . 0.0 110.029 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -34.65 70.9 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.577 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.2 tt -54.66 -45.16 73.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 67' ' ' PHE . 3.4 tt -59.22 -40.2 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.027 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -64.98 -45.0 87.46 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.203 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.86 79.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.079 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.7 tp -54.85 -34.98 63.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.761 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 71' ' ' PHE . 11.0 tt -58.44 -37.79 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.387 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.2 -45.05 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.066 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -63.86 -41.17 97.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 110.392 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 t -64.52 -35.13 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.349 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -50.05 170.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.689 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 80' ' ' LEU . 14.9 tm-20 -73.27 151.67 41.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' N ' ' CD ' ' A' ' 79' ' ' GLU . 14.5 mt -61.92 97.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.56 71.31 3.65 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.983 0.421 . . . . 0.0 110.92 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 37.65 -95.07 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.759 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -20.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.0 -35.59 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m -64.88 -45.0 87.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.8 mp -65.12 -34.85 73.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.483 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' CZ2' ' A' ' 115' ' ' TRP . 1.8 t80 -54.77 -42.35 71.59 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.7 73.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.506 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.3 p -54.78 -34.86 63.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -57.33 -34.82 69.14 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.297 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 41.5 mtp -54.88 -45.26 74.61 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.313 -0.555 . . . . 0.0 112.063 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -65.45 -45.55 83.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.677 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 92' ' ' THR . 68.8 m -65.56 -45.34 83.72 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.17 -41.7 96.8 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.803 -177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 94' ' ' GLY . 11.2 mt -35.97 156.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.541 0.67 . . . . 0.0 110.65 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' LYS . 15.1 p -138.5 179.27 6.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.089 0.471 . . . . 0.0 111.421 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.418 ' C ' ' H ' ' A' ' 99' ' ' ILE . 91.0 m95 58.25 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' SER . 20.9 mtpp 68.67 -43.99 0.51 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.447 0.467 . . . . 0.0 110.562 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -76.98 -80.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 102' ' ' LEU . 38.0 mt-30 -81.22 -69.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.368 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 102' ' ' LEU . 4.2 m 64.0 -68.46 0.09 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.841 0.353 . . . . 0.0 110.686 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 100' ' ' GLN . 4.8 tp 90.39 80.58 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.774 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 102' ' ' LEU . 81.8 Cg_exo -48.59 -130.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 123.294 2.663 . . . . 0.0 113.702 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.0 t 67.96 136.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.663 ' CD1' ' O ' ' A' ' 105' ' ' PHE . 1.9 t80 53.77 1.7 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.64 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 3.4 m-30 68.88 95.29 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.97 -56.82 2.53 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.06 96.32 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.533 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mtp -59.99 -39.5 85.93 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.681 0.753 . . . . 0.0 109.819 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.466 HD13 ' CE1' ' A' ' 105' ' ' PHE . 3.3 tp -59.56 -40.05 86.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.114 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 111' ' ' LEU . 3.3 tp -59.96 -39.98 87.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.923 0.392 . . . . 0.0 111.471 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' HH12 ' A' ' 90' ' ' ARG . . . -59.89 -39.74 86.36 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 1.8 m-30 -59.67 -39.12 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' O ' HD23 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -59.36 -39.83 84.51 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -173.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.785 ' O ' HD11 ' A' ' 175' ' ' ILE . 0.0 OUTLIER -60.27 -39.43 86.8 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 5.4 tt -59.64 -40.25 77.79 Favored Pre-proline 0 N--CA 1.485 1.297 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.856 ' O ' HG12 ' A' ' 39' ' ' VAL . 29.4 Cg_endo -59.97 -39.64 69.14 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.345 2.03 . . . . 0.0 115.963 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -61.19 -141.49 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 3.0 mt 80.92 -67.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.334 -2.666 . . . . 0.0 113.158 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.628 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -59.92 -41.02 83.03 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 117.746 -1.581 . . . . 0.0 110.454 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 54.5 Cg_endo -60.46 -39.67 63.9 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.185 2.59 . . . . 0.0 110.007 172.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 125' ' ' ILE . 10.0 t80 -59.44 -39.95 85.23 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.388 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.08 -39.68 86.91 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.03 -39.9 96.31 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.784 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.4 tt -60.01 -39.73 81.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 122.199 -0.589 . . . . 0.0 112.437 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.44 88.42 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 pt -60.44 -40.32 83.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 118.61 -1.236 . . . . 0.0 109.348 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -60.21 -39.84 88.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.622 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -59.92 -39.92 87.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.225 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -40.02 87.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.188 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.67 93.08 8.75 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.3 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 71.52 154.17 0.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.047 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.736 ' H ' HD13 ' A' ' 132' ' ' LEU . 3.6 t 69.14 131.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -171.15 139.53 1.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -152.59 137.02 10.54 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.222 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.88 -64.13 0.28 Allowed 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.53 2.154 . . . . 0.0 115.627 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 137' ' ' LEU . 1.7 pt? -62.24 -45.1 94.84 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.789 1.404 . . . . 0.0 114.789 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 139' ' ' MET . 2.4 m -65.11 -45.22 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.627 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.487 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 67.1 mtp -64.93 -45.07 87.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.405 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.8 tp -60.27 -44.26 95.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.4 p -65.1 -45.1 86.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.054 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.625 ' CE1' ' CZ ' ' A' ' 122' ' ' PHE . 1.7 m-85 -65.13 -44.54 88.33 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.061 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.3 93.47 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.057 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.3 -45.74 83.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 118.727 1.263 . . . . 0.0 111.509 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.63 -45.27 90.21 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.269 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 150' ' ' ILE . 12.7 tmm? -65.32 -42.41 93.0 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.45 84.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.6 t -65.7 -45.89 90.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 118.335 -1.346 . . . . 0.0 112.536 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 150' ' ' ILE . 8.9 t -65.84 -45.25 82.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.492 ' N ' HG23 ' A' ' 149' ' ' THR . 9.5 tp -61.15 -37.0 76.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.483 -176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.465 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.784 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB1' HD21 ' A' ' 167' ' ' LEU . . . -65.1 -45.16 86.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.92 -34.67 71.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.637 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.7 -34.71 62.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -54.83 -34.46 62.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.041 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.61 -39.03 67.49 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.74 -11.22 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.079 -1.058 . . . . 0.0 110.729 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 156' ' ' MET . 22.3 mm-40 -108.91 -67.2 0.99 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.705 0.288 . . . . 0.0 110.415 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -166.59 23.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.708 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.463 ' H ' ' HA ' ' A' ' 156' ' ' MET . 0.1 OUTLIER 46.41 -157.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.685 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.38 -175.93 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 14.1 ptpt -78.71 -45.2 21.81 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.273 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 162.22 48.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.56 115.51 2.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 123.023 1.392 . . . . 0.0 110.512 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.547 ' O ' HG22 ' A' ' 168' ' ' ILE . 27.6 t80 -57.81 -37.7 74.25 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -37.51 73.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.838 0.352 . . . . 0.0 111.124 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 152' ' ' ALA . 6.4 mp -57.77 -37.52 73.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.275 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 165' ' ' PHE . 7.0 tp -57.42 -37.48 57.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.024 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -57.84 -38.2 75.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.579 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -58.81 -37.76 77.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 110.367 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 170' ' ' LYS . 39.3 t -59.38 -39.96 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 175' ' ' ILE . 34.0 m -62.11 -42.39 99.18 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.579 -178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.57 99.62 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.076 -1.535 . . . . 0.0 115.185 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.88 99.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 118.377 -1.329 . . . . 0.0 112.956 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.785 HD11 ' O ' ' A' ' 115' ' ' TRP . 2.1 tp -63.04 -42.8 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.9 m -62.54 -42.05 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.07 -37.82 84.03 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 2.2 tt -57.88 -42.55 84.85 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.332 -0.947 . . . . 0.0 112.994 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.58 -42.55 99.62 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 117.979 -1.488 . . . . 0.0 111.468 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 0.8 OUTLIER -62.57 -42.57 99.64 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.995 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.44 99.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.933 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.418 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.24 -42.11 99.02 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.376 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 184' ' ' ALA . 78.2 t80 -62.04 -41.63 98.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -36.52 106.72 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.255 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.865 ' H ' HD22 ' A' ' 185' ' ' LEU . 2.1 mm? -60.2 176.68 0.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.994 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 187' ' ' GLU . 4.2 m 60.21 -155.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.068 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.971 ' H ' HG22 ' A' ' 186' ' ' THR . 1.5 pp20? 14.05 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 190' ' ' LEU . 9.8 p -170.35 145.39 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.157 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 24.1 mt -37.29 89.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.26 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 188' ' ' VAL . 0.3 OUTLIER -92.28 112.94 25.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.993 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 190' ' ' LEU . 1.8 tt -162.09 91.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.423 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.484 ' NE2' ' C ' ' A' ' 1' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -164.47 33.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.631 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtm -140.91 45.05 1.8 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.99 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.21 -40.02 84.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 6' ' ' ALA . 5.8 p90 -58.2 -42.02 85.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.489 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -62.09 -38.92 90.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.844 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.99 -42.07 84.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -57.96 -38.34 88.65 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.5 mm -57.8 -37.75 61.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.082 0.468 . . . . 0.0 110.062 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -57.85 -37.88 74.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.712 -179.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' O ' ' CE ' ' A' ' 156' ' ' MET . 19.2 t -62.06 -41.88 98.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.822 0.82 . . . . 0.0 109.681 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.0 t -62.02 -37.64 78.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.395 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' A' ' 12' ' ' VAL . 72.0 t80 -12.95 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.194 0.934 . . . . 0.0 112.696 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.518 ' OG ' ' SD ' ' A' ' 156' ' ' MET . 0.9 OUTLIER -109.72 150.4 41.23 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.35 -160.0 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.595 2.197 . . . . 0.0 112.991 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -171.24 -118.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.951 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 20' ' ' VAL . 1.8 p -76.86 175.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 3.0 mt -62.97 -69.21 0.63 Allowed Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.063 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 9.4 Cg_endo -52.87 -44.82 45.31 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.938 1.759 . . . . 0.0 112.333 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 20' ' ' VAL . 8.6 p 27.62 64.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.76 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 9.0 p -173.25 -30.74 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.76 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 45.0 Cg_endo -99.19 -13.87 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.22 1.946 . . . . 0.0 112.877 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mp -104.62 -44.91 4.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.033 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 26' ' ' ALA . 3.3 pt -137.3 126.27 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.627 0.251 . . . . 0.0 110.661 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.91 88.27 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -156.87 173.64 16.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.644 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -156.66 163.73 32.28 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.254 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' ' 32' ' ' ALA . 5.4 m -164.42 -151.6 0.16 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.18 -0.51 . . . . 0.0 109.873 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 40.36 -98.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.269 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.91 -43.87 0.02 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.593 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -61.88 -37.97 86.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.112 0.482 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' H ' ' A' ' 28' ' ' SER . . . -57.96 -37.81 74.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.375 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.742 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -57.86 -38.04 74.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' N ' HD13 ' A' ' 33' ' ' LEU . 9.8 t70 -58.2 -38.03 75.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -60.16 -37.86 81.4 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -57.84 -37.56 74.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.744 -179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 5.4 tt -57.72 -37.61 73.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.216 -178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 35' ' ' ALA . 7.5 tt -57.87 -37.85 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.927 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 118' ' ' ALA . 5.7 t -57.79 -42.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.37 -37.58 86.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.777 176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.95 94.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 115.515 0.966 . . . . 0.0 115.515 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.95 -37.92 86.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.852 1.326 . . . . 0.0 112.569 -178.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 31.7 p -62.04 -42.32 99.05 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 pt -62.53 -42.9 97.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.651 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.72 99.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 123.5 1.619 . . . . 0.0 109.843 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -62.39 -41.69 98.85 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 111.437 -2.619 . . . . 0.0 115.122 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.84 -37.91 74.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.604 0.716 . . . . 0.0 109.378 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -57.97 -37.45 61.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.807 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -57.74 -37.96 74.49 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' CA ' HG11 ' A' ' 188' ' ' VAL . . . -46.49 -22.36 1.01 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' N ' ' C ' ' A' ' 49' ' ' LEU . 35.3 t80 -165.73 66.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.382 -0.409 . . . . 0.0 109.923 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -46.32 144.11 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.185 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.75 139.73 48.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.283 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.3 m -81.84 32.08 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.136 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 tp -168.15 38.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.369 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 87.3 t80 -135.87 7.54 3.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.332 0.587 . . . . 0.0 109.711 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 67.08 74.4 0.33 Allowed 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.223 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.79 -34.56 56.91 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 59.4 m-85 -54.59 -34.47 62.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.994 -0.603 . . . . 0.0 111.607 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -54.49 -38.95 67.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.226 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -45.57 84.55 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.437 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 110' ' ' LEU . 11.4 t -65.58 -45.83 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.1 t -65.54 -34.71 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.72 -34.82 62.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.269 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.429 ' SD ' ' O ' ' A' ' 110' ' ' LEU . 8.2 mtm -56.82 -34.9 68.17 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.088 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -58.94 -45.23 90.95 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.673 0.273 . . . . 0.0 111.379 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -58.91 -43.62 91.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 111.437 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' HG2' ' A' ' 117' ' ' PRO . 74.6 mt -57.0 -34.81 68.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.205 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.2 tp -54.92 -36.53 65.34 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.113 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.55 -45.12 86.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.593 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' ILE . 15.7 m-85 -65.1 -45.12 86.49 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.638 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.86 82.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -55.21 -35.32 64.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.742 -178.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.2 tp -60.68 -37.77 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -65.07 -45.12 86.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.449 -178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' N ' HD22 ' A' ' 76' ' ' LEU . 3.6 mm? -65.12 -35.04 79.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 78' ' ' ASP . 93.2 p -54.86 -34.91 63.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.315 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 21.6 p30 -22.38 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.875 0.734 . . . . 0.0 112.942 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.2 tm-20 -146.86 -73.56 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.66 78.98 0.06 Allowed 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.064 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' O ' HG22 ' A' ' 84' ' ' VAL . 1.2 m-20 -102.78 172.8 6.63 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 84' ' ' VAL . 12.2 pt-20 -103.41 170.89 7.68 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 86' ' ' ILE . 0.0 OUTLIER 71.55 -37.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 82' ' ' GLU . 3.2 m -65.26 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.2 t -60.27 -45.09 94.52 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.437 HD12 ' OG1' ' A' ' 172' ' ' THR . 6.2 pt -55.07 -34.44 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.92 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.53 -42.33 70.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.657 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.07 -37.05 86.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -65.05 -35.43 81.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.769 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.64 ' CZ ' ' NE1' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -60.06 -34.88 74.02 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.498 ' HA ' HH21 ' A' ' 90' ' ' ARG . 40.0 mtp -55.09 -45.32 75.4 Favored 'General case' 0 C--O 1.23 0.068 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.55 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.7 m -65.35 -45.37 84.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.948 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -65.38 -45.24 84.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.162 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.02 94.68 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 96' ' ' SER . 0.3 OUTLIER -36.98 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.767 0.318 . . . . 0.0 110.859 -177.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.934 ' N ' HD12 ' A' ' 95' ' ' LEU . 31.3 p -140.28 155.66 46.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.924 0.393 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.432 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.9 OUTLIER 59.6 144.53 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.104 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -149.76 -37.18 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.283 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mt -57.99 -67.45 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.303 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -83.18 -155.55 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.239 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.9 p -148.13 112.68 5.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.776 0.322 . . . . 0.0 110.462 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 102' ' ' LEU . 2.9 mm? -63.34 151.8 86.45 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -36.03 154.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.389 2.059 . . . . 0.0 112.419 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 106' ' ' PHE . 13.2 t -58.16 -121.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 41.0 18.96 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.599 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.863 ' O ' HD13 ' A' ' 110' ' ' LEU . 3.8 m-85 47.71 73.81 0.19 Allowed 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 121.228 0.537 . . . . 0.0 109.718 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -76.37 -57.1 4.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.254 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.97 -40.12 96.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.972 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.5 mmt -60.08 -40.04 88.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.25 0.548 . . . . 0.0 110.887 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 106' ' ' PHE . 5.2 mp -60.04 -39.96 87.76 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.531 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -60.06 -40.08 88.21 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.832 0.349 . . . . 0.0 111.841 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.622 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.79 87.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.028 0.918 . . . . 0.0 110.932 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 4.7 m-30 -59.7 -39.05 83.29 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.771 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.643 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.8 OUTLIER -59.27 -39.98 84.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -174.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.64 ' NE1' ' CZ ' ' A' ' 90' ' ' ARG . 41.6 p-90 -60.75 -40.13 91.31 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -59.87 -40.31 77.39 Favored Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -174.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.653 ' HG2' HD13 ' A' ' 68' ' ' LEU . 22.2 Cg_exo -59.9 -39.77 68.6 Favored 'Trans proline' 0 C--N 1.293 -2.373 0 C-N-CA 122.889 2.392 . . . . 0.0 114.555 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -70.09 -150.15 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 120' ' ' LEU . 2.8 mt 122.85 -79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 16.1 mt -60.12 -40.73 79.97 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.54 -40.25 58.23 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 CA-C-N 122.018 1.756 . . . . 0.0 109.688 176.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -40.01 88.21 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.662 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.65 85.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 113.684 -1.598 . . . . 0.0 107.161 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.2 96.74 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.096 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.487 HD12 ' NE2' ' A' ' 129' ' ' GLN . 1.5 pt -60.4 -39.62 81.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 O-C-N 121.916 -0.755 . . . . 0.0 112.4 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.423 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -59.7 -40.12 86.87 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.5 pt -59.99 -39.9 81.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.186 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.605 ' O ' HD12 ' A' ' 131' ' ' LEU . 7.3 m -60.04 -39.72 86.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.359 0.599 . . . . 0.0 110.873 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -59.76 -39.46 84.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.064 -178.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -59.69 -40.03 86.52 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.637 ' H ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -96.01 130.98 42.86 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 178.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 131' ' ' LEU . 83.0 mt 59.24 145.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.031 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t 75.68 163.27 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.047 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.98 136.05 15.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 111.009 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.524 ' ND2' ' OE2' ' A' ' 187' ' ' GLU . 40.8 m-80 -159.65 71.6 3.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.783 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.49 -48.23 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.081 2.52 . . . . 0.0 113.966 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 137' ' ' LEU . 8.5 mp -57.74 -45.14 86.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.424 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -44.98 95.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 58.8 ttp -65.13 -44.96 86.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.834 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -62.94 -45.03 94.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.5 t -65.07 -45.1 86.65 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.294 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -65.13 -41.23 95.02 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.74 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.22 81.04 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.778 -0.646 . . . . 0.0 114.143 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.8 tt -65.31 -45.83 82.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.077 -1.449 . . . . 0.0 111.085 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 149' ' ' THR . . . -65.79 -45.34 89.16 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.447 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 150' ' ' ILE . 13.9 ttp -65.33 -45.12 85.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.57 84.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.634 -1.227 . . . . 0.0 112.918 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 149' ' ' THR . 29.1 m -66.06 -45.73 89.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.226 -0.99 . . . . 0.0 113.503 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' GLY . 8.0 t -65.76 -45.38 82.78 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 149' ' ' THR . 7.4 tp -61.82 -34.86 64.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.231 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.411 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -63.3 -39.39 94.43 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.884 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.527 ' CB ' HD22 ' A' ' 167' ' ' LEU . . . -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.18 -34.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.75 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -54.71 -34.97 63.14 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.509 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -59.93 -34.77 73.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.406 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.518 ' SD ' ' OG ' ' A' ' 14' ' ' SER . 15.6 tmm? -54.87 -45.0 74.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.155 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.45 -40.49 0.12 Allowed Glycine 0 N--CA 1.468 0.776 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -95.46 -50.27 5.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -177.55 113.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.47 ' CD2' ' CG ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -54.56 -178.0 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 162' ' ' LYS . 2.3 p -103.16 165.98 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.546 ' N ' HG22 ' A' ' 161' ' ' VAL . 34.4 ttmt -35.7 -49.75 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -179.21 -42.7 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 163' ' ' ALA . 26.4 t-20 51.73 108.51 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.726 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.75 -37.23 73.26 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.013 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -57.31 -37.25 72.19 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.765 -0.584 . . . . 0.0 110.119 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 152' ' ' ALA . 41.5 mt -57.55 -37.53 73.24 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -57.26 -36.92 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 120.04 1.291 . . . . 0.0 108.051 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 172' ' ' THR . 0.0 OUTLIER -57.58 -37.28 72.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.524 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' CE ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.36 -37.49 72.69 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.853 -0.529 . . . . 0.0 111.393 -178.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.4 m -58.35 -42.15 83.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 169' ' ' ARG . 5.4 t -62.11 -38.31 88.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.13 -41.86 99.71 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.814 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.24 98.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.212 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.53 -42.94 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.75 -42.96 98.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.758 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -62.83 -37.86 88.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.5 tt -58.03 -42.47 85.38 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -62.51 -42.55 99.58 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 118.066 -1.453 . . . . 0.0 111.55 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.736 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.6 -42.5 99.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.46 -37.89 87.67 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.996 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 185' ' ' LEU . 19.6 t80 -57.91 -40.07 79.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.971 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -47.89 91.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.098 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -75.96 71.95 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.95 -179.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -174.14 155.03 2.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 111.203 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.524 ' OE2' ' ND2' ' A' ' 135' ' ' ASN . 19.6 tt0 67.97 21.43 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.062 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.416 HG11 ' CA ' ' A' ' 50' ' ' GLY . 45.0 t -58.54 -50.97 77.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 41.2 tp -174.95 132.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.056 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 24.8 mt -67.68 -74.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.875 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.402 ' C ' HD13 ' A' ' 191' ' ' LEU . 0.3 OUTLIER 69.7 -69.68 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.083 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.573 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.496 ' H3 ' ' HB2' ' A' ' 4' ' ' ALA . 5.9 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -78.11 -22.55 48.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.699 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -98.83 -3.1 36.23 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.556 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.496 ' HB2' ' H3 ' ' A' ' 1' ' ' GLN . . . -57.83 -37.88 74.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.031 0.443 . . . . 0.0 110.247 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -57.99 -37.96 75.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.722 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.29 -39.9 80.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.48 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 7' ' ' LEU . 11.2 mp -58.85 -42.09 88.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.893 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' C ' ' CE1' ' A' ' 36' ' ' PHE . . . -57.84 -41.51 94.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.509 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' CD1' ' CD2' ' A' ' 36' ' ' PHE . 13.5 mm -57.88 -37.98 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.1 tp -58.52 -38.08 76.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' SD ' ' A' ' 156' ' ' MET . 29.5 t -62.23 -42.29 99.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.101 0.477 . . . . 0.0 111.298 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' SER . 21.1 t -62.35 -37.65 79.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.891 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 12' ' ' VAL . 89.8 t80 -14.16 -49.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.541 1.15 . . . . 0.0 112.756 -178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.9 OUTLIER -112.18 154.19 44.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.64 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.1 -171.79 1.17 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.529 2.153 . . . . 0.0 111.341 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -153.69 -144.15 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.19 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.762 HG13 ' H ' ' A' ' 20' ' ' VAL . 7.5 p -56.17 99.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.939 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mm? -1.04 -69.03 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 123.272 0.629 . . . . 0.0 112.628 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' VAL . 30.9 Cg_endo -61.84 -45.54 16.49 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.881 1.721 . . . . 0.0 113.915 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.762 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.2 OUTLIER 39.96 -161.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.426 0.557 . . . . 0.0 110.043 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' H ' HG12 ' A' ' 20' ' ' VAL . 20.6 t 89.19 -69.66 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.571 1.548 . . . . 0.0 112.867 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 20' ' ' VAL . 89.9 Cg_endo -92.61 9.94 2.47 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 CA-C-N 123.145 2.159 . . . . 0.0 112.009 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' PHE . 3.8 mm? -118.39 166.16 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.521 ' C ' ' N ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER 31.7 27.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.641 179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER 40.11 26.9 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -98.04 -168.68 1.7 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 113.811 -1.54 . . . . 0.0 111.375 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.0 -175.92 20.55 Favored Glycine 0 N--CA 1.466 0.68 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -174.78 157.71 2.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 111.105 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 59.38 151.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.686 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 34' ' ' ASP . . . 43.46 -90.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.866 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.2 tpt180 -57.91 -40.63 80.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 -41.99 98.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.1 -42.34 99.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.422 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -62.29 -38.59 89.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.114 0.483 . . . . 0.0 110.735 179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.0 -37.97 75.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.653 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' CD2' ' CD1' ' A' ' 9' ' ' ILE . 16.8 m-85 -58.13 -41.64 84.1 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.953 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.494 HD12 ' H ' ' A' ' 37' ' ' LEU . 6.7 mp -62.1 -42.16 98.94 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.02 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -42.59 95.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.772 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.795 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.5 m -62.35 -41.96 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.592 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -61.37 -37.47 83.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.049 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.62 -37.81 84.83 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.029 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -57.93 -40.66 81.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 118.145 0.972 . . . . 0.0 110.874 -179.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 8.4 p -62.06 -42.25 98.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.776 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.6 mp -62.34 -42.35 95.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.751 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.37 -42.1 99.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.781 0.8 . . . . 0.0 110.349 178.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.445 ' HA ' HH22 ' A' ' 61' ' ' ARG . 1.6 tmt? -58.89 -42.1 88.72 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.62 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.63 -37.99 77.1 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.12 -42.37 94.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 52' ' ' THR . 8.0 mt -62.45 -42.1 99.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.251 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -37.86 -70.2 0.28 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -101.31 77.28 1.78 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.716 0.293 . . . . 0.0 110.333 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 49' ' ' LEU . 67.1 p -58.84 94.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.816 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' SER . . . -88.51 170.29 11.01 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 56' ' ' PHE . 5.1 t -59.28 -141.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -54.98 84.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 54' ' ' SER . 6.3 t80 -113.81 -101.59 0.42 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -153.9 33.32 0.44 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.543 0.211 . . . . 0.0 111.243 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.14 -34.72 58.84 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.5 t80 -54.89 -34.52 63.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.428 -0.886 . . . . 0.0 112.326 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -54.34 -41.8 69.5 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 HH22 ' HA ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -65.11 -45.36 85.49 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.159 -177.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -65.72 -45.66 91.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 118.601 -1.239 . . . . 0.0 114.041 -178.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -66.08 -45.13 91.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.853 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.42 71.95 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.433 ' CG ' ' O ' ' A' ' 62' ' ' VAL . 2.4 ptm -54.99 -34.41 63.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -34.99 63.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.63 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -55.29 -35.04 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.601 . . . . 0.0 110.047 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.86 -34.78 68.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.675 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -54.72 -37.35 65.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.809 -177.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 mm -61.45 -45.22 99.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.931 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -65.17 -44.99 86.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.268 0.556 . . . . 0.0 110.697 179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.87 77.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.157 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tp -54.88 -41.89 71.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 71' ' ' PHE . 6.3 tt -65.05 -43.45 95.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.3 tp -64.93 -45.25 86.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.14 -36.17 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.816 0.341 . . . . 0.0 110.71 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 78' ' ' ASP . 72.3 p -55.09 -35.17 64.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' SER . 32.3 p-10 -40.97 164.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.47 176.15 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.005 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 81' ' ' ASP . 3.5 tt -57.91 117.95 4.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.585 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.3 m-20 -143.37 -178.66 5.98 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.993 0.425 . . . . 0.0 110.797 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 pm0 -95.84 160.25 14.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.823 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HG3' ' HZ3' ' A' ' 83' ' ' LYS . 0.5 OUTLIER 66.94 -33.69 0.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 ' H ' ' C ' ' A' ' 82' ' ' GLU . 2.4 m -65.38 -44.5 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.454 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 97.2 p -64.24 -45.14 89.45 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.3 pt -62.97 -34.29 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.21 -41.09 68.24 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.534 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.19 -34.93 79.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -61.84 -34.85 76.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.041 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.634 ' NH2' ' CG ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -54.84 -34.91 63.42 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.421 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.402 ' HG2' ' N ' ' A' ' 92' ' ' THR . 8.2 ptm -55.38 -39.12 69.74 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.571 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD23 ' A' ' 95' ' ' LEU . 43.6 p -65.05 -45.12 86.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.94 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.1 p -63.5 -45.14 92.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.451 ' CA ' ' NH2' ' A' ' 90' ' ' ARG . . . -65.07 -34.91 91.03 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -30.84 149.91 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.787 0.327 . . . . 0.0 111.759 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 95' ' ' LEU . 23.1 t -160.58 -170.95 2.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' O ' ' O ' ' A' ' 96' ' ' SER . 85.8 m95 54.47 108.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.483 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -140.84 -41.41 0.4 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.251 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 mm -72.45 132.35 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.977 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 44.67 55.95 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.519 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -42.54 141.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.86 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.6 mt -116.65 83.56 14.04 Favored Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.274 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -46.58 133.53 16.65 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 112.915 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.6 m -168.74 -136.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.201 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.75 56.9 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 40.76 63.8 1.09 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.514 0.673 . . . . 0.0 109.797 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.631 ' CD2' ' N ' ' A' ' 108' ' ' GLY . 30.7 p90 -44.59 -57.23 3.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.396 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.631 ' N ' ' CD2' ' A' ' 107' ' ' PHE . . . -60.04 -40.31 96.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.791 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.9 mtt -60.39 -39.94 89.1 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.1 mt -59.93 -39.86 86.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.522 HD13 ' CZ ' ' A' ' 179' ' ' TYR . 2.4 pp -59.86 -39.63 85.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 118.498 0.59 . . . . 0.0 112.311 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.567 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.76 -39.7 85.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.348 0.594 . . . . 0.0 111.729 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.7 -39.24 83.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.433 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.673 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 6.7 mt -59.53 -39.6 84.45 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.567 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 47.0 p-90 -60.46 -39.22 86.79 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.58 -39.81 74.5 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.795 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.1 Cg_exo -59.71 -39.8 70.14 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 122.119 1.879 . . . . 0.0 113.978 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.592 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -47.19 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 123.928 1.823 . . . . 0.0 115.461 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 84.72 -71.92 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 110.706 -2.952 . . . . 0.0 114.09 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.678 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -60.08 -40.54 78.49 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 121.69 2.041 . . . . 0.0 108.438 -178.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 85.3 Cg_exo -59.7 -39.54 72.66 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 124.107 3.205 . . . . 0.0 110.124 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -59.47 -40.21 86.17 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.67 -40.13 90.94 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.895 174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.39 -40.42 97.53 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.245 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 pt -60.39 -39.63 81.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 118.003 0.902 . . . . 0.0 112.428 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.3 87.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.01 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.43 -40.19 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.843 178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 1.01 ' N ' HD13 ' A' ' 127' ' ' ILE . 3.8 m -60.34 -39.82 88.48 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.941 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -40.03 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.082 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 131' ' ' LEU . 73.9 p -60.02 -39.83 87.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.973 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 130' ' ' THR . 15.0 tp -53.38 -126.2 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.954 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -81.68 -19.03 42.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.595 ' N ' HD22 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -69.95 154.11 42.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.805 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -123.52 -115.52 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.367 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 50.79 65.33 6.89 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.121 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.2 -15.24 2.02 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.867 2.378 . . . . 0.0 113.824 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.3 tp -64.46 -45.23 88.32 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.758 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.606 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 3.6 m -65.22 -45.2 94.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.445 0.64 . . . . 0.0 109.822 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.512 ' N ' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -64.54 -44.76 89.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.707 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.11 -45.03 90.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.246 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.5 m -65.22 -45.21 85.63 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.893 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 5.3 m-30 -65.41 -37.16 86.12 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.712 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -55.5 -45.15 85.07 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.123 -0.944 . . . . 0.0 114.614 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER -65.41 -45.88 82.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 118.049 -1.46 . . . . 0.0 112.866 -176.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.91 -45.86 85.44 Favored Glycine 0 N--CA 1.466 0.646 0 C-N-CA 118.967 -1.587 . . . . 0.0 110.908 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 146' ' ' MET . 3.2 tmm? -65.82 -45.75 81.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.97 80.87 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.7 t -65.98 -46.0 89.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.19 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 170' ' ' LYS . 70.6 p -65.75 -45.24 83.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.743 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.501 ' CD1' ' HZ1' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -54.96 -34.7 31.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.08 -177.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.78 -42.85 72.24 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.739 ' HB3' HD21 ' A' ' 167' ' ' LEU . . . -65.28 -42.37 93.23 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.444 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -34.79 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.65 -34.9 62.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -54.83 -34.88 63.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.169 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.474 ' C ' ' N ' ' A' ' 158' ' ' GLU . 19.4 ttt -54.77 -35.03 63.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.341 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -43.28 -22.52 0.2 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.474 ' N ' ' C ' ' A' ' 156' ' ' MET . 61.7 mm-40 -142.47 83.11 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 158' ' ' GLU . 31.9 mtmm 57.65 118.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.533 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.474 ' CE2' ' SD ' ' A' ' 156' ' ' MET . 0.1 OUTLIER -67.98 -150.62 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.96 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 162' ' ' LYS . 7.2 p -137.37 -179.06 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.716 ' H ' HG22 ' A' ' 161' ' ' VAL . 91.0 mttt -32.71 -48.07 0.18 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 0.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.54 -33.99 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.608 ' OD1' HG11 ' A' ' 161' ' ' VAL . 0.6 OUTLIER 61.79 102.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.169 0.985 . . . . 0.0 109.375 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 20.4 t80 -57.76 -37.68 74.08 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.578 ' C ' HE21 ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.59 -37.73 73.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.069 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' A' ' 152' ' ' ALA . 62.2 mt -57.81 -37.94 74.66 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -57.75 -37.62 60.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.652 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -37.64 74.41 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.815 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.501 ' HZ1' ' CD1' ' A' ' 150' ' ' ILE . 0.0 OUTLIER -57.57 -37.87 73.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.2 m -58.95 -42.19 85.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.18 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 m -62.36 -42.63 99.55 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.59 -42.6 99.68 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.067 -1.539 . . . . 0.0 113.38 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.71 99.64 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.722 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.74 -42.96 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.48 -42.48 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.136 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.9 mt -62.42 -40.86 97.91 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.68 -42.61 88.9 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.634 ' CG ' ' NH2' ' A' ' 90' ' ' ARG . 11.7 t80 -62.56 -42.76 99.74 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 117.56 -1.656 . . . . 0.0 110.94 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.64 -42.6 99.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.715 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.11 99.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.276 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.467 ' OH ' ' CB ' ' A' ' 49' ' ' LEU . 20.2 t80 -62.03 -42.19 98.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 185' ' ' LEU . 1.7 t80 -62.19 -41.97 98.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.173 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 34.8 -94.51 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.56 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 183' ' ' PHE . 2.5 tp -154.66 175.29 13.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.43 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 186' ' ' THR . 0.0 OUTLIER -69.59 63.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 110.181 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 185' ' ' LEU . 6.5 tp10 -173.11 106.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.362 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 188' ' ' VAL . 4.0 m -64.34 -171.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -74.84 104.62 5.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.231 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.581 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.9 OUTLIER -66.84 115.29 6.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.073 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.581 ' N ' HD13 ' A' ' 190' ' ' LEU . 44.9 tp -130.94 123.14 28.23 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.058 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.501 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.405 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 1.9 tp-100 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.405 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 6.0 tp -173.91 47.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.404 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.9 ttp -170.21 -33.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.898 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.01 -37.93 75.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.413 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.96 -37.9 75.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.97 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.927 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.7 mm? -62.08 -42.12 98.88 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.419 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.03 -42.24 99.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.919 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.16 -38.19 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 117.721 0.76 . . . . 0.0 111.895 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -57.98 -37.92 75.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.08 -42.09 98.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.563 0.696 . . . . 0.0 109.578 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.2 t -62.05 -37.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.564 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -49.84 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.664 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.2 p -61.35 120.17 52.86 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.325 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.6 -177.89 3.39 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.916 1.744 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.76 -143.4 0.14 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 109.997 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG13 ' H ' ' A' ' 20' ' ' VAL . 1.1 p -65.66 167.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 mm? -65.2 -66.82 1.23 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.167 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 20' ' ' VAL . 8.4 Cg_endo -52.89 -26.19 30.33 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.023 1.815 . . . . 0.0 113.194 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' H ' ' A' ' 21' ' ' VAL . 5.3 p 11.79 -83.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.064 ' H ' HG13 ' A' ' 20' ' ' VAL 0.292 2.1 p 39.54 -140.18 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.112 0 CA-C-O 114.726 -2.559 . . . . 0.0 107.766 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.911 ' CD ' HG13 ' A' ' 21' ' ' VAL . 48.1 Cg_exo -60.81 -130.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 1 CA-C-N 128.676 4.134 . . . . 0.0 112.438 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.4 mt 68.89 -57.72 0.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.603 ' CG2' HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -123.54 16.61 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CE1' HG21 ' A' ' 171' ' ' VAL . 3.5 m-30 53.52 -90.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . 39.45 -162.3 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.898 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.56 134.99 3.73 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 p -177.73 65.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.712 0.292 . . . . 0.0 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -175.11 -171.17 0.49 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.163 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.46 -70.69 1.16 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -62.03 -39.62 92.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.42 88.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.645 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -58.9 -38.36 78.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.188 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.656 ' N ' HD13 ' A' ' 33' ' ' LEU . 67.0 m-20 -57.87 -37.89 74.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.934 0.397 . . . . 0.0 110.746 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.84 74.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.258 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -57.85 -37.91 74.73 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.799 -178.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 1.2 tt -58.48 -37.78 76.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.061 0.458 . . . . 0.0 110.651 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.87 -37.72 61.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.922 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 117' ' ' PRO . 1.5 m -57.74 -42.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.828 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -62.14 -37.78 86.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.502 0.667 . . . . 0.0 109.29 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.46 -39.88 95.45 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.579 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.519 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.04 -42.31 99.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.029 -177.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.519 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 67.9 p -62.62 -42.55 99.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 tt -62.63 -42.94 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 118.804 -1.158 . . . . 0.0 113.759 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -42.79 99.91 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 123.442 1.592 . . . . 0.0 110.136 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 2.5 tpt -62.4 -42.1 99.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 112.19 -2.277 . . . . 0.0 114.223 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.8 -40.55 80.21 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.939 0.4 . . . . 0.0 111.114 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' NH1' ' A' ' 61' ' ' ARG . 70.0 mt -58.1 -37.59 62.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.316 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 49' ' ' LEU . 3.3 tm? -57.78 -42.07 83.33 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -45.12 -37.56 5.83 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 52' ' ' THR . 14.5 m-85 -87.71 -82.29 0.23 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 1.1 m 83.35 101.88 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.524 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.07 -123.63 0.16 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.524 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -140.59 -30.16 0.66 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -132.27 50.23 2.25 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.059 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -112.75 7.81 18.67 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.559 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 68.3 m-85 58.63 59.88 2.75 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.271 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.77 57.73 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 63' ' ' VAL . 43.6 m-85 -55.08 -34.85 63.98 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' HB3' ' HE ' ' A' ' 61' ' ' ARG . 24.1 t80 -54.9 -37.21 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -65.01 -45.58 84.93 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.945 -176.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.82 -45.85 90.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -65.58 -35.33 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.904 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.94 -34.82 63.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.33 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 6.9 mtt -54.85 -34.9 63.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.577 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 110' ' ' LEU . 46.1 mt -65.02 -42.1 94.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.455 ' O ' HG22 ' A' ' 70' ' ' ILE . 73.8 t80 -55.05 -45.03 75.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.769 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 65' ' ' MET . 0.3 OUTLIER -65.08 -34.51 78.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.503 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.508 HD13 ' CG ' ' A' ' 113' ' ' PHE . 2.1 tp -54.59 -34.87 62.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 71' ' ' PHE . 15.5 tt -54.93 -45.05 75.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.727 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.736 ' O ' HD12 ' A' ' 74' ' ' ILE . 57.4 m-85 -65.18 -41.1 94.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -34.75 79.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.8 tp -54.84 -35.0 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -63.86 -34.78 70.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.288 -179.223 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.893 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -63.19 -45.02 93.69 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.145 -178.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.17 -44.98 86.77 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.119 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.2 p -65.02 -37.92 89.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 79' ' ' GLU . 38.1 t0 -38.54 157.02 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.185 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -41.46 163.52 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.8 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 80' ' ' LEU . 1.4 pt? -72.41 141.89 48.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.815 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -155.81 -169.15 3.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.741 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -83.18 -81.65 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.055 0.455 . . . . 0.0 111.898 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.09 -34.09 0.15 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.099 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 85' ' ' SER . 3.2 m -54.9 -41.46 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.505 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.441 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.5 t -65.1 -42.82 93.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.215 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.7 mp -64.85 -36.56 77.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.043 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE1' HD13 ' A' ' 116' ' ' LEU . 8.2 t80 -55.01 -44.59 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.9 79.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 m -54.96 -35.34 64.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.224 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.625 ' NH1' ' NE1' ' A' ' 115' ' ' TRP . 0.3 OUTLIER -55.09 -34.55 63.75 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.5 mtp -54.53 -45.06 73.32 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.536 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 p -65.2 -45.43 84.82 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.15 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -65.74 -45.45 82.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.433 0.635 . . . . 0.0 112.083 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.42 -45.17 91.57 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 95' ' ' LEU . 2.1 pp -46.38 174.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.7 0.75 . . . . 0.0 111.74 -176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 56.4 m -164.67 -105.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.144 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.401 ' HE1' ' HB2' ' A' ' 107' ' ' PHE . 1.4 p90 -65.93 121.73 15.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.054 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -153.9 -21.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.9 mt -55.59 -69.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -171.38 58.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.576 HG22 HD23 ' A' ' 102' ' ' LEU . 47.6 m -80.72 -100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 101' ' ' THR . 3.8 mm? -100.78 106.11 41.83 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.3 Cg_exo -45.45 -24.06 1.57 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.079 1.853 . . . . 0.0 112.497 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 106' ' ' PHE . 15.2 p -55.71 -161.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.691 0.282 . . . . 0.0 110.514 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -51.97 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' SER . 79.1 m-85 -16.49 -48.28 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.208 0.942 . . . . 0.0 112.739 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 45.4 m-85 85.59 -40.66 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.213 0.946 . . . . 0.0 112.255 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.67 97.67 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 118.523 -1.799 . . . . 0.0 111.85 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 mmt -60.76 -40.45 92.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.899 0.857 . . . . 0.0 110.698 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 110' ' ' LEU . 2.5 mm? -60.26 -39.98 88.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.89 -39.93 86.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.178 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.93 -39.86 86.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.21 0.529 . . . . 0.0 112.227 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 3.2 m-30 -59.82 -39.1 83.91 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.802 0.841 . . . . 0.0 112.58 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.555 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 5.7 tp -59.34 -39.33 82.81 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.625 ' NE1' ' NH1' ' A' ' 90' ' ' ARG . 1.1 p90 -60.21 -39.64 87.31 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 3.5 tp -59.6 -40.13 76.96 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.647 ' O ' HG12 ' A' ' 39' ' ' VAL . 32.5 Cg_exo -59.91 -39.95 66.9 Favored 'Trans proline' 0 C--N 1.298 -2.127 0 C-N-CA 121.789 1.66 . . . . 0.0 114.123 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -39.31 -133.82 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.805 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.6 OUTLIER 78.53 -93.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 112.165 -2.289 . . . . 0.0 111.75 -177.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.805 ' N ' HG22 ' A' ' 119' ' ' ILE . 1.7 mt -60.11 -40.73 79.95 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 56.5 Cg_endo -60.65 -40.29 56.73 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 CA-C-N 121.194 1.462 . . . . 0.0 109.239 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 142' ' ' TYR . 37.1 t80 -60.15 -40.55 90.23 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.81 -40.03 91.18 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.427 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.54 -40.65 98.09 Favored Glycine 0 C--N 1.346 1.121 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.663 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.923 HD13 ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -60.63 -39.65 82.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 118.285 1.042 . . . . 0.0 111.112 179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.923 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -59.83 -40.23 87.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 130' ' ' THR . 7.1 tt -60.36 -40.45 84.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 118.456 -1.298 . . . . 0.0 109.721 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.6 m -60.59 -40.09 90.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.799 0.809 . . . . 0.0 110.65 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.42 ' OE1' HG11 ' A' ' 138' ' ' VAL . 1.3 tt0 -60.17 -39.87 87.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.394 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.2 t -59.87 -40.09 87.47 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.97 -7.46 33.02 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.936 0.789 . . . . 0.0 111.602 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -92.86 -69.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 129' ' ' GLN . 93.3 p -138.44 -157.27 0.76 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.26 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -159.77 154.93 25.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 110.989 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 139' ' ' MET . 3.9 t-20 -151.23 141.12 14.28 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 -60.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.023 1.815 . . . . 0.0 114.127 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.64 -45.15 81.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.42 HG11 ' OE1' ' A' ' 129' ' ' GLN . 2.3 t -65.13 -45.02 95.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.412 ' CG ' ' O ' ' A' ' 135' ' ' ASN . 72.7 mmm -64.54 -45.11 88.55 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -65.02 -45.19 86.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.979 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 m -65.04 -43.96 90.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.975 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.516 ' CZ ' ' CZ ' ' A' ' 122' ' ' PHE . 4.5 m-85 -65.02 -35.1 80.11 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.54 -45.48 94.49 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.163 -1.017 . . . . 0.0 114.061 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.39 -45.81 82.55 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.808 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.74 -45.37 89.22 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 121.894 0.719 . . . . 0.0 111.727 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 150' ' ' ILE . 26.5 ttm -65.3 -45.09 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.57 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.973 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 148' ' ' VAL . 1.8 m -65.9 -45.6 90.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.687 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.405 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . 19.4 m -65.66 -45.19 83.87 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 151' ' ' ALA . 18.3 tt -65.02 -38.55 83.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.588 -176.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.14 -45.2 85.97 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.778 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.69 ' HB3' ' NZ ' ' A' ' 170' ' ' LYS . . . -65.4 -45.36 84.28 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.211 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.552 ' O ' ' SD ' ' A' ' 156' ' ' MET . 14.3 p -65.16 -34.9 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -54.78 -34.93 63.26 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.418 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' GLU . 17.8 tptt -55.94 -34.82 65.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.685 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.647 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.72 -43.02 72.22 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.647 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -45.25 -20.17 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' MET . 38.4 mp0 -145.42 103.8 3.86 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 160' ' ' PHE . 15.4 pttp 35.02 97.5 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.373 0.421 . . . . 0.0 111.152 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -53.35 -111.38 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.386 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 162' ' ' LYS . 13.6 p -169.42 173.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 O-C-N 121.758 -0.589 . . . . 0.0 110.464 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.626 ' N ' HG22 ' A' ' 161' ' ' VAL . 13.2 mtpp -46.85 -68.62 0.18 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -168.14 -43.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.579 ' OD1' HG21 ' A' ' 161' ' ' VAL . 27.2 m120 60.37 109.81 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 122.301 1.048 . . . . 0.0 110.656 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.653 ' O ' HG22 ' A' ' 168' ' ' ILE . 34.7 t80 -57.72 -37.69 73.96 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.169 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.64 -37.49 73.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.131 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.603 HD23 ' CG2' ' A' ' 24' ' ' ILE . 7.0 mp -57.78 -37.43 73.7 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.694 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 165' ' ' PHE . 6.1 tt -57.31 -37.58 57.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.657 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -61.21 -37.67 83.81 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.69 ' NZ ' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -57.79 -37.25 73.4 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 168' ' ' ILE . 3.7 p -57.76 -38.77 67.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 119.926 -0.709 . . . . 0.0 112.908 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 p -62.07 -42.07 98.82 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.31 99.72 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 119.419 -1.372 . . . . 0.0 114.765 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.76 -42.9 99.9 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 116.437 -2.105 . . . . 0.0 110.456 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.467 HG22 ' CD ' ' A' ' 90' ' ' ARG . 41.2 mm -62.99 -43.03 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 177' ' ' LEU . 29.9 m -62.51 -42.51 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.165 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 176' ' ' VAL . 49.8 tp -62.35 -41.58 98.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.897 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.0 tt -58.02 -42.37 85.13 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -174.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 117.786 -1.565 . . . . 0.0 110.783 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 2.1 mm? -62.8 -42.6 99.78 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.844 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.2 99.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.256 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.432 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.4 OUTLIER -62.14 -37.93 87.07 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.11 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.435 ' CD2' ' O ' ' A' ' 184' ' ' ALA . 62.5 t80 -62.08 -41.98 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.068 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 183' ' ' PHE . . . 35.42 -150.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.519 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 186' ' ' THR . 0.2 OUTLIER -139.31 91.92 2.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.575 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER 34.33 96.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.427 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 188' ' ' VAL . 59.6 mt-10 -144.64 -105.94 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.276 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 187' ' ' GLU . 43.2 t 54.19 106.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 189' ' ' LEU . 10.1 mp -44.57 114.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.433 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.2 OUTLIER -91.01 17.61 7.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.21 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.45 ' CG ' ' H ' ' A' ' 192' ' ' GLU . 4.9 tp 63.49 -135.88 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.305 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 191' ' ' LEU . 11.5 pt-20 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 1' ' ' GLN . 3.2 pm0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -154.22 -161.88 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.438 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 2' ' ' LEU . 12.0 ttt 80.33 -28.43 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.65 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.47 90.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 91.9 m-85 -57.92 -41.98 83.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.232 0.539 . . . . 0.0 109.926 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -62.06 -37.82 86.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.282 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -61.98 -42.27 98.95 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.074 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -42.22 99.72 Favored Glycine 0 CA--C 1.546 2.026 0 C-N-CA 120.558 -0.83 . . . . 0.0 115.03 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 6' ' ' ALA . 19.9 tt -62.34 -39.97 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 11' ' ' SER . 2.1 pp -62.24 -37.76 86.62 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.905 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -61.91 -42.11 98.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.505 0.669 . . . . 0.0 109.815 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.86 -37.82 62.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.013 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.92 -48.21 60.68 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.639 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 156' ' ' MET . 50.2 m -67.78 116.36 37.26 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.177 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.98 157.1 13.42 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.201 1.934 . . . . 0.0 112.955 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.76 -140.15 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.988 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 3.9 t -50.92 174.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 9.3 mp -82.83 -71.08 0.12 Allowed Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' VAL . 71.3 Cg_exo -38.21 -50.02 2.22 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.159 1.906 . . . . 0.0 113.818 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 19' ' ' PRO . 20.3 m 45.76 9.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.634 ' H ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 p -110.37 -29.66 0.15 Allowed Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' HD3' ' H ' ' A' ' 21' ' ' VAL . 72.6 Cg_endo -95.42 -15.12 0.54 Allowed 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 121.824 1.683 . . . . 0.0 111.744 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 23' ' ' LEU . 4.2 mm? -99.77 -97.36 0.24 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.499 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.6 mt -86.74 160.85 2.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 25.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -69.02 -168.64 0.14 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.428 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.22 149.26 19.48 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.084 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.64 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.7 t -157.21 -179.1 7.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.168 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? 48.96 -152.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.379 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.58 -35.92 2.95 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.06 -41.93 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.0 110.36 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 28' ' ' SER . . . -61.35 -37.97 85.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.93 -42.06 84.08 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.451 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.05 -42.14 98.87 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.067 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.03 98.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.423 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.24 -37.9 81.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.687 -179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.6 tp -57.91 -37.61 74.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -57.71 -37.78 61.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.166 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 117' ' ' PRO . 2.5 m -57.76 -42.05 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.966 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 5' ' ' PHE . . . -62.14 -37.6 85.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.149 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.99 -38.96 91.1 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.446 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -62.15 -42.15 98.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.442 -0.903 . . . . 0.0 112.129 -177.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.514 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 21.8 p -62.48 -42.52 99.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -62.51 -42.9 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.972 -178.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -42.62 99.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 123.016 1.389 . . . . 0.0 110.249 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.513 ' CE ' ' CD2' ' A' ' 182' ' ' TYR . 7.4 mtp -62.2 -37.72 86.39 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.109 -2.314 . . . . 0.0 113.37 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.4 mt -57.69 -37.72 73.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.81 -37.69 61.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.981 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.416 HD12 ' NH1' ' A' ' 61' ' ' ARG . 7.2 tp -59.82 -39.13 84.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.513 0.197 . . . . 0.0 111.276 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -34.99 -38.54 0.14 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' THR . 51.4 m-85 -118.69 179.7 4.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' TYR . 41.4 p -53.77 -170.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -171.94 112.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.422 0.629 . . . . 0.0 111.859 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.63 ' C ' HD22 ' A' ' 55' ' ' LEU . 58.0 m -130.07 -52.7 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 54' ' ' SER . 4.4 mm? -121.1 4.99 10.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.628 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 2.3 m-30 -82.44 20.28 1.12 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.753 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.3 38.21 23.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.491 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.92 -35.53 92.01 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -34.63 63.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.533 -0.334 . . . . 0.0 111.346 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -54.51 -34.96 62.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.588 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' O ' ' SD ' ' A' ' 65' ' ' MET . 13.5 mtm180 -62.98 -45.58 91.73 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.416 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -65.79 -45.83 90.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -65.54 -34.99 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 67' ' ' PHE . . . -54.78 -34.81 63.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -56.93 -34.81 68.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.0 mm? -56.78 -45.2 82.28 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 64' ' ' ALA . 11.5 p90 -65.2 -34.77 79.15 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 119.614 -0.834 . . . . 0.0 110.203 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -54.92 -34.69 63.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.257 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 113' ' ' PHE . 80.1 mt -54.73 -34.95 63.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.582 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -54.91 -45.13 75.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.351 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' ILE . 55.4 m-85 -65.13 -45.17 86.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 0.0 110.827 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.97 79.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.226 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 tt -55.01 -44.73 74.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.936 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.1 tt -64.68 -34.87 72.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.558 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -58.74 -45.19 90.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.362 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 76' ' ' LEU . 10.7 mp -65.1 -45.14 86.43 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.264 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 78' ' ' ASP . 57.3 m -65.06 -36.16 83.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.593 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 77' ' ' SER . 25.2 t0 -32.76 -105.51 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -166.94 156.95 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.994 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.04 150.83 44.52 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.152 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' GLU . 48.5 t0 -165.34 34.76 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.32 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' VAL . 8.2 pt-20 48.32 147.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.973 0.796 . . . . 0.0 113.023 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 68.34 -35.04 0.27 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.664 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' GLU . 6.3 m -62.12 -34.94 66.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.131 0.491 . . . . 0.0 109.765 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -64.44 -35.04 79.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.148 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -58.04 -34.92 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.94 -41.19 70.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.96 85.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.7 p -56.26 -34.65 66.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.449 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.653 HH21 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -54.74 -34.42 62.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.9 mtp -54.69 -43.4 72.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.626 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.919 ' O ' HD22 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -65.14 -45.26 85.73 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.314 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 92' ' ' THR . 34.7 t -65.42 -45.35 84.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.029 0.442 . . . . 0.0 111.789 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.653 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . -65.17 -35.1 91.28 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.279 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD22 ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -35.9 158.5 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.752 0.31 . . . . 0.0 111.134 -178.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.1 m -144.86 -124.52 0.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.661 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -63.18 81.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.892 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 99' ' ' ILE . 24.5 ttpp -82.13 -55.36 4.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.329 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -52.07 -171.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.804 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -70.77 117.9 12.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.248 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.4 m -161.0 -75.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.453 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.69 79.31 48.22 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.135 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -84.74 118.42 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.685 2.257 . . . . 0.0 111.675 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.8 t -154.59 -129.07 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -79.1 55.6 1.85 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.7 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 110' ' ' LEU . 4.4 m-85 42.69 56.43 3.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.516 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.25 -56.2 20.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.291 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -40.35 97.15 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.0 mmt -60.22 -40.27 89.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.595 0.712 . . . . 0.0 110.06 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 106' ' ' PHE . 4.5 mp -60.1 -39.93 87.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.2 tp -59.77 -39.95 86.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.25 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 115' ' ' TRP . . . -59.82 -39.64 85.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.652 0.739 . . . . 0.0 111.904 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 113' ' ' PHE . 2.2 m-30 -59.69 -38.43 81.54 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 125.188 1.395 . . . . 0.0 113.0 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.625 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 21.7 tp -58.79 -39.24 80.53 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -173.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 1.4 p90 -60.16 -39.39 86.23 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -59.48 -39.96 76.08 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -172.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.758 ' O ' HG12 ' A' ' 39' ' ' VAL . 39.3 Cg_exo -59.99 -39.98 65.91 Favored 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 122.182 1.922 . . . . 0.0 114.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -55.1 -144.03 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.5 OUTLIER 78.83 -75.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 111.197 -2.729 . . . . 0.0 114.344 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.6 ' N ' HG22 ' A' ' 119' ' ' ILE . 27.1 tp -59.97 -40.95 82.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 117.555 -1.658 . . . . 0.0 112.399 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 44.1 Cg_endo -60.52 -39.99 60.57 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.098 1.866 . . . . 0.0 109.108 172.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 177' ' ' LEU . 1.5 t80 -59.7 -40.02 86.51 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.142 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.58 85.9 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -59.98 -39.66 95.91 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.209 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.2 tt -60.01 -39.64 80.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 O-C-N 122.541 -0.388 . . . . 0.0 111.879 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.24 88.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -60.28 -40.13 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.319 179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.72 ' N ' HD13 ' A' ' 127' ' ' ILE . 5.3 t -60.14 -39.94 88.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.17 0.509 . . . . 0.0 110.693 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.426 HE22 HG12 ' A' ' 138' ' ' VAL . 24.4 tt0 -59.94 -39.93 87.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.875 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -39.89 87.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.447 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 131' ' ' LEU . 1.6 tt -53.73 -56.65 15.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.314 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 133' ' ' SER . 0.2 OUTLIER -159.86 123.41 3.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.408 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.592 ' N ' HD13 ' A' ' 132' ' ' LEU . 2.9 m 174.17 -69.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.975 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 57.61 90.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 139' ' ' MET . 2.4 m120 -132.18 144.91 55.11 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 137' ' ' LEU . 70.6 Cg_endo -75.71 -70.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.556 1.504 . . . . 0.0 113.823 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' PRO . 1.5 mp -65.14 -45.06 86.56 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.2 t -65.08 -45.32 94.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.979 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 135' ' ' ASN . 3.6 ptt? -65.37 -45.06 85.61 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.957 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.704 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.9 tm? -65.05 -45.28 86.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.507 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 t -65.25 -45.11 85.9 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.793 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 2.8 m-85 -65.19 -45.09 86.22 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.665 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.34 -45.11 94.69 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.567 -0.742 . . . . 0.0 114.51 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.03 -45.5 85.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.982 -176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.65 88.73 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 118.503 -1.808 . . . . 0.0 110.953 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.593 ' N ' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -65.69 -45.24 83.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HD11 ' A' ' 150' ' ' ILE . . . -57.7 -45.3 85.89 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.28 -45.28 94.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.316 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 167' ' ' LEU . 92.1 m -65.36 -45.39 84.32 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 147' ' ' ALA . 3.6 pt -54.74 -36.86 38.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.651 -174.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.84 -45.36 94.14 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 117.517 -1.673 . . . . 0.0 109.279 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.46 -45.05 85.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 0.0 110.933 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.09 -45.06 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.816 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -34.86 65.22 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.83 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -57.6 -35.09 69.96 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.361 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 158' ' ' GLU . 7.1 ptm -55.17 -35.09 64.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -37.51 -23.93 0.01 OUTLIER Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 156' ' ' MET . 1.8 tm-20 -119.82 -42.03 2.64 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 12.6 tmtt? -175.61 118.81 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.561 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -58.58 -111.94 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.2 p -168.66 -58.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 119.121 0.873 . . . . 0.0 110.927 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.622 ' H ' HG13 ' A' ' 161' ' ' VAL . 6.4 tppt? -168.17 -85.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 164' ' ' ASN . . . -166.49 28.24 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.08 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' ALA . 3.8 m120 -16.13 105.74 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 122.417 1.103 . . . . 0.0 112.298 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.707 ' O ' HG22 ' A' ' 168' ' ' ILE . 15.3 p90 -57.95 -37.7 74.63 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.202 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.63 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 1.7 pt20 -57.7 -37.67 73.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.237 0.542 . . . . 0.0 109.9 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 149' ' ' THR . 1.0 OUTLIER -57.76 -37.58 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.029 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 165' ' ' PHE . 5.2 tt -57.7 -37.46 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.374 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -57.74 -37.55 73.79 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.523 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.632 ' HE3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.62 -37.5 73.38 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.759 -178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' A' ' 170' ' ' LYS . 85.3 t -57.96 -42.63 83.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.486 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 61.7 p -62.68 -42.83 99.83 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 118.323 -1.351 . . . . 0.0 112.567 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.73 99.58 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.724 -1.227 . . . . 0.0 113.473 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.72 99.78 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.657 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 mt -62.96 -42.87 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.1 m -62.88 -42.86 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 117.358 -1.737 . . . . 0.0 113.323 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -62.82 -42.03 99.56 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 179' ' ' TYR . 0.0 OUTLIER -57.95 -42.42 84.92 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.48 ' H ' HD23 ' A' ' 178' ' ' LEU . 14.1 t80 -62.5 -42.66 99.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.109 -1.437 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.61 -42.23 99.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.16 99.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.072 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CD2' ' CE ' ' A' ' 46' ' ' MET . 1.1 t80 -62.13 -37.85 86.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.178 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.11 95.42 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 35.99 -144.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.357 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.71 -70.99 0.76 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 p -152.83 4.84 0.36 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.919 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -98.33 32.8 2.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.096 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.13 -39.41 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.275 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.5 OUTLIER -160.48 143.65 13.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.864 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 189' ' ' LEU . 42.5 tp -155.79 -46.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.496 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.611 HD22 ' N ' ' A' ' 191' ' ' LEU . 3.3 mm? -71.9 108.95 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.196 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.538 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -167.1 0.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.62 -28.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.382 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.97 85.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.194 0.521 . . . . 0.0 110.787 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -62.11 -37.97 87.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.023 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.86 86.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.321 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -62.12 -42.14 98.93 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.558 -177.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.19 -42.18 99.72 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.237 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.6 tt -62.33 -41.72 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.008 0.904 . . . . 0.0 111.046 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.27 -42.05 99.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.849 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -62.32 -42.5 99.43 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.827 0.676 . . . . 0.0 112.827 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 13' ' ' PHE . 8.7 m -62.33 -37.69 79.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' VAL . 36.1 t80 -28.21 -64.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.648 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.6 t -72.32 115.89 43.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.381 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.3 -170.14 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.889 1.726 . . . . 0.0 112.379 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.68 -111.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.818 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.562 HG13 ' H ' ' A' ' 20' ' ' VAL . 4.9 p -70.39 158.49 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 19' ' ' PRO . 8.9 mt -42.24 -68.71 0.25 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.729 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 38.3 Cg_endo -63.84 -28.97 67.74 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.347 2.031 . . . . 0.0 115.13 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER 36.7 73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 118.763 0.711 . . . . 0.0 111.238 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.859 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.2 p 175.2 -16.53 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.859 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 40.3 Cg_endo -91.0 -8.07 3.53 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 CA-C-N 121.398 1.535 . . . . 0.0 114.551 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mt -147.04 -36.49 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 162' ' ' LYS . 0.7 OUTLIER -97.96 -0.78 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.176 0.898 . . . . 0.0 111.333 -178.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 42.69 42.82 3.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' GLY . . . -132.99 -165.09 1.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.783 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' ALA . . . 45.06 -174.01 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 p -160.12 -159.88 0.75 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.334 0.587 . . . . 0.0 111.587 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -177.9 -147.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.87 -68.85 1.51 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -62.25 -37.74 86.6 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.806 0.336 . . . . 0.0 111.898 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' N ' ' A' ' 29' ' ' ARG . . . -57.9 -37.85 74.77 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -57.93 -37.72 74.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.346 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.694 ' H ' HD12 ' A' ' 33' ' ' LEU . 12.7 t70 -58.03 -38.35 76.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 32' ' ' ALA . . . -62.08 -38.53 89.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.699 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -58.27 -37.92 75.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.05 -37.66 77.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.187 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.4 mm -58.02 -42.01 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 117' ' ' PRO . 14.7 m -62.03 -40.59 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.883 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.62 86.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.986 0.422 . . . . 0.0 111.909 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.8 -38.26 87.65 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD23 HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -58.01 -38.76 76.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 119.144 1.472 . . . . 0.0 111.078 -178.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.457 HG23 HD23 ' A' ' 42' ' ' LEU . 66.1 p -60.73 -42.34 97.11 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 mm -62.13 -42.43 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.38 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -62.43 -42.02 99.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.703 1.24 . . . . 0.0 110.058 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttp -62.15 -37.87 86.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.364 -2.198 . . . . 0.0 115.791 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -57.91 -42.24 84.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.41 -175.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.594 HD12 ' CZ ' ' A' ' 61' ' ' ARG . 3.7 mt -62.43 -37.91 79.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' C ' ' N ' ' A' ' 51' ' ' TYR . 2.3 tp -58.02 -38.51 76.35 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.573 -178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.21 -21.26 1.75 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' CG ' ' N ' ' A' ' 52' ' ' THR . 73.3 t80 -127.03 -179.78 5.02 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 51' ' ' TYR . 5.8 m -59.23 -122.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.64 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -174.22 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.199 0.523 . . . . 0.0 110.702 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m 58.73 -99.85 0.1 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.797 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 33.86 3.35 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.429 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' O ' HD13 ' A' ' 48' ' ' ILE . 9.7 m-85 -111.41 23.67 13.71 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 54.07 57.3 6.07 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.394 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.61 -34.83 60.86 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -57.3 -34.62 68.88 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -54.88 -45.42 74.62 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.061 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HD2' ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -65.33 -45.68 83.29 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.271 -1.371 . . . . 0.0 112.53 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 63' ' ' VAL . 2.2 m -65.77 -45.87 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' HG23 ' A' ' 62' ' ' VAL . 2.9 t -65.96 -45.27 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.293 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.89 -34.77 63.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.742 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.643 ' CE ' HD21 ' A' ' 114' ' ' LEU . 32.9 ttm -54.63 -38.73 67.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.702 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.98 -40.67 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -54.82 -34.93 63.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 110.102 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.15 -34.73 76.94 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.774 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 113' ' ' PHE . 48.2 tp -54.95 -44.98 74.81 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.415 ' H ' HG23 ' A' ' 70' ' ' ILE . 5.1 pt -55.13 -39.76 52.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.477 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.52 -35.05 79.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.307 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.54 94.6 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -54.91 -34.89 63.58 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.2 -45.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.516 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 78' ' ' ASP . 27.5 tp -65.14 -45.13 86.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.115 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -44.97 87.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.308 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.7 t -65.0 -44.7 88.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.957 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 36.2 t70 -95.03 177.64 5.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.804 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 35.3 tp10 61.42 132.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 84.46 2.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.216 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.3 m-20 -129.75 -175.25 3.54 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.3 pm0 -93.64 -28.57 15.92 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -65.52 -22.43 66.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 109.639 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 81' ' ' ASP . 4.1 m -65.2 -39.33 85.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.535 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 84' ' ' VAL . 79.5 p -65.12 -45.39 85.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 172' ' ' THR . 17.7 pt -65.3 -34.67 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.425 0.631 . . . . 0.0 110.214 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.69 -42.01 70.92 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.2 -35.33 80.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.7 t -54.94 -34.74 63.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.279 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -54.97 -34.63 63.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.584 -179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 69.3 mtm -54.85 -45.23 74.49 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.646 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -45.13 85.96 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.039 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.9 m -65.31 -45.25 85.1 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.742 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.498 ' N ' HH21 ' A' ' 90' ' ' ARG . . . -65.37 -45.14 91.87 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 31.68 -159.92 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.581 -0.809 . . . . 0.0 112.097 179.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 27.0 t -179.54 -170.84 0.17 Allowed 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.971 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.517 ' N ' ' OG ' ' A' ' 96' ' ' SER . 21.0 m-90 -63.83 135.98 57.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -145.79 47.23 1.26 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.766 0.317 . . . . 0.0 110.917 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.9 mt -138.76 -48.07 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.757 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.34 43.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.41 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.9 t -59.44 -160.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.125 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.71 96.08 26.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.881 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.34 152.96 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.325 2.017 . . . . 0.0 113.449 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 106' ' ' PHE . 29.2 p -175.89 -162.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.888 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.604 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -59.54 -4.83 0.69 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.299 -0.56 . . . . 0.0 109.626 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 11.7 m-85 136.15 115.75 0.0 OUTLIER 'General case' 0 C--N 1.342 0.246 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -90.12 -61.66 1.64 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.11 96.48 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.193 -0.527 . . . . 0.0 113.433 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.59 ' SD ' ' CG ' ' A' ' 106' ' ' PHE . 21.2 mtp -60.02 -39.64 86.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.007 0.432 . . . . 0.0 111.273 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 106' ' ' PHE . 1.1 mm? -59.63 -40.06 86.37 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.276 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 95' ' ' LEU . 13.3 tp -60.22 -40.27 89.59 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.428 0.632 . . . . 0.0 111.411 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.11 -39.26 85.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.759 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' CE1' HD13 ' A' ' 69' ' ' LEU . 6.9 m-30 -59.26 -38.9 81.23 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.643 HD21 ' CE ' ' A' ' 65' ' ' MET . 4.1 mm? -59.14 -40.02 84.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.52 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 35.6 p-90 -60.54 -39.58 88.42 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 116' ' ' LEU . 5.6 mp -59.83 -40.78 81.44 Favored Pre-proline 0 N--CA 1.482 1.141 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.835 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.8 Cg_endo -60.29 -39.86 63.95 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 CA-C-N 121.566 1.595 . . . . 0.0 113.08 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -35.44 -149.7 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.665 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.6 mp 79.39 -85.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 109.775 -3.375 . . . . 0.0 112.912 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.665 ' N ' HG22 ' A' ' 119' ' ' ILE . 7.8 mt -60.03 -40.92 81.93 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 117.725 -1.59 . . . . 0.0 111.814 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 53.2 Cg_endo -60.66 -39.94 59.64 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 122.202 1.935 . . . . 0.0 109.299 172.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.61 ' CE2' ' CE2' ' A' ' 142' ' ' TYR . 12.9 t80 -59.81 -39.88 86.52 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.68 -39.43 84.47 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.74 -39.78 95.73 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.991 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 122' ' ' PHE . 2.0 tt -59.87 -39.92 81.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.674 -0.898 . . . . 0.0 111.764 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.38 89.47 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 pt -60.5 -40.23 83.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 119.041 -1.063 . . . . 0.0 110.38 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.7 p -60.17 -40.27 89.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.953 0.406 . . . . 0.0 110.845 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.507 ' OE1' ' SD ' ' A' ' 139' ' ' MET . 7.1 tt0 -60.07 -40.01 88.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.561 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -60.03 -40.04 87.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.538 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 tp -69.93 -53.57 17.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.031 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -61.16 -173.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.714 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.2 t -69.42 179.47 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 20.9 mp0 -73.01 160.09 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 75.1 m-20 -138.71 156.82 72.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -89.54 -106.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.189 1.926 . . . . 0.0 116.132 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 137' ' ' LEU . 10.8 mp -55.51 -45.13 77.13 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 139' ' ' MET . 12.2 p -55.68 -45.21 79.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.595 ' N ' HG13 ' A' ' 138' ' ' VAL . 0.4 OUTLIER -65.12 -45.14 86.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.695 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 140' ' ' LEU . 2.7 tm? -65.06 -45.3 85.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.432 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.689 ' OG ' HD21 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -65.13 -45.08 86.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 122' ' ' PHE . 4.2 t80 -65.15 -42.46 93.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.314 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.94 -45.05 82.33 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 114.242 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.2 tt -65.01 -45.3 86.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 117.828 0.814 . . . . 0.0 112.605 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 149' ' ' THR . . . -65.3 -45.11 92.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.604 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.6 ttp -65.4 -45.06 85.45 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.88 -45.24 74.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 149' ' ' THR . 11.6 p -65.34 -43.54 94.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -65.02 -45.4 85.63 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.509 ' CG2' ' CE1' ' A' ' 154' ' ' PHE . 47.0 mm -58.65 -35.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.263 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.01 78.99 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.34 92.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -38.55 82.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.143 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CE1' ' CG2' ' A' ' 150' ' ' ILE . 2.6 m-85 -54.86 -34.8 63.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -55.69 -34.69 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 158' ' ' GLU . 3.7 ptt? -54.86 -45.14 74.52 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' N ' ' CG ' ' A' ' 156' ' ' MET . . . -42.57 -21.06 0.08 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 156' ' ' MET . 8.4 pt-20 -134.6 62.22 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 160' ' ' PHE . 1.0 OUTLIER 58.48 119.22 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.336 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 159' ' ' LYS . 26.4 m-85 -45.44 -98.47 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.044 0.449 . . . . 0.0 109.919 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.64 HG13 ' H ' ' A' ' 162' ' ' LYS . 5.9 p -172.53 -56.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.64 ' H ' HG13 ' A' ' 161' ' ' VAL . 13.2 ttpt -175.47 -80.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.642 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -177.13 39.77 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -44.67 143.04 1.48 Allowed 'General case' 0 N--CA 1.414 -2.226 0 CA-C-O 123.455 1.598 . . . . 0.0 110.933 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 166' ' ' GLN . 2.8 p90 -57.72 -37.74 74.06 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 110.889 -2.869 . . . . 0.0 111.968 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.535 ' N ' ' CD1' ' A' ' 165' ' ' PHE . 31.3 tt0 -57.67 -37.71 73.89 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.782 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 167' ' ' LEU . 9.0 mp -61.51 -37.85 85.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 165' ' ' PHE . 7.4 pt -62.15 -37.58 78.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 118.376 -1.33 . . . . 0.0 109.816 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -57.76 -38.05 74.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.185 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.04 -37.73 77.66 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.505 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.98 -42.15 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.04 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.46 ' OG1' HD12 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.64 -0.824 . . . . 0.0 112.108 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.45 -42.32 99.71 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.83 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.49 99.41 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.547 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.84 -43.38 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 1.4 p -63.2 -42.69 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 119.431 -0.908 . . . . 0.0 113.379 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.689 HD21 ' OG ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -62.61 -42.19 99.43 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -176.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.3 -42.38 95.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 111' ' ' LEU . 39.1 t80 -62.25 -42.61 99.48 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.796 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.2 mm? -62.59 -42.41 99.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 119.914 -0.715 . . . . 0.0 110.778 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.365 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -42.07 92.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.99 -42.07 98.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.677 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.76 89.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.455 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.95 -24.74 62.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.935 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 27.9 p -80.6 -89.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.603 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -140.39 149.97 43.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.324 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 188' ' ' VAL . 7.8 p -105.79 34.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 188' ' ' VAL . 0.2 OUTLIER 84.0 -77.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.296 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 189' ' ' LEU . 11.9 mt 51.52 173.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 0.0 110.619 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 191' ' ' LEU . 2.3 tm? -77.79 -54.52 6.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.866 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.443 ' N ' HD13 ' A' ' 191' ' ' LEU . 16.5 pt-20 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.53 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 4' ' ' ALA . 5.7 tp -71.31 -128.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.366 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 mtt 63.56 -68.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.684 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 2' ' ' LEU . . . -58.39 -40.68 83.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.395 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 18.2 t80 -61.58 -42.09 98.36 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.37 88.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.885 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.89 87.04 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.866 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.0 mm -57.82 -39.88 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 O-C-N 122.368 -0.489 . . . . 0.0 111.014 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.8 mt -62.1 -37.94 86.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.197 0.522 . . . . 0.0 110.176 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.7 p -62.11 -37.9 86.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.842 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.3 t -57.78 -37.69 61.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.437 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -38.82 -66.76 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.249 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -45.05 137.15 4.73 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.08 -53.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.132 1.888 . . . . 0.0 113.368 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . 62.19 -153.16 0.35 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 110.946 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' ALA . 33.8 t -34.08 -97.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -171.49 -48.88 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD2' ' H ' ' A' ' 18' ' ' LEU . 70.0 Cg_endo -93.09 -17.75 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 122.613 2.209 . . . . 0.0 109.82 177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 0.4 OUTLIER 31.63 47.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.379 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.978 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -96.72 -44.97 0.25 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.137 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 19.7 Cg_endo -101.36 -157.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.151 2.567 . . . . 0.0 111.859 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 43.78 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -88.75 124.67 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.507 -178.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ALA . 3.1 m-85 -49.55 -13.75 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -37.66 162.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.34 152.84 24.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.877 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 p -173.59 62.95 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.761 0.315 . . . . 0.0 110.939 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -163.82 165.08 23.31 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.321 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.64 -60.29 7.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -58.12 -38.22 76.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.83 83.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.579 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.644 ' C ' HD13 ' A' ' 33' ' ' LEU . 3.3 tm? -57.87 -42.1 83.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.207 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -58.48 -42.35 87.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.06 -37.82 86.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.672 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.735 ' O ' HG22 ' A' ' 39' ' ' VAL . 3.5 t80 -57.86 -37.94 74.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.976 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -61.38 -37.84 84.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.224 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -58.86 -42.06 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.761 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 117' ' ' PRO . 27.5 m -60.47 -42.38 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 118.812 -1.155 . . . . 0.0 110.315 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.62 86.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.359 0.6 . . . . 0.0 111.194 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.88 -37.96 86.76 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' CD2' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -61.87 -42.22 98.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 119.587 1.694 . . . . 0.0 112.79 -176.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.458 HG23 ' CD2' ' A' ' 42' ' ' LEU . 68.8 p -62.3 -42.82 99.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 pt -62.89 -43.34 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.819 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -63.27 -43.14 98.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 123.066 1.413 . . . . 0.0 111.417 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 81.9 mmm -62.74 -38.26 89.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 111.612 -2.54 . . . . 0.0 115.234 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -57.62 -37.98 74.2 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.195 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.9 -37.76 62.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.5 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER -57.86 -37.99 74.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -178.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -19.75 -49.79 0.01 OUTLIER Glycine 0 N--CA 1.472 1.067 0 O-C-N 123.613 0.57 . . . . 0.0 112.857 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' N ' ' O ' ' A' ' 49' ' ' LEU . 87.6 t80 -173.63 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.9 p -41.62 152.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 55' ' ' LEU . . . -169.65 -74.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.499 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 55' ' ' LEU . 38.9 p 59.86 -71.2 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.647 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 ' N ' ' OG ' ' A' ' 54' ' ' SER . 2.2 tt -151.73 64.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -117.63 5.37 12.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.42 64.93 0.41 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.312 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.75 -34.87 56.98 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 63' ' ' VAL . 54.3 m-85 -54.85 -34.27 62.72 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.913 -0.644 . . . . 0.0 111.861 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -54.42 -40.55 68.41 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 ptt85 -65.02 -45.38 85.74 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 118.079 -1.448 . . . . 0.0 111.677 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.535 ' O ' ' SD ' ' A' ' 65' ' ' MET . 16.2 m -65.65 -45.76 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 59' ' ' PHE . 0.9 OUTLIER -65.52 -45.06 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 118.886 -1.126 . . . . 0.0 112.162 -179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.85 63.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.255 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -54.94 -34.81 63.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.372 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' ' HG2' ' A' ' 65' ' ' MET . 61.7 mt -55.02 -44.91 75.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -55.91 -34.99 66.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.463 0.649 . . . . 0.0 109.879 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -55.68 -34.73 65.3 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.428 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 69' ' ' LEU . 4.5 tt -54.69 -34.82 62.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.8 mt -54.78 -45.02 73.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.985 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 74' ' ' ILE . 41.2 m-85 -65.14 -41.01 95.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.987 0.422 . . . . 0.0 110.799 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.91 79.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -54.81 -34.95 63.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -177.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 71' ' ' PHE . 7.8 tt -58.76 -45.06 91.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.28 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 78' ' ' ASP . 28.6 tp -65.07 -45.4 85.45 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.307 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.3 -44.97 86.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.011 0.434 . . . . 0.0 111.222 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.2 t -55.58 -44.97 77.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.638 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 75' ' ' LEU . 54.9 p30 -134.18 -163.84 1.42 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.997 0.427 . . . . 0.0 111.484 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 80' ' ' LEU . 5.6 tp10 63.08 86.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.709 ' N ' HD12 ' A' ' 80' ' ' LEU . 5.8 mp -59.9 -130.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.602 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.55 177.51 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.449 . . . . 0.0 111.551 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.618 ' O ' HG13 ' A' ' 84' ' ' VAL . 70.4 mm-40 -92.1 -175.46 4.08 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.078 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.61 ' NZ ' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER 67.15 -40.9 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 82' ' ' GLU . 1.0 OUTLIER -65.17 -45.19 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.455 ' N ' ' CG2' ' A' ' 84' ' ' VAL . 9.9 t -65.27 -45.22 85.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.7 0.762 . . . . 0.0 109.823 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.99 -34.43 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.567 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -54.42 -34.96 62.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -177.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -34.72 79.06 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.305 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 m -57.66 -34.82 69.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.568 ' CB ' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -62.19 -34.83 77.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.485 -178.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 91' ' ' MET . 0.6 OUTLIER -54.91 -45.18 74.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.673 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.884 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.19 -45.04 86.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.371 -0.531 . . . . 0.0 111.769 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -65.17 -45.01 86.63 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.04 -34.96 91.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.919 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -33.96 157.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.981 0.42 . . . . 0.0 111.536 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.918 ' N ' HD22 ' A' ' 95' ' ' LEU . 26.9 t -144.86 -116.34 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.536 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -41.95 148.32 0.18 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.362 . . . . 0.0 111.075 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -155.84 -71.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.307 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.3 pt -75.27 139.77 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 45.52 50.34 10.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -78.08 161.68 27.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.66 148.58 45.8 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.117 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.59 110.32 3.04 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.207 1.938 . . . . 0.0 112.217 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.534 ' OG ' ' CD2' ' A' ' 107' ' ' PHE . 89.6 p -173.65 -171.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.411 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -50.33 -78.14 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 46.5 m-85 -166.28 69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CD2' ' OG ' ' A' ' 104' ' ' SER . 12.9 m-85 -35.97 -47.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.947 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.43 97.22 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.34 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -60.54 -40.24 90.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 117.577 0.689 . . . . 0.0 110.737 178.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 62' ' ' VAL . 1.2 mp -60.2 -40.17 89.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.395 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.28 -39.88 88.45 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -60.09 -39.47 86.25 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -59.48 -39.94 85.34 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 -172.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.568 ' CZ3' ' CB ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -60.62 -40.6 92.47 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 118.074 2.62 . . . . 0.0 118.074 -176.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 115' ' ' TRP . 60.1 tp -60.64 -40.54 76.45 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.767 ' O ' HG12 ' A' ' 39' ' ' VAL . 34.3 Cg_exo -60.23 -39.87 64.54 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.166 2.577 . . . . 0.0 115.733 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' H ' ' A' ' 119' ' ' ILE . . . -70.52 -135.74 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 120' ' ' LEU . 0.3 OUTLIER 85.22 -70.34 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 112.07 -2.332 . . . . 0.0 112.116 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.584 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 35.8 tp -60.12 -41.22 83.42 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.852 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 43.3 Cg_endo -60.54 -39.78 62.18 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.649 2.233 . . . . 0.0 108.602 171.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.778 ' O ' HG22 ' A' ' 125' ' ' ILE . 4.0 t80 -59.68 -39.78 85.67 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 113.663 -1.608 . . . . 0.0 106.74 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.83 -39.56 85.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.97 -39.71 95.98 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 114.937 -1.028 . . . . 0.0 112.197 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.7 tt -59.88 -39.28 79.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.08 86.36 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.7 pt -60.03 -40.13 82.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.474 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 t -60.17 -39.9 88.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.884 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.504 ' OE1' ' CG ' ' A' ' 142' ' ' TYR . 51.7 mt-30 -59.65 -39.86 85.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 131' ' ' LEU . 17.0 m -59.81 -39.86 86.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.209 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 130' ' ' THR . 61.1 mt -61.26 -125.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.627 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -92.09 176.52 6.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 132' ' ' LEU . 23.9 m 55.71 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.186 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 134' ' ' GLU . 0.6 OUTLIER -174.05 153.07 2.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.75 179.39 1.12 Allowed Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -83.32 -58.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.657 1.571 . . . . 0.0 113.619 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 137' ' ' LEU . 3.8 mm? -58.39 -44.95 89.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 139' ' ' MET . 13.3 m -62.85 -45.31 99.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.448 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.611 ' N ' HG23 ' A' ' 138' ' ' VAL . 2.1 tmm? -65.05 -45.13 86.65 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -58.73 -45.08 90.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 177' ' ' LEU . 8.7 t -65.16 -45.08 86.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.563 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.642 ' OH ' HG21 ' A' ' 125' ' ' ILE . 1.5 m-85 -65.09 -38.82 91.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.957 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.08 -45.33 96.8 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.658 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.51 -45.74 82.37 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.965 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.75 -45.54 88.24 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.313 -0.47 . . . . 0.0 113.587 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -65.33 -45.02 85.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -54.95 -45.39 74.89 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.522 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 m -65.49 -45.37 92.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.38 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.5 m -65.54 -45.19 84.38 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.24 -36.61 78.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.182 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.02 -45.11 75.11 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.282 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 170' ' ' LYS . . . -65.21 -43.25 92.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.375 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.589 ' O ' ' SD ' ' A' ' 156' ' ' MET . 55.3 t -60.07 -34.78 57.87 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.162 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -54.67 -34.82 62.83 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.628 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -61.8 -34.55 76.11 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.69 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.702 ' SD ' ' N ' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -54.8 -34.77 63.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.702 ' N ' ' SD ' ' A' ' 156' ' ' MET . . . -47.39 -60.29 5.31 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -75.89 -68.13 0.61 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 8.8 mtmp? -161.59 115.06 1.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.333 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -54.18 162.9 0.91 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG22 ' N ' ' A' ' 162' ' ' LYS . 4.6 p -86.45 166.39 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 161' ' ' VAL . 51.8 tttm -46.25 -65.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 176.68 44.75 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB3' HD13 ' A' ' 167' ' ' LEU . 17.9 t-20 -29.63 140.74 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.336 1.541 . . . . 0.0 112.31 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 168' ' ' ILE . 3.7 t80 -58.04 -38.62 76.59 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 112.169 -2.287 . . . . 0.0 110.567 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -57.98 -37.61 74.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.229 0.538 . . . . 0.0 111.764 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 164' ' ' ASN . 4.6 mp -57.77 -37.73 74.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.153 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.61 HD12 ' NZ ' ' A' ' 83' ' ' LYS . 2.1 pt -57.76 -37.9 62.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.399 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -62.15 -40.63 96.63 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.941 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -62.02 -37.86 86.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.419 HG13 ' H ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -62.05 -41.95 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.922 -177.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 42.5 p -62.24 -42.56 99.43 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.967 -1.093 . . . . 0.0 113.335 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -63.01 -42.67 99.6 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.163 -1.97 . . . . 0.0 114.687 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.68 99.75 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 118.6 -1.24 . . . . 0.0 112.629 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -42.92 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.48 -42.59 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.814 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.9 tp -62.51 -37.64 86.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 178' ' ' LEU . 3.2 tt -57.73 -42.21 83.41 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 53.8 t80 -62.31 -42.41 99.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 117.483 -1.687 . . . . 0.0 111.206 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.43 -42.61 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.299 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.43 99.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.321 -0.551 . . . . 0.0 112.252 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -41.63 98.68 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.062 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -62.08 -41.56 98.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.788 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.75 138.67 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.804 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 185' ' ' LEU . 7.3 mp -87.6 128.67 35.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.062 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.9 p -143.26 56.61 1.38 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 187' ' ' GLU . 28.5 mp0 45.36 94.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.681 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.91 -51.67 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER 179.73 22.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.864 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER 62.15 -75.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.064 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 189' ' ' LEU . 6.8 tp 39.84 63.41 1.04 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.937 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 192' ' ' GLU . 4.2 pm0 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.833 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.9 mm? -48.3 118.68 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.3 mtt 39.95 45.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.03 98.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.658 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 6' ' ' ALA . 36.6 p90 -58.07 -39.2 77.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.321 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' A' ' 5' ' ' PHE . . . -62.03 -37.96 86.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.03 -42.12 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.097 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.91 86.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.13 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG23 ' H ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -57.74 -37.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.383 0.591 . . . . 0.0 112.319 -177.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' N ' HG13 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -57.97 -42.08 84.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.663 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 p -62.2 -42.27 99.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.724 0.773 . . . . 0.0 109.725 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.29 -37.79 79.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.598 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -40.22 -61.09 0.94 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.406 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 156' ' ' MET . 4.0 m -82.35 120.02 76.07 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.7 169.63 19.39 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.99 1.793 . . . . 0.0 112.571 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -129.68 100.41 5.5 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.304 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 16' ' ' ALA . 6.5 t 57.24 153.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' O ' ' N ' ' A' ' 20' ' ' VAL . 3.5 mm? -45.38 149.87 0.93 Allowed Pre-proline 0 C--O 1.223 -0.34 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' C ' ' O ' ' A' ' 18' ' ' LEU . 20.5 Cg_exo -19.68 74.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.334 2.69 . . . . 0.0 113.131 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 18' ' ' LEU . 7.1 p -61.19 157.69 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.445 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' N ' HG22 ' A' ' 20' ' ' VAL . 4.3 m -63.37 139.85 97.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.691 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -39.41 102.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.822 1.681 . . . . 0.0 111.613 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -150.43 -31.81 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.271 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -114.7 124.11 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ALA . 2.4 m-85 -46.04 -13.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -48.6 -111.47 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.401 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.51 167.35 17.4 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -177.2 37.17 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.121 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -143.7 163.56 32.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.995 0.426 . . . . 0.0 110.625 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.12 -42.56 48.83 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -61.78 -38.27 87.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 109.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.16 -38.06 78.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.261 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.0 -42.04 84.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.15 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.82 -42.14 92.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.456 . . . . 0.0 109.967 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.73 86.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.893 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -57.87 -39.07 76.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.05 -37.71 85.98 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.913 0.387 . . . . 0.0 110.275 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.509 HG23 HD21 ' A' ' 68' ' ' LEU . 43.4 mm -57.7 -42.51 81.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 117' ' ' PRO . 6.1 m -62.47 -42.19 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 117.652 -1.619 . . . . 0.0 111.237 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.08 -37.63 85.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.274 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.71 -38.09 86.5 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.449 -0.64 . . . . 0.0 113.809 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -61.77 -38.6 88.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.834 1.317 . . . . 0.0 110.605 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 75.0 p -62.05 -42.1 98.82 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -62.18 -42.55 95.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 118.49 -1.284 . . . . 0.0 109.922 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 55.5 m -62.4 -38.18 88.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 122.587 1.184 . . . . 0.0 110.308 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.509 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 12.0 tmm? -57.92 -37.78 74.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 112.602 -2.09 . . . . 0.0 114.444 -176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.73 -37.78 74.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.942 0.401 . . . . 0.0 110.739 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.598 HG22 ' NH2' ' A' ' 61' ' ' ARG . 9.0 mm -57.98 -37.95 64.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.713 ' N ' HH21 ' A' ' 61' ' ' ARG . 21.7 mt -57.93 -37.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 122.044 -0.41 . . . . 0.0 111.498 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' O ' ' CD2' ' A' ' 51' ' ' TYR . . . -68.42 60.54 0.44 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 50' ' ' GLY . 20.2 m-85 85.94 149.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.375 0.67 . . . . 0.0 111.135 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.874 HG22 ' H ' ' A' ' 53' ' ' ALA . 24.5 m -96.96 -177.91 4.03 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.855 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 52' ' ' THR . . . -149.29 176.08 10.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.468 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.9 m -59.31 84.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 53' ' ' ALA . 10.9 mt 66.06 68.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.1 35.83 0.22 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 55' ' ' LEU . 8.8 t80 40.74 48.29 2.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.465 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.9 -34.71 57.72 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 114.241 -1.345 . . . . 0.0 113.522 -178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 63' ' ' VAL . 65.3 m-85 -54.72 -34.6 62.66 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -54.63 -45.07 73.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.713 HH21 ' N ' ' A' ' 49' ' ' LEU . 1.1 ptp85 -65.05 -45.69 84.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 117.856 -1.538 . . . . 0.0 112.832 -176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' H ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -66.1 -46.06 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 119.368 -0.933 . . . . 0.0 113.374 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 59' ' ' PHE . 3.9 t -66.04 -39.31 84.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.69 -34.93 63.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.213 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.8 mmt -65.07 -38.73 91.74 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.724 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.7 mm? -65.34 -37.58 87.51 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 70' ' ' ILE . 57.4 t80 -55.0 -34.77 63.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.203 1.001 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -54.85 -33.98 62.38 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.321 -1.763 . . . . 0.0 113.262 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 HD23 ' CE2' ' A' ' 113' ' ' PHE . 20.7 mt -53.98 -34.85 60.93 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.703 0.683 . . . . 0.0 111.871 -174.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 71' ' ' PHE . 10.4 tp -55.01 -42.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.425 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.522 ' N ' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -65.13 -42.45 93.88 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.253 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -65.17 -36.88 85.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -55.04 -45.06 75.18 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.984 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.7 pt -65.15 -45.1 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -65.03 -45.16 86.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.717 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -45.03 86.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -65.09 -45.05 86.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' GLU . 8.9 m-20 -95.96 168.81 10.4 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.21 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.3 OUTLIER 57.3 128.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.004 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.86 94.83 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 82' ' ' GLU . 11.7 t70 -121.27 -163.0 1.0 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.45 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 pm0 -92.84 -47.05 7.23 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -62.53 -30.67 71.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.042 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 85' ' ' SER . 18.2 m -55.16 -43.93 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.6 ' N ' HG23 ' A' ' 84' ' ' VAL . 13.8 m -64.87 -44.02 91.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.95 -35.85 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.13 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -54.86 -45.17 74.52 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' N ' ' CD1' ' A' ' 87' ' ' PHE . . . -65.25 -34.85 79.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.868 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 t -64.55 -34.87 79.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.935 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -58.97 -34.7 72.11 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 53.7 mtm -54.8 -38.11 66.92 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.545 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.87 ' O ' HD12 ' A' ' 95' ' ' LEU . 37.6 p -64.25 -45.16 89.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.383 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.1 m -65.11 -45.21 86.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.497 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' LEU . . . -65.14 -34.88 90.87 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.635 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -30.24 153.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.302 0.573 . . . . 0.0 112.199 -178.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.85 ' N ' HD22 ' A' ' 95' ' ' LEU . 50.4 p -146.63 -104.1 0.1 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.861 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -90.53 173.32 8.14 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.148 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -147.11 -54.31 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.732 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.76 -19.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.46 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -84.49 42.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.728 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.7 m -157.13 -101.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.576 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp -160.09 77.2 2.76 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.833 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -50.73 167.08 0.29 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.894 2.396 . . . . 0.0 112.94 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 106' ' ' PHE . 7.6 t -173.77 -137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -66.83 67.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 104' ' ' SER . 37.2 m-85 53.85 62.69 2.5 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.748 ' O ' HD23 ' A' ' 110' ' ' LEU . 51.1 t80 -52.14 -62.7 1.47 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.044 -0.98 . . . . 0.0 113.622 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.31 97.18 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.693 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.4 OUTLIER -60.31 -40.25 89.89 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 107' ' ' PHE 0.26 0.2 OUTLIER -60.28 -39.6 87.43 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -176.804 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 112' ' ' ALA . 2.6 pp -59.5 -39.44 83.8 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.862 0.756 . . . . 0.0 109.823 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.577 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -59.59 -39.19 83.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.112 0.958 . . . . 0.0 108.719 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -59.15 -38.64 80.22 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.838 -179.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.66 -39.33 80.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.459 -175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.577 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 27.8 p-90 -60.07 -39.51 86.3 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 120.751 1.614 . . . . 0.0 114.818 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 3.1 tt -59.47 -40.52 80.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.833 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.9 Cg_endo -59.64 -39.61 72.61 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 CA-C-N 121.566 1.595 . . . . 0.0 113.827 178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -52.17 -142.5 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.416 ' H ' ' HB1' ' A' ' 118' ' ' ALA . 13.1 mt 75.37 -75.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 111.035 -2.802 . . . . 0.0 113.3 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 12.1 tp -60.06 -41.13 83.17 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 118.037 -1.465 . . . . 0.0 111.712 -177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 47.2 Cg_endo -60.36 -39.52 66.2 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.566 2.844 . . . . 0.0 109.357 170.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.414 ' HE2' HD21 ' A' ' 177' ' ' LEU . 2.9 t80 -59.29 -39.11 81.96 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 113.156 -1.838 . . . . 0.0 106.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -59.25 -39.02 81.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -59.5 -39.51 95.03 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -39.0 78.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 122.315 -0.521 . . . . 0.0 111.176 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 142' ' ' TYR . . . -59.31 -39.83 84.3 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.1 pt -59.89 -39.97 81.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 118.039 -1.464 . . . . 0.0 108.353 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.1 t -60.03 -39.93 87.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -39.65 86.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.512 -178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -59.62 -40.17 86.72 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.493 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.481 ' H ' ' HG ' ' A' ' 131' ' ' LEU . 1.6 pp -93.28 137.45 32.58 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt 60.88 111.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.0 p -60.34 153.86 21.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.566 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 135' ' ' ASN . 42.2 mt-10 -153.69 67.43 0.76 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.957 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 134' ' ' GLU . 3.3 p30 57.14 136.63 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.686 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.56 -19.98 9.72 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.945 1.763 . . . . 0.0 113.804 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 137' ' ' LEU . 3.6 mm? -61.39 -45.13 95.66 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.965 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 139' ' ' MET . 4.4 p -65.2 -45.09 94.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.358 0.599 . . . . 0.0 109.514 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.496 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 28.5 ttp -62.24 -42.26 99.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.128 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 tp -65.03 -45.15 86.67 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.809 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.6 m -65.18 -45.16 85.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.552 0.692 . . . . 0.0 109.826 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' A' ' 126' ' ' ALA . 14.7 t80 -65.01 -34.99 79.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.375 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -58.31 -44.92 94.84 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.422 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.12 -45.36 85.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.214 1.007 . . . . 0.0 112.402 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.32 -40.53 96.58 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 58.2 ttp -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -55.66 -45.5 77.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.394 -176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.4 -45.2 93.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.452 . . . . 0.0 111.757 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -65.16 -45.17 86.03 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.26 -35.37 75.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.084 -1.047 . . . . 0.0 112.404 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.0 86.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.19 -45.08 86.3 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.156 -0.617 . . . . 0.0 112.537 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.19 -34.44 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -54.5 -34.71 62.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.705 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -54.79 -34.78 63.1 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -54.91 -41.85 71.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -37.96 -28.1 0.04 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 156' ' ' MET . 80.6 mm-40 -115.54 -48.08 2.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 109.854 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 160' ' ' PHE . 7.7 ptmt -170.4 110.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.043 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -50.08 -175.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.397 0.618 . . . . 0.0 110.405 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 164' ' ' ASN . 3.4 m -89.84 159.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.767 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 40.9 mmtt -58.45 -44.24 89.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 166.21 43.93 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.205 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 166' ' ' GLN . 56.8 t-20 -46.03 116.56 1.26 Allowed 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 122.864 1.316 . . . . 0.0 110.973 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.76 -37.74 74.16 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 112.022 -2.353 . . . . 0.0 109.25 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.432 ' N ' ' OD1' ' A' ' 164' ' ' ASN . 16.0 mm100 -57.8 -37.68 74.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.962 0.41 . . . . 0.0 110.838 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 24' ' ' ILE . 7.0 tt -57.81 -42.1 83.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.9 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' H ' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -58.68 -37.82 67.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.403 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.583 ' HE ' ' C ' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -57.89 -37.82 74.66 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.785 -178.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' N ' ' HG3' ' A' ' 169' ' ' ARG . 0.2 OUTLIER -58.05 -37.55 74.62 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.376 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.03 -42.31 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.1 p -62.38 -42.37 99.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.342 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.21 99.72 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.94 -1.124 . . . . 0.0 112.975 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 177' ' ' LEU . . . -62.5 -42.46 99.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 118.729 -1.188 . . . . 0.0 109.846 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 175' ' ' ILE . 0.1 OUTLIER -63.04 -43.34 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -178.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 p -63.16 -43.22 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.757 ' C ' HD22 ' A' ' 177' ' ' LEU 0.273 0.0 OUTLIER -62.95 -37.9 88.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -178.806 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.575 ' H ' HD13 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -61.11 -42.57 98.76 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.427 ' N ' HD23 ' A' ' 178' ' ' LEU . 85.7 t80 -62.6 -42.57 99.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 117.892 -1.523 . . . . 0.0 110.61 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -62.72 -42.24 99.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.217 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.32 99.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.883 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' OH ' ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.14 -37.96 87.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.855 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -57.92 -37.9 74.91 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.612 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.26 91.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.934 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -69.07 -16.12 63.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 186' ' ' THR . 17.1 m -92.33 46.07 1.24 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.796 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -177.19 31.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.906 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.762 HG12 HD13 ' A' ' 189' ' ' LEU . 2.3 t -77.24 -124.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.762 HD13 HG12 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -141.34 171.77 13.6 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.054 0.388 . . . . 0.0 110.706 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -171.0 174.78 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -144.35 159.68 42.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.315 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.541 -179.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.28 82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.072 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.2 ttp -174.06 -6.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.606 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.92 80.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.002 0.43 . . . . 0.0 110.809 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 5' ' ' PHE . 4.0 p90 -60.93 -37.89 83.9 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.171 0.51 . . . . 0.0 110.278 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 5' ' ' PHE . . . -58.0 -37.86 75.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.542 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mt -61.12 -42.07 97.86 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.943 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 36' ' ' PHE . . . -62.15 -42.09 99.72 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 120.976 -0.631 . . . . 0.0 114.069 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -62.02 -37.75 79.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 117.875 0.838 . . . . 0.0 111.533 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.89 -37.95 74.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.542 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' CZ ' ' A' ' 36' ' ' PHE . 80.2 p -62.12 -39.4 92.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.499 0.666 . . . . 0.0 109.549 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -57.93 -37.71 62.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -42.98 -65.47 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.612 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 99.1 p -60.33 119.62 44.36 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.15 177.78 7.49 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.043 1.829 . . . . 0.0 112.355 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -157.11 -140.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.545 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 18' ' ' LEU . 3.9 p -54.54 -165.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.738 ' H ' HG22 ' A' ' 17' ' ' VAL . 2.4 mt -87.23 -62.78 0.23 Allowed Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' O ' HG22 ' A' ' 20' ' ' VAL . 77.2 Cg_exo -41.52 -52.26 3.81 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.065 1.843 . . . . 0.0 113.016 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' H ' ' CG1' ' A' ' 17' ' ' VAL . 22.0 m 46.78 42.54 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.777 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 10.0 p -164.39 -29.92 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.777 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 43.3 Cg_endo -101.27 16.79 0.32 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.167 1.911 . . . . 0.0 111.86 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 163' ' ' ALA . 3.8 tp -143.84 -66.07 0.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.533 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG23 ' CD2' ' A' ' 167' ' ' LEU . 1.6 mt -88.63 20.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.069 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' ILE . 14.3 t80 35.93 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.01 0.434 . . . . 0.0 110.745 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -110.65 -161.64 0.76 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.8 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 28' ' ' SER . . . -162.14 139.66 6.1 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 27' ' ' GLY . 1.7 m -169.42 72.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 5.9 tpm_? -164.12 -106.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.286 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.11 -65.68 0.06 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -62.13 -37.8 86.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 0.0 110.823 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.81 -38.05 74.87 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.84 -38.12 75.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.028 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -58.87 -38.14 78.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.975 0.417 . . . . 0.0 110.086 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.9 77.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.562 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.0 OUTLIER -60.94 -38.02 84.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.757 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.4 mm? -58.15 -37.98 75.7 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.627 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -62.11 -42.05 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 117' ' ' PRO . 19.0 m -60.07 -42.11 88.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.156 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 43' ' ' THR . . . -62.13 -37.63 85.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.194 0.521 . . . . 0.0 111.081 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.7 -37.9 85.64 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.511 -0.768 . . . . 0.0 114.499 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.06 84.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.752 1.276 . . . . 0.0 111.014 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 40' ' ' ALA . 3.2 p -59.76 -42.3 92.93 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 mm -62.34 -42.64 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.847 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.547 ' C ' ' HE ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER -62.49 -42.17 99.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.331 1.063 . . . . 0.0 110.754 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -57.95 -37.41 74.09 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.209 -178.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.21 -37.47 72.27 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 56' ' ' PHE . 27.2 mm -57.74 -37.71 61.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.196 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -58.02 -41.85 84.02 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.856 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.63 39.27 2.35 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 41.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 71.9 m 51.97 -95.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 52' ' ' THR . . . 160.71 25.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -56.15 78.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.1 tp 60.48 31.25 20.26 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.2 m-85 -104.47 25.7 9.88 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.548 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 55.29 52.96 10.62 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.747 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.03 -34.73 58.4 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -54.86 -34.39 62.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.408 -0.896 . . . . 0.0 111.077 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -54.47 -34.79 62.17 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.408 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -64.8 -45.67 85.26 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.778 -1.169 . . . . 0.0 112.851 -178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 62' ' ' VAL . 5.0 m -65.94 -45.95 89.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -37.14 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.93 63.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.574 ' CE ' HH12 ' A' ' 61' ' ' ARG . 2.3 mtt -63.76 -34.88 78.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.203 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -55.17 -45.12 75.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.51 -37.21 86.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.865 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.7 -34.36 76.98 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -54.42 -34.73 61.93 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -54.65 -43.88 67.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.225 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 70' ' ' ILE . 67.2 m-85 -65.25 -37.31 86.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.889 0.376 . . . . 0.0 111.309 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.78 -34.97 70.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.1 mt -54.82 -35.0 63.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.473 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -60.15 -45.08 96.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.453 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 tp -65.14 -45.12 86.34 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.435 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.46 -34.91 74.71 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 78' ' ' ASP . 39.9 m -59.74 -45.08 93.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.544 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 6.2 t70 28.52 -134.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.944 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 15.5 tp10 -157.19 33.74 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.631 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.15 79.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.965 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.66 -169.53 1.56 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.486 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 84' ' ' VAL . 23.0 tt0 -107.31 157.35 18.0 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.109 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 70.76 -26.7 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.596 ' H ' ' C ' ' A' ' 82' ' ' GLU . 30.8 m -65.11 -34.88 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.1 t -64.85 -45.51 85.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 119.439 -0.905 . . . . 0.0 111.421 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 86' ' ' ILE . 39.3 pt -65.39 -34.79 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.212 0.529 . . . . 0.0 110.328 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -54.69 -41.95 70.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.17 -35.62 81.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.195 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.6 t -54.97 -34.5 63.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 176' ' ' VAL . 0.0 OUTLIER -54.6 -34.65 62.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.7 ttp -54.77 -45.22 74.22 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.3 p -65.31 -45.11 85.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.382 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 t -65.09 -45.1 86.63 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.32 -43.87 84.61 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.578 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 98' ' ' LYS . 1.1 pp -40.52 154.89 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 117.043 0.422 . . . . 0.0 110.957 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 38.7 m -124.32 -89.87 0.57 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.528 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -87.5 110.51 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.655 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.685 ' HG3' HD13 ' A' ' 95' ' ' LEU . 19.7 mmmt -132.61 -24.08 2.02 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.825 HD13 ' H ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -54.35 -91.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 101' ' ' THR . 88.8 mt-30 -86.74 -54.33 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 100' ' ' GLN . 9.8 t 44.7 175.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.182 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mp -112.99 106.13 55.29 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -42.96 128.4 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.816 1.678 . . . . 0.0 112.304 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m -163.74 -139.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.403 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -80.07 52.99 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' O ' ' N ' ' A' ' 108' ' ' GLY . 85.5 m-85 68.85 -48.48 0.58 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.439 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 62.07 -64.61 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.064 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 106' ' ' PHE . . . -60.24 -40.42 97.31 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.256 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.575 ' SD ' ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -60.17 -40.14 88.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.435 0.636 . . . . 0.0 110.854 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mp -59.98 -39.93 87.37 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.44 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 111' ' ' LEU . 13.7 mt -60.07 -40.47 89.64 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.67 -0.644 . . . . 0.0 112.243 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' O ' ' CD1' ' A' ' 115' ' ' TRP . . . -60.37 -40.02 89.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 122.396 1.094 . . . . 0.0 111.154 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.58 ' CZ ' HD12 ' A' ' 69' ' ' LEU . 5.9 m-30 -60.04 -39.39 85.76 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.727 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.582 ' CD1' HH22 ' A' ' 61' ' ' ARG . 5.7 tp -59.54 -39.9 85.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 112' ' ' ALA . 66.5 p-90 -60.52 -39.2 86.96 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 6.2 mp -59.57 -40.43 79.52 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.72 ' O ' HG12 ' A' ' 39' ' ' VAL . 19.5 Cg_endo -59.68 -39.85 70.02 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 CA-C-N 121.917 1.72 . . . . 0.0 112.423 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -24.0 -171.61 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 118.693 2.849 . . . . 0.0 118.693 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.749 HG22 ' N ' ' A' ' 120' ' ' LEU 0.269 1.3 mt 85.23 -92.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 108.577 -3.92 . . . . 0.0 115.75 176.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.749 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.1 -41.0 82.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 117.663 -1.615 . . . . 0.0 112.664 -174.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 57.7 Cg_endo -60.97 -40.36 53.13 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.889 1.353 . . . . 0.0 109.145 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.619 ' CD1' HD12 ' A' ' 178' ' ' LEU . 14.3 t80 -60.22 -40.1 88.95 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.342 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.09 -39.77 87.28 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 113.875 -1.511 . . . . 0.0 108.629 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.78 97.91 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 119.195 -1.478 . . . . 0.0 113.974 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -60.65 -39.83 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 118.236 1.018 . . . . 0.0 111.515 178.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 -39.98 86.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.541 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.547 ' O ' HD13 ' A' ' 127' ' ' ILE . 0.2 OUTLIER -60.1 -40.04 82.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.0 m -60.33 -40.13 89.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.809 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -39.93 87.56 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.377 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 m -59.87 -40.11 87.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.791 0.329 . . . . 0.0 110.51 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.1 tp -71.51 -39.49 70.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.35 -160.61 0.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.2 p -47.5 176.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.389 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -92.27 160.13 15.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -154.96 73.73 5.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.88 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.22 -68.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.591 2.861 . . . . 0.0 114.528 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.59 -45.16 77.45 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -65.12 -45.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . . . . . . . . . 10.4 tpt -65.07 -45.03 87.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.315 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.98 -45.11 87.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.363 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.9 t -65.13 -45.16 86.19 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.201 -0.6 . . . . 0.0 110.044 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.447 ' OH ' ' CB ' ' A' ' 181' ' ' ALA . 5.0 m-30 -65.26 -41.08 94.62 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.028 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.98 -45.26 81.88 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.109 -0.951 . . . . 0.0 114.489 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 144' ' ' LEU . 1.2 tt -65.41 -46.0 81.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 117.72 -1.592 . . . . 0.0 111.575 -177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.9 -45.49 87.76 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.846 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.449 ' O ' HG22 ' A' ' 150' ' ' ILE . 1.3 tmt? -65.45 -44.99 85.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.435 -1.382 . . . . 0.0 114.541 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.4 92.34 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.124 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 58.7 t -65.78 -45.46 91.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.0 -1.08 . . . . 0.0 110.45 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.488 HG23 ' HD3' ' A' ' 170' ' ' LYS . 22.9 m -65.55 -45.44 83.36 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 151' ' ' ALA . 10.6 tp -65.11 -41.14 91.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.514 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.559 ' N ' HG23 ' A' ' 150' ' ' ILE . . . -65.23 -43.77 90.37 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.707 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 167' ' ' LEU . . . -65.24 -45.04 86.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.384 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.21 -35.11 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.585 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -54.97 -34.85 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.29 0.567 . . . . 0.0 110.116 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -54.81 -34.49 62.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.925 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 158' ' ' GLU . 2.8 ptt? -54.46 -35.01 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -33.05 -30.75 0.01 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.74 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 156' ' ' MET . 59.6 tt0 -99.26 -52.95 3.37 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -140.43 -110.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.838 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.548 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 173.69 10.31 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 160' ' ' PHE . 15.0 p 51.54 159.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 124.197 0.936 . . . . 0.0 110.604 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.479 ' O ' HD11 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -41.14 -59.03 1.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.46 ' CB ' HD23 ' A' ' 23' ' ' LEU . . . 173.11 -38.47 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 166' ' ' GLN . 0.1 OUTLIER 59.29 118.29 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.401 179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.532 ' N ' HD22 ' A' ' 164' ' ' ASN . 25.3 t80 -57.61 -37.68 73.68 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 113.525 -1.671 . . . . 0.0 110.369 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER -57.66 -37.33 73.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.208 0.527 . . . . 0.0 110.315 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.509 ' CD2' HG23 ' A' ' 24' ' ' ILE . 14.5 tp -57.59 -37.77 73.75 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.435 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 pp -57.58 -37.55 59.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.395 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -57.99 -37.76 74.85 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.65 -37.39 73.27 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.207 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.49 -42.23 87.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.018 -176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 98.2 m -62.4 -42.37 99.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.46 -42.32 99.71 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.69 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.3 -42.64 99.53 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.918 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -42.72 97.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.533 ' O ' ' NH2' ' A' ' 90' ' ' ARG . 2.8 p -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.968 -1.493 . . . . 0.0 114.014 -176.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 1.5 pp -62.88 -40.18 96.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.619 HD12 ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -61.76 -42.5 99.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -175.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.583 ' N ' HD23 ' A' ' 178' ' ' LEU . 39.6 t80 -62.59 -42.32 99.49 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 118.333 -1.347 . . . . 0.0 111.445 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.46 HD23 ' NH2' ' A' ' 90' ' ' ARG . 3.5 mm? -62.44 -42.18 99.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.715 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' CB ' ' OH ' ' A' ' 142' ' ' TYR . . . -62.28 -42.53 99.43 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.226 -0.589 . . . . 0.0 112.348 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.488 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.3 OUTLIER -62.43 -39.33 92.98 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.987 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -60.88 -37.98 84.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.225 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -37.9 -45.55 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 185' ' ' LEU . 0.3 OUTLIER 71.84 -56.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.374 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 187' ' ' GLU . 0.1 OUTLIER -40.56 107.92 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.406 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 186' ' ' THR . 15.0 tt0 81.18 107.86 0.07 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.316 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 190' ' ' LEU . 1.8 t -146.4 58.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.637 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 190' ' ' LEU . 9.0 mp 57.07 6.31 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.789 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 188' ' ' VAL . 0.4 OUTLIER 25.01 -113.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.888 0.743 . . . . 0.0 112.351 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.456 ' H ' ' CG ' ' A' ' 190' ' ' LEU . 18.9 tp 52.01 54.04 11.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.479 ' N ' ' OE2' ' A' ' 192' ' ' GLU . 2.2 mp0 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.02 -0.99 . . . . 0.0 111.012 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.5 tp -169.88 39.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.58 -13.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.456 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.12 98.92 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.145 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -37.84 85.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.917 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.7 tp -57.88 -42.18 84.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.37 97.53 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.666 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -57.99 -37.47 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -178.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' N ' HG13 ' A' ' 9' ' ' ILE . 38.9 tp -57.89 -37.96 74.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.011 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 t -62.12 -40.7 96.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.79 0.805 . . . . 0.0 109.366 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 13' ' ' PHE . 11.9 t -62.02 -37.75 79.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.229 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' C ' ' O ' ' A' ' 12' ' ' VAL . 49.3 t80 -19.58 -53.01 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.092 0.87 . . . . 0.0 111.902 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 156' ' ' MET . 20.8 p -97.19 107.8 40.39 Favored Pre-proline 0 CA--C 1.541 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.624 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 81.5 Cg_exo -44.64 -71.71 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.368 2.045 . . . . 0.0 113.54 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 15' ' ' PRO . . . 109.89 -153.54 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.332 1.02 . . . . 0.0 109.861 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 18' ' ' LEU . 1.3 t -49.96 -177.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.648 178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.537 ' N ' ' CG1' ' A' ' 17' ' ' VAL . 1.7 mt -75.47 -69.49 0.25 Allowed Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 21' ' ' VAL . 11.1 Cg_endo -52.96 -65.2 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.04 1.827 . . . . 0.0 111.691 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 17' ' ' VAL . 6.4 t 60.56 -22.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 19' ' ' PRO . 4.5 p -72.0 -34.46 2.95 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.383 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 21' ' ' VAL . 71.7 Cg_endo -102.4 -1.3 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.821 2.347 . . . . 0.0 111.386 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.07 -88.64 0.46 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.321 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 26' ' ' ALA . 1.1 mt -89.15 148.9 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 171' ' ' VAL . 0.1 OUTLIER -62.52 6.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' H ' ' C ' ' A' ' 24' ' ' ILE . . . -83.53 -154.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.671 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 146.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -155.44 -12.64 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.619 0.247 . . . . 0.0 110.988 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 39.39 -107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.126 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.64 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -38.08 86.9 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.21 -37.81 78.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.206 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.8 -37.87 74.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.606 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -57.87 -40.15 79.51 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.743 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.07 -41.51 98.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.099 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.612 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -58.0 -37.89 75.11 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.899 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -57.82 -37.51 73.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.216 0.531 . . . . 0.0 110.342 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 35' ' ' ALA . 2.7 tt -57.61 -37.32 58.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.763 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.7 m -57.29 -39.83 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.326 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 39' ' ' VAL . . . -61.52 -37.38 83.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -58.83 -37.87 91.27 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 113.537 -1.665 . . . . 0.0 113.017 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.557 ' O ' ' SD ' ' A' ' 46' ' ' MET . 0.5 OUTLIER -57.94 -42.07 84.14 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.181 -1.008 . . . . 0.0 111.733 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.446 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.6 p -62.18 -42.7 99.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 45' ' ' SER . 2.9 tp -62.68 -42.84 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 118.669 -1.212 . . . . 0.0 112.722 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.408 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 1.7 p -62.75 -42.48 99.7 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 122.641 1.21 . . . . 0.0 111.109 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.557 ' SD ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -62.28 -37.81 86.93 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.507 -2.133 . . . . 0.0 112.941 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.5 tp -57.46 -37.71 73.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 mm -58.02 -37.72 62.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.704 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.1 tt -59.7 -40.98 89.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.375 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -29.96 -61.74 0.18 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.15 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -143.07 130.69 21.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.628 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 m -54.16 139.06 36.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -129.02 2.99 5.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.027 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 89.03 -155.56 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.94 -179.468 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -55.22 77.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.49 0.662 . . . . 0.0 111.443 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 54' ' ' SER . 3.9 m-85 -116.49 -97.49 0.46 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -149.87 33.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.314 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.41 -36.9 94.0 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 63' ' ' VAL . 1.7 t80 -65.17 -34.8 79.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.883 0.373 . . . . 0.0 111.17 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -58.12 -44.97 88.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 61' ' ' ARG . 10.4 ptt180 -65.13 -45.17 86.19 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 63' ' ' VAL . 12.9 p -65.53 -45.59 92.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.273 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 3.0 t -65.83 -34.94 73.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.048 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.81 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.225 -177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.1 mtt -54.81 -34.72 63.1 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.566 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.2 mm? -55.69 -34.8 65.37 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -54.83 -34.88 63.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.704 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.84 -34.41 62.84 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.797 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.3 mm? -54.56 -40.84 69.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 71' ' ' PHE . 1.6 pt -64.4 -45.37 96.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.921 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 24.5 m-85 -65.46 -44.01 88.57 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.551 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.3 -34.97 74.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.607 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 69' ' ' LEU . 1.3 mm? -54.91 -35.08 63.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.085 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.567 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -64.96 -41.07 91.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.24 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.06 -45.0 87.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.646 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 76' ' ' LEU . 8.8 mp -65.02 -36.58 84.84 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.477 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.8 t -56.58 -34.87 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.808 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -36.96 147.87 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.398 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 80' ' ' LEU . 35.7 tt0 -86.82 88.82 7.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.761 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.3 mm? 56.03 158.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.564 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 179.74 -178.35 0.39 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.113 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -111.02 9.97 22.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 109.893 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.08 -45.27 2.0 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.72 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 85' ' ' SER . 6.2 m -55.06 -44.91 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.161 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.538 ' N ' HG23 ' A' ' 84' ' ' VAL . 25.6 p -65.05 -45.37 85.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.642 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.14 -40.69 89.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.359 0.6 . . . . 0.0 109.826 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 87' ' ' PHE . 4.7 t80 -54.89 -45.33 74.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.87 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.68 81.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.657 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.9 t -55.1 -34.99 64.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.555 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.669 HH12 ' N ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -63.15 -34.72 78.23 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.978 -179.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 57.3 mtp -54.74 -44.99 74.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 95' ' ' LEU . 12.7 m -65.14 -45.09 86.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.065 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.3 m -65.15 -45.04 86.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 111.207 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.669 ' N ' HH12 ' A' ' 90' ' ' ARG . . . -64.49 -34.95 91.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.18 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.708 ' C ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.5 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 117.076 0.438 . . . . 0.0 110.885 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.678 ' N ' HD12 ' A' ' 95' ' ' LEU . 3.2 m -145.4 161.03 40.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.034 0.445 . . . . 0.0 110.881 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 72.0 m95 51.26 -101.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.646 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm 53.7 50.75 16.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.346 . . . . 0.0 110.99 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 pp -152.12 -31.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 101' ' ' THR . 41.1 tt0 -174.69 30.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -57.59 -139.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.184 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.08 73.57 4.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.601 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.89 174.28 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.911 2.407 . . . . 0.0 112.412 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.1 p -178.43 -102.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.806 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -91.06 50.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 60.38 27.0 16.56 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -33.51 -52.5 0.39 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.394 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.34 96.92 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 64.1 mtt -60.29 -39.95 88.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 110' ' ' LEU . 3.2 mt -59.84 -39.84 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -59.97 -40.08 87.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.14 -40.07 88.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.053 0.93 . . . . 0.0 111.283 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' CD2' HD21 ' A' ' 69' ' ' LEU . 40.1 m-85 -59.82 -38.58 82.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.741 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 0.4 OUTLIER -58.64 -39.78 81.53 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.573 ' CE2' ' O ' ' A' ' 112' ' ' ALA . 29.2 p-90 -60.11 -39.11 85.06 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -59.28 -40.24 79.14 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 -171.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 39.1 Cg_exo -59.98 -40.09 64.97 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 CA-C-N 121.715 1.648 . . . . 0.0 114.197 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -36.63 -144.44 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 120' ' ' LEU . 1.5 mp 82.93 -79.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 110.784 -2.917 . . . . 0.0 113.324 -178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.589 ' N ' HG22 ' A' ' 119' ' ' ILE . 5.0 mt -60.03 -40.62 79.37 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.9 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 74.1 Cg_exo -60.2 -39.75 65.83 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.005 2.47 . . . . 0.0 109.794 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -40.31 87.58 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.4 -40.3 90.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.236 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.65 98.03 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 118.914 -1.613 . . . . 0.0 114.182 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -60.46 -39.82 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 117.291 0.545 . . . . 0.0 111.887 179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.08 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 127' ' ' ILE . 2.6 mp -60.09 -40.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.883 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.0 m -60.48 -40.4 91.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.445 0.641 . . . . 0.0 111.622 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.2 -39.85 88.01 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 127' ' ' ILE . 1.3 t -59.82 -39.94 86.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.941 -177.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 132' ' ' LEU . 0.2 OUTLIER -110.19 -76.2 0.61 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.47 0.176 . . . . 0.0 111.322 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.503 ' H ' HD12 ' A' ' 132' ' ' LEU . 4.1 mp -46.8 -103.19 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.6 t -52.41 163.55 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 111.653 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 135' ' ' ASN . 23.0 mm-40 -144.08 121.71 11.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 134' ' ' GLU . 78.3 m-20 -156.95 94.65 2.24 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.989 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.501 ' O ' HD13 ' A' ' 140' ' ' LEU . 52.1 Cg_exo -52.74 -43.14 58.11 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.267 1.978 . . . . 0.0 115.156 -178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.2 -45.38 88.53 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.545 ' O ' ' CD1' ' A' ' 142' ' ' TYR . 2.0 m -65.25 -45.12 94.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.722 . . . . 0.0 109.059 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 55.4 mtp -59.96 -45.19 93.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.755 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 136' ' ' PRO . 6.3 mp -65.06 -45.08 86.78 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.632 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.2 m -65.12 -41.58 94.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.291 0.567 . . . . 0.0 110.47 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 138' ' ' VAL . 5.9 m-30 -65.15 -34.82 79.29 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.287 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.9 -45.37 80.69 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-O 119.335 -0.703 . . . . 0.0 114.57 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 145' ' ' GLY . 3.0 pp -65.29 -45.8 82.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 117.729 -1.588 . . . . 0.0 111.53 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 144' ' ' LEU . . . -65.89 -45.24 89.31 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 177.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.4 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 9.8 tmm? -65.24 -45.24 85.43 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 -175.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.53 84.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 118.434 -1.306 . . . . 0.0 111.782 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 149' ' ' THR . 35.1 m -65.68 -45.02 93.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.48 0.657 . . . . 0.0 111.574 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 170' ' ' LYS . 21.3 m -65.1 -45.35 85.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 153' ' ' VAL . 78.8 mt -65.16 -34.92 73.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.092 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.81 77.03 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.18 86.32 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 150' ' ' ILE . 14.8 p -65.25 -34.69 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -54.46 -34.77 62.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.67 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -54.85 -34.36 62.82 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.279 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -54.6 -35.0 62.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -176.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -35.12 -27.8 0.01 OUTLIER Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.728 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 156' ' ' MET . 72.1 mm-40 -124.89 -109.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -87.97 111.65 21.72 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -73.15 52.96 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.089 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 160' ' ' PHE . 3.4 m 39.79 -171.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.035 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 15.1 tptm -72.05 -54.11 10.83 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 175.15 23.19 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.5 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER 14.39 109.58 0.0 OUTLIER 'General case' 0 C--N 1.35 0.592 0 C-N-CA 124.475 1.11 . . . . 0.0 113.152 178.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 165' ' ' PHE . 0.1 OUTLIER -57.74 -37.9 74.38 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.522 178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.531 ' H ' ' CD ' ' A' ' 166' ' ' GLN . 21.3 mp0 -60.86 -37.72 83.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 170' ' ' LYS . 8.2 tt -57.77 -37.83 74.35 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -37.75 59.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -58.28 -37.6 75.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.713 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.516 ' HD3' HG23 ' A' ' 149' ' ' THR . 0.0 OUTLIER -57.7 -37.6 73.76 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.2 p -61.05 -42.03 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.908 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.32 -42.32 99.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 118.969 -1.092 . . . . 0.0 113.302 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.69 99.67 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.223 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.57 99.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 118.748 -1.181 . . . . 0.0 110.449 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.5 HG23 ' CE3' ' A' ' 115' ' ' TRP . 27.5 mm -62.91 -42.79 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.89 -42.58 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.078 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -37.9 87.87 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.654 HD23 ' C ' ' A' ' 178' ' ' LEU . 9.3 tt -58.0 -42.76 85.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' HB3' HH21 ' A' ' 90' ' ' ARG . 13.3 t80 -62.7 -42.57 99.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.567 -1.653 . . . . 0.0 111.962 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.66 -42.49 99.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.257 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.27 99.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.301 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' A' ' 46' ' ' MET . 0.8 OUTLIER -62.1 -37.95 87.02 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.736 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 184' ' ' ALA . 0.2 OUTLIER -57.94 -42.02 84.03 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.913 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . 27.31 -132.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.159 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.18 -167.83 1.95 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.713 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 186' ' ' THR . 6.1 p -86.5 101.06 12.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.63 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 188' ' ' VAL . 8.6 pt-20 -169.72 -48.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.86 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 187' ' ' GLU . 45.1 t 56.91 155.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.337 . . . . 0.0 110.604 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 189' ' ' LEU . 3.5 mm? -64.2 91.25 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.026 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.44 163.89 26.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.608 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.6 OUTLIER -159.66 19.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.502 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.613 179.978 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.552 ' CG ' ' H ' ' A' ' 2' ' ' LEU . 16.1 tt0 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.552 ' H ' ' CG ' ' A' ' 1' ' ' GLN . 0.2 OUTLIER 78.4 22.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.419 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 5.6 ttm -173.41 -38.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.705 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.17 98.74 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.07 0.462 . . . . 0.0 111.287 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.24 -39.1 91.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 109.911 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.05 86.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.687 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.16 -42.31 99.13 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.884 -178.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.12 99.72 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 120.165 -1.016 . . . . 0.0 112.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -59.92 -40.88 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 122.267 -0.549 . . . . 0.0 111.507 -177.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.4 tp -62.21 -38.01 87.53 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.96 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.532 ' O ' ' SD ' ' A' ' 156' ' ' MET . 0.3 OUTLIER -62.23 -42.31 99.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 14' ' ' SER . 7.0 m -61.91 -37.52 78.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 12' ' ' VAL . 63.1 t80 -21.08 -45.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.034 0.834 . . . . 0.0 112.349 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' VAL . 30.8 p -92.85 109.71 40.91 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.724 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.79 -163.66 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.423 2.082 . . . . 0.0 113.599 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 18' ' ' LEU . . . -175.61 -141.39 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.194 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.9 t -50.98 96.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.4 mm? -30.13 -62.88 0.22 Allowed Pre-proline 0 N--CA 1.474 0.774 0 O-C-N 122.953 0.158 . . . . 0.0 111.089 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' O ' ' N ' ' A' ' 21' ' ' VAL . 75.9 Cg_exo -37.13 -22.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.246 1.964 . . . . 0.0 113.326 177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 17' ' ' VAL . 5.2 m -27.12 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.741 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 11.0 t -124.57 -40.22 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.328 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.741 ' CD ' ' H ' ' A' ' 21' ' ' VAL . 26.0 Cg_endo -103.75 -2.1 0.27 Allowed 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 123.064 2.509 . . . . 0.0 110.833 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 mt -86.74 -93.36 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.096 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.646 HG13 HD11 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -131.66 131.82 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.309 -178.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -46.39 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . -160.92 178.8 9.04 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.764 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.93 -179.49 53.29 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.118 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m -153.83 151.19 29.25 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' ARG . 57.1 ttt-85 -172.0 38.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.574 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 33' ' ' LEU . . . 66.05 -74.83 0.12 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' ARG . 1.2 mmt-85 -62.08 -37.95 86.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.381 . . . . 0.0 110.037 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.96 75.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.898 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? -57.88 -37.95 74.88 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -59.12 -42.04 89.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -62.1 -42.05 98.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.523 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' VAL . 35.4 t80 -58.77 -37.81 77.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.181 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -57.88 -37.45 73.98 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.287 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 37' ' ' LEU . 7.1 tp -57.77 -38.06 63.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.55 -177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 117' ' ' PRO . 4.2 m -58.9 -42.29 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 117.614 -1.634 . . . . 0.0 109.53 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 39' ' ' VAL . . . -62.45 -37.93 87.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.397 0.618 . . . . 0.0 111.126 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.81 -37.98 86.52 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 114.949 -1.023 . . . . 0.0 114.41 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -58.07 -37.8 75.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 118.078 0.939 . . . . 0.0 111.714 -177.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 70.6 p -62.33 -42.84 99.71 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 45' ' ' SER . 17.1 tt -63.14 -43.28 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 117.773 -1.571 . . . . 0.0 113.588 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' N ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -63.15 -42.54 99.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 123.631 1.681 . . . . 0.0 111.005 178.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.44 ' SD ' ' OH ' ' A' ' 182' ' ' TYR . 7.3 tmm? -62.25 -38.01 87.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 110.626 -2.988 . . . . 0.0 114.494 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 tt -57.7 -37.76 74.05 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -57.97 -37.73 62.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.947 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 ' CE1' ' A' ' 182' ' ' TYR . 4.3 tp -57.88 -38.0 74.97 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.7 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -44.33 -39.14 5.4 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -101.77 -177.39 3.41 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -81.86 -20.31 39.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.387 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.01 87.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.826 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.6 m -101.47 -23.35 14.34 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.71 11.16 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.784 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -96.17 40.97 1.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.605 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 43.0 52.66 5.25 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' NH1' ' A' ' 61' ' ' ARG . . . -54.89 -35.02 57.96 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CD1' ' C ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -60.43 -34.97 74.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.434 -0.383 . . . . 0.0 111.941 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -54.89 -45.18 74.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 58' ' ' GLY . 1.9 ptt-85 -65.12 -45.03 86.76 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -176.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -65.42 -46.1 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 117.964 -1.494 . . . . 0.0 113.885 -176.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -66.17 -44.07 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.44 63.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.762 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -34.92 62.67 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.224 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.63 -34.85 67.68 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 67' ' ' PHE . 2.6 t80 -54.66 -34.84 62.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.623 0.249 . . . . 0.0 111.56 -177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.2 mt -54.94 -34.75 63.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 69' ' ' LEU . 8.9 mp -54.68 -35.04 63.14 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.7 mp -55.0 -45.01 76.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.269 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -45.1 86.66 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.494 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.0 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 73' ' ' LEU . 6.5 tt -55.24 -34.95 64.44 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.471 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.2 mt -62.68 -42.22 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.89 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 78' ' ' ASP . 36.0 tp -61.95 -45.05 95.37 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.104 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.505 ' N ' HD22 ' A' ' 76' ' ' LEU . 4.0 mm? -64.98 -34.91 79.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.4 m -54.96 -34.93 63.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.413 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' LEU . 51.0 p-10 -159.94 -145.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 46.44 93.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.653 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.1 mt -97.69 134.14 41.28 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.425 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -166.85 176.66 6.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 110.813 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 84' ' ' VAL . 22.2 mm-40 -61.94 -85.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.729 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -41.75 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.379 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.8 OUTLIER -61.99 -44.62 99.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' GLU . 32.5 t -65.23 -45.22 85.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.707 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mm -65.23 -35.71 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.929 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.1 t80 -54.94 -45.22 74.84 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.21 89.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.766 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 m -60.61 -34.98 75.04 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.029 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.708 HH22 ' CA ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -56.41 -34.82 67.12 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.1 ttp -55.51 -44.95 77.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.355 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.61 ' O ' HD11 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -65.1 -35.16 80.24 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.14 -179.105 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.8 m -65.14 -36.46 84.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.708 ' CA ' HH22 ' A' ' 90' ' ' ARG . . . -64.94 -45.21 93.1 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.6 OUTLIER -44.36 132.44 5.95 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.147 0.974 . . . . 0.0 110.89 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 97' ' ' TRP . 86.6 p -75.72 -105.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' N ' ' OG ' ' A' ' 96' ' ' SER . 15.1 t-105 -75.24 171.52 14.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.514 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' CG ' ' H ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -142.71 -178.0 5.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.161 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' ' CG ' ' A' ' 98' ' ' LYS . 76.6 mt 58.28 -90.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 101' ' ' THR . 63.4 tt0 -71.34 -77.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 102' ' ' LEU . 50.7 m 51.92 169.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.642 ' N ' HG22 ' A' ' 101' ' ' THR . 30.6 tp -105.03 106.92 57.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 102' ' ' LEU . 30.8 Cg_exo -38.12 -106.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.501 2.134 . . . . 0.0 113.48 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 106' ' ' PHE . 2.6 p 71.28 131.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.28 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 27.1 t80 -1.24 -65.31 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.223 0.952 . . . . 0.0 112.923 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 105' ' ' PHE . 22.4 m-85 -174.7 87.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.55 -66.07 0.94 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.0 96.25 Favored Glycine 0 N--CA 1.468 0.811 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.33 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -39.67 86.74 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 109.872 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 106' ' ' PHE . 1.2 mp -59.82 -39.63 85.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.488 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -40.08 87.39 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.878 0.37 . . . . 0.0 110.903 -177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' O ' ' NE1' ' A' ' 115' ' ' TRP . . . -60.03 -39.87 87.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.967 0.889 . . . . 0.0 111.669 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.466 ' CD1' HD11 ' A' ' 69' ' ' LEU . 4.0 m-30 -59.84 -39.42 85.05 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -59.41 -39.82 84.68 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.598 ' NE1' ' O ' ' A' ' 112' ' ' ALA . 50.9 p-90 -60.42 -39.55 87.84 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 117.405 2.372 . . . . 0.0 117.405 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.499 HD12 ' CE2' ' A' ' 87' ' ' PHE . 5.3 tt -59.66 -40.34 78.47 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -172.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.744 ' O ' HG12 ' A' ' 39' ' ' VAL . 24.5 Cg_exo -60.47 -40.05 60.57 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 CA-C-N 122.379 1.885 . . . . 0.0 113.062 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 117' ' ' PRO . . . -17.83 -177.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 120.642 3.571 . . . . 0.0 120.642 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 174' ' ' ALA 0.25 17.1 mt 82.78 -61.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 1 CA-C-N 107.514 -4.403 . . . . 0.0 117.727 175.753 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.857 HD22 ' H ' ' A' ' 120' ' ' LEU . 2.1 mm? -60.05 -41.19 83.51 Favored Pre-proline 0 N--CA 1.475 0.807 0 CA-C-N 122.272 2.305 . . . . 0.0 112.285 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 120' ' ' LEU . 55.0 Cg_endo -60.68 -39.9 59.75 Favored 'Trans proline' 0 N--CA 1.507 2.32 0 C-N-CA 123.69 2.927 . . . . 0.0 111.697 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -59.71 -39.9 86.19 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.79 -39.52 85.21 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.02 -39.94 96.35 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.711 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 122' ' ' PHE . 1.3 tt -59.85 -39.96 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 122.707 -0.29 . . . . 0.0 111.705 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.26 88.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.429 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.15 -40.47 83.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 t -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 132' ' ' LEU . 19.3 tt0 -60.0 -40.1 88.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.253 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -60.05 -39.98 87.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.1 0.476 . . . . 0.0 110.828 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.24 -24.06 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.336 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 133' ' ' SER . 0.4 OUTLIER -143.86 -165.2 2.05 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.175 0.512 . . . . 0.0 111.423 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.576 ' H ' ' CD2' ' A' ' 132' ' ' LEU . 89.4 p -55.67 -159.74 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.435 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.91 -168.41 1.6 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.715 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -141.63 118.98 7.53 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -41.47 -52.6 3.61 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.858 1.705 . . . . 0.0 114.432 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 137' ' ' LEU . 3.5 mm? -65.12 -45.28 85.75 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.552 ' O ' ' CG ' ' A' ' 142' ' ' TYR . 1.4 m -65.27 -45.19 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.935 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.453 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -64.53 -45.07 88.78 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.739 -179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 47.1 tp -65.07 -45.26 86.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.811 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t -65.18 -44.94 86.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.811 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' A' ' 177' ' ' LEU . 4.8 m-30 -65.05 -41.91 94.75 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.15 90.51 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.829 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.4 tp -65.16 -45.75 83.67 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.683 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.6 -45.37 89.87 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 146' ' ' MET . 12.2 tmm? -65.37 -45.03 85.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 113.766 -1.217 . . . . 0.0 114.061 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.41 86.99 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.349 -0.941 . . . . 0.0 113.105 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 170' ' ' LYS . 7.2 p -65.85 -45.88 90.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 118.24 -1.384 . . . . 0.0 112.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 170' ' ' LYS . 1.1 t -65.81 -45.27 82.97 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 149' ' ' THR . 4.4 tp -56.49 -34.96 42.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.661 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.39 85.47 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 118.842 -1.143 . . . . 0.0 113.04 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.52 -45.41 83.63 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.154 -1.018 . . . . 0.0 112.761 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.468 ' O ' ' CG ' ' A' ' 156' ' ' MET . 12.6 p -65.2 -34.73 72.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.244 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.53 -34.81 62.39 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.753 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.993 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.532 ' SD ' ' O ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -54.93 -34.99 63.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -48.59 -13.23 0.25 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 156' ' ' MET . 43.2 mm-40 -134.76 -38.37 0.81 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -169.83 117.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.369 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.73 -172.32 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 m -83.27 138.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.78 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 42.2 tttm -47.9 -37.76 14.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 162' ' ' LYS . . . 157.14 55.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.29 101.54 4.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.272 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -57.65 -37.82 74.0 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.546 -1.661 . . . . 0.0 110.404 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -57.82 -37.68 74.25 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.18 0.514 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.908 ' O ' HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -57.75 -37.35 73.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.807 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.829 ' N ' HD13 ' A' ' 167' ' ' LEU . 1.1 pp -57.8 -37.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.793 -0.567 . . . . 0.0 110.703 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.402 ' N ' HG13 ' A' ' 168' ' ' ILE . 15.3 ptt85 -57.57 -37.62 73.45 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.628 ' HD2' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -57.75 -37.3 73.37 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.363 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 168' ' ' ILE . 1.7 m -57.69 -37.63 60.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.9 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 169' ' ' ARG . 1.0 OUTLIER -57.79 -37.87 74.49 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.465 -178.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -58.8 -42.24 96.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.408 -1.377 . . . . 0.0 111.512 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' A' ' 119' ' ' ILE . . . -62.23 -42.32 99.21 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.772 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.38 -42.73 96.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.4 p -62.61 -42.29 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.537 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 177' ' ' LEU . 3.1 tm? -62.36 -41.96 99.02 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -57.93 -42.49 84.95 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.236 -0.986 . . . . 0.0 112.665 -175.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.545 ' CB ' HH12 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -62.57 -42.66 99.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.675 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.63 -42.43 99.59 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.35 99.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.254 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' CE1' HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -62.42 -37.99 87.96 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.574 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 184' ' ' ALA . 41.6 t80 -57.91 -37.91 74.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.008 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 183' ' ' PHE . . . -27.25 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.084 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 185' ' ' LEU . 10.1 mp -45.11 -53.45 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.773 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.1 m -157.02 103.79 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.499 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.41 -44.04 2.68 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.696 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.5 t -50.97 110.62 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.538 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 47.2 mt -52.91 174.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.472 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -155.89 177.11 11.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.785 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 191' ' ' LEU . 0.5 OUTLIER -160.54 18.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.662 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.605 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.484 ' C ' HD22 ' A' ' 2' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 2' ' ' LEU . 0.9 OUTLIER 44.07 63.89 1.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.507 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -144.0 -57.35 0.38 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.398 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.01 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.656 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.97 -40.28 80.24 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.43 88.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.6 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 7' ' ' LEU . 4.6 mm? -62.08 -42.11 98.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.203 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.15 -42.34 99.72 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.978 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 pt -62.1 -39.56 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 117.817 0.808 . . . . 0.0 111.064 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.6 mt -61.51 -37.92 85.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.7 t -61.88 -42.04 98.59 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 109.67 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.19 -37.81 70.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.407 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -42.44 -67.31 0.28 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.535 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 156' ' ' MET . 27.3 m -53.86 111.09 2.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.231 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.18 170.3 10.91 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.119 1.879 . . . . 0.0 113.15 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.32 -173.75 4.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.118 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 18' ' ' LEU . 37.8 t -49.76 164.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 21' ' ' VAL . 8.9 mp -83.16 -69.86 0.15 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.002 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 18' ' ' LEU . 68.9 Cg_exo -33.49 -30.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.429 2.086 . . . . 0.0 114.111 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' LEU . 10.1 m -86.85 9.79 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.382 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' LEU . 1.4 t -47.93 -49.36 59.19 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.88 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -92.88 59.99 0.53 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.659 2.239 . . . . 0.0 111.218 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.4 tt -153.17 -57.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.374 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' C ' ' N ' ' A' ' 26' ' ' ALA . 4.0 mt -83.37 27.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.747 0.308 . . . . 0.0 110.46 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 119' ' ' ILE . 0.1 OUTLIER 44.93 21.5 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.375 0.607 . . . . 0.0 109.384 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' N ' ' C ' ' A' ' 24' ' ' ILE . . . -122.5 -149.55 0.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.402 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.88 -155.23 16.4 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.4 m -154.29 -101.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.379 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 50.95 -172.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.39 -42.78 1.44 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 52.7 ttp180 -60.29 -37.87 81.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.237 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.84 74.66 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.0 pp -57.85 -42.12 83.77 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.433 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 35' ' ' ALA . 2.0 p30 -62.09 -42.2 98.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 34' ' ' ASP . . . -62.27 -42.04 99.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.947 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -61.33 -42.04 98.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.994 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 tt -61.23 -37.94 84.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.549 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 38' ' ' ILE . 4.4 mm -60.55 -39.69 82.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 117' ' ' PRO . 65.5 t -57.95 -42.69 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.416 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.4 -37.31 85.29 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 122.292 1.044 . . . . 0.0 108.572 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.97 -37.74 86.38 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.303 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 43' ' ' THR . 1.4 pp -60.66 -42.74 97.63 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 117.127 -1.829 . . . . 0.0 113.996 -175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 ' N ' ' HG ' ' A' ' 42' ' ' LEU . 69.3 p -63.07 -43.2 99.24 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.7 mt -63.33 -43.49 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.618 ' CB ' HH11 ' A' ' 61' ' ' ARG . 19.0 m -63.3 -42.89 99.1 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 122.651 1.215 . . . . 0.0 111.976 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.462 ' CG ' ' CZ ' ' A' ' 182' ' ' TYR . 43.1 tpp -62.44 -37.36 85.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.299 -2.228 . . . . 0.0 113.955 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -56.96 -37.21 71.26 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -176.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 45' ' ' SER . 5.1 tp -57.28 -37.46 56.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.881 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 51' ' ' TYR . 5.4 tp -57.79 -37.71 74.2 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.553 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.46 73.93 0.01 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' LEU . 29.7 m-85 64.47 -173.48 0.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.621 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER 34.31 79.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.609 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.964 ' HB1' ' CE1' ' A' ' 56' ' ' PHE . . . -175.98 94.07 0.06 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 t -127.65 -23.58 3.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.991 0.424 . . . . 0.0 110.394 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.68 46.65 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.964 ' CE1' ' HB1' ' A' ' 53' ' ' ALA . 17.0 p90 -97.08 -63.81 1.1 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.998 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.63 ' N ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 175.3 50.99 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.821 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.92 64.07 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.606 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -61.9 -45.13 95.07 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.901 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.618 HH11 ' CB ' ' A' ' 45' ' ' SER . 2.3 tpm_? -65.25 -45.87 82.86 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 118.858 -1.137 . . . . 0.0 112.965 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 63' ' ' VAL . 4.5 p -66.31 -46.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' N ' HG13 ' A' ' 62' ' ' VAL . 2.8 t -66.02 -34.81 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.576 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -54.63 -34.68 62.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.898 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.491 ' HG2' HH21 ' A' ' 61' ' ' ARG . 29.0 mmt -54.93 -34.9 63.64 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.195 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 110' ' ' LEU . 2.8 mm? -56.14 -36.21 68.01 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.4 m-30 -54.95 -45.0 74.86 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -57.45 -34.67 69.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.238 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -54.73 -38.67 67.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.435 -177.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 71' ' ' PHE . 6.1 tt -64.97 -45.25 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.741 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 25.1 m-85 -65.26 -39.09 92.19 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.086 0.469 . . . . 0.0 110.312 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.88 74.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.044 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.5 mt -54.93 -42.54 72.37 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.176 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.8 mt -65.05 -40.89 90.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.9 tp -64.9 -45.12 87.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.67 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.431 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 4.1 mm? -64.99 -34.97 79.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.442 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 78' ' ' ASP . 14.0 m -55.01 -45.03 75.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.669 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 79' ' ' GLU . 2.8 p30 26.64 -146.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.339 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 10.5 pt-20 -143.79 61.98 1.37 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.488 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.2 mm? 57.13 77.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.579 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -114.56 167.98 10.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.96 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -98.82 -13.4 20.13 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' NZ ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -93.35 -28.26 16.29 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 110.097 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 81' ' ' ASP . 32.7 m -65.16 -35.16 74.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.693 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.406 ' N ' HG23 ' A' ' 84' ' ' VAL . 70.8 m -65.05 -45.05 86.99 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 pt -58.61 -34.76 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.507 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' O ' ' CH2' ' A' ' 115' ' ' TRP . 9.4 m-30 -54.8 -45.05 74.3 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.6 -35.5 81.19 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -65.15 -34.88 79.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.997 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.91 79.54 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.0 ttt -58.72 -45.2 90.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.69 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.899 ' O ' HD22 ' A' ' 95' ' ' LEU . 70.6 p -65.15 -45.48 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.421 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.1 m -65.35 -45.28 84.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 110.924 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' LEU . . . -65.28 -37.51 94.04 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.065 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.899 HD22 ' O ' ' A' ' 92' ' ' THR . 0.3 OUTLIER -27.13 138.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.25 0.548 . . . . 0.0 112.31 -178.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.4 t -105.81 -127.13 0.24 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.832 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -56.76 155.05 8.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 99' ' ' ILE . 65.1 tttp -157.08 -45.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.738 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 101' ' ' THR . 28.8 mm -53.24 -105.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.269 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -75.17 30.11 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 0.0 110.492 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 99' ' ' ILE . 12.6 t -48.53 154.96 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 102' ' ' LEU . 3.3 mm? -85.28 126.88 65.98 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.59 61.45 7.96 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.923 1.749 . . . . 0.0 111.762 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' PHE . 2.5 m -99.54 -130.04 0.21 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.793 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.1 24.63 0.13 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.484 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' SER . 89.4 m-85 59.6 83.11 0.14 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.127 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.44 -51.25 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.96 -40.31 96.76 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.202 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.6 mtt -60.24 -39.93 88.47 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.022 0.915 . . . . 0.0 109.525 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 62' ' ' VAL . 2.7 tp -60.0 -39.78 86.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.645 -1.616 . . . . 0.0 112.34 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -59.88 -40.0 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.701 0.286 . . . . 0.0 111.435 -177.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' A' ' 115' ' ' TRP . . . -60.0 -40.07 87.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.362 0.601 . . . . 0.0 111.76 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CZ ' HD23 ' A' ' 69' ' ' LEU . 2.2 m-30 -59.92 -39.31 85.03 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 13.0 tp -59.38 -40.51 86.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.58 ' CE3' HD11 ' A' ' 175' ' ' ILE 0.277 11.1 p-90 -61.0 -39.68 90.63 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 116' ' ' LEU . 3.4 tm? -59.54 -39.53 72.3 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 114' ' ' LEU . 20.1 Cg_exo -59.85 -39.91 67.88 Favored 'Trans proline' 0 C--N 1.289 -2.566 0 C-N-CA 121.295 1.33 . . . . 0.0 113.227 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -85.51 172.96 10.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 120' ' ' LEU . 0.2 OUTLIER 161.07 -63.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.1 1 CA-C-N 108.36 -4.018 . . . . 0.0 109.86 -179.854 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' N ' HG22 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -60.05 -40.41 77.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.388 -177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' LEU . 72.1 Cg_exo -59.8 -39.69 70.31 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 123.453 2.768 . . . . 0.0 109.434 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 125' ' ' ILE . 19.7 t80 -59.46 -40.26 86.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 120' ' ' LEU . . . -60.61 -40.56 92.3 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 117.582 -1.647 . . . . 0.0 107.628 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 121' ' ' PRO . . . -60.76 -40.88 98.74 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.794 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 122' ' ' PHE . 5.5 pt -60.63 -39.41 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.15 86.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -40.29 82.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.447 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 p -60.25 -39.93 88.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.672 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.81 -39.7 85.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.9 m -59.72 -39.91 86.26 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.716 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 33.3 tp -140.19 97.85 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.708 0.29 . . . . 0.0 110.72 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.5 tp -168.36 -66.58 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.196 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 p -156.07 66.41 0.59 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.761 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 36.55 -116.14 0.12 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.674 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 67.15 89.99 0.09 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -81.68 -34.57 0.5 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.272 1.981 . . . . 0.0 114.502 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 137' ' ' LEU . 11.0 mp -65.05 -45.24 86.21 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.808 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 139' ' ' MET . 6.2 p -65.32 -45.11 94.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.325 0.584 . . . . 0.0 109.471 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.494 ' N ' ' CG1' ' A' ' 138' ' ' VAL . 4.6 ttt -65.17 -44.96 86.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tt -63.81 -45.01 91.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.127 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.416 ' O ' HD21 ' A' ' 177' ' ' LEU . 15.2 m -65.08 -43.82 90.92 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.43 ' CG ' ' O ' ' A' ' 138' ' ' VAL . 4.9 m-30 -65.06 -34.99 79.73 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.226 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.88 -45.41 80.39 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.537 -0.84 . . . . 0.0 114.072 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 144' ' ' LEU . 1.7 mp -65.62 -46.07 80.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 117.828 -1.549 . . . . 0.0 112.893 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.98 -45.63 86.5 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.46 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 147' ' ' ALA . 0.3 OUTLIER -65.43 -45.29 84.47 Favored 'General case' 0 C--O 1.224 -0.289 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -176.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' A' ' 146' ' ' MET . . . -65.13 -45.31 85.59 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -175.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 149' ' ' THR . 7.2 p -65.37 -45.22 93.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.681 HG22 ' HB2' ' A' ' 170' ' ' LYS . 82.7 p -65.29 -45.21 85.33 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL . 3.5 pt -62.31 -37.38 78.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.32 74.87 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.289 -1.365 . . . . 0.0 110.436 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB1' HD11 ' A' ' 167' ' ' LEU . . . -65.5 -45.55 83.16 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.56 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 150' ' ' ILE . 0.3 OUTLIER -65.47 -39.7 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -34.82 63.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.139 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -54.66 -34.85 62.84 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.645 0.26 . . . . 0.0 110.524 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 158' ' ' GLU . 1.2 ptt? -54.82 -39.59 68.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 156' ' ' MET . . . -29.01 -34.99 0.01 OUTLIER Glycine 0 N--CA 1.471 0.972 0 O-C-N 123.426 0.454 . . . . 0.0 112.068 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 156' ' ' MET . 55.6 mt-10 -109.63 -66.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 160' ' ' PHE . 24.7 mtpt -145.46 128.64 16.69 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.604 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 159' ' ' LYS . 1.2 m-85 -57.94 -161.56 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 162' ' ' LYS . 7.5 p -122.12 -23.35 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.302 -0.249 . . . . 0.0 111.61 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER 143.26 -65.44 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 164' ' ' ASN . . . -169.28 -45.65 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 163' ' ' ALA . 2.2 m120 52.96 117.32 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 122.831 1.301 . . . . 0.0 111.049 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' O ' HG13 ' A' ' 168' ' ' ILE . 1.8 t80 -57.73 -37.59 73.84 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.793 -2.003 . . . . 0.0 109.767 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.429 ' O ' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -57.64 -37.58 73.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.943 0.401 . . . . 0.0 111.731 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.622 HD11 ' HB1' ' A' ' 152' ' ' ALA . 7.9 mp -57.7 -37.25 73.16 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.776 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.543 ' CD1' ' NZ ' ' A' ' 83' ' ' LYS . 2.0 pp -57.3 -37.59 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.044 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 168' ' ' ILE . 60.0 mtm180 -57.95 -37.58 74.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.89 0.376 . . . . 0.0 110.597 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 149' ' ' THR . 1.3 ptmm? -57.63 -37.8 73.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.292 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 168' ' ' ILE . 1.6 p -60.42 -37.85 75.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.383 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 175' ' ' ILE . 5.8 p -62.22 -42.46 99.33 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -62.75 -42.61 99.66 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 118.423 -1.846 . . . . 0.0 115.851 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . . . -62.79 -42.84 99.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 117.257 -1.777 . . . . 0.0 112.674 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.58 HD11 ' CE3' ' A' ' 115' ' ' TRP . 7.1 tt -63.01 -43.02 98.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.475 HG13 ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -62.76 -42.79 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 118.06 -1.456 . . . . 0.0 112.845 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 176' ' ' VAL . 11.2 mp -62.63 -38.05 88.7 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.9 tt -57.79 -42.53 84.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -62.64 -42.45 99.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 117.992 -1.483 . . . . 0.0 111.106 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 180' ' ' LEU . 3.0 mm? -62.56 -42.36 99.5 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.29 99.3 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.462 ' CZ ' ' CG ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -62.22 -38.16 88.14 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.064 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -61.95 -42.01 98.63 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 109.968 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 36.74 -149.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.562 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 19.1 tp -144.25 67.58 1.27 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 8.3 m 53.13 62.19 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.499 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 190' ' ' LEU . 3.7 tm-20 -166.18 75.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.423 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.5 t -85.07 63.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 tp 65.24 21.57 12.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.445 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 187' ' ' GLU . 6.1 tp 46.5 44.19 12.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.445 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.35 -46.32 90.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.232 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.561 179.86 . . . . . . . . 0 0 . 1 stop_ save_